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Host recognition of intracellular bacterial pathogens results in the formation of a multiprotein complex 
termed the inflammasome, which leads to the recruitment and activation of inflammatory caspases. 
These caspases promote IL-1 family cytokine release and pyroptosis, a lytic form of cell death, which are 
critical for anti-bacterial defense. In mice, interferon-gamma (IFN-) is a potent inducer of the both the 
noncanonical and canonical inflammasomes. Specifically, a family of IFN-inducible GTPases known as 
guanylate binding proteins (GBPs) promote inflammasome responses to a variety of bacteria in mice. The 
functions of the mouse GBPs include stimulating the rupture of pathogen-containing vacuoles and 
bacteriolysis of cytosolic bacteria in order to release pathogen-derived products, such lipopolysaccharide 
(LPS), into the cytosol for downstream host sensing and inflammasome activation. In contrast to mice, 
which possess 11 GBPs, humans have 7 GBPs and their role in inflammasome activation in human 
macrophages is poorly understood. Here, we use Legionella pneumophila, a vacuolar intracellular gram-
negative bacterium, to elucidate the functions of human GBPs on inflammasome responses in 
macrophages. We determined that human GBP1 is essential for maximal inflammasome responses to L. 
pneumophila as well as is important for disrupting the L. pneumophila-containing vacuole (LCV) in order 
to make this vacuolar bacterium more accessible for cytosolic sensing. In addition, LPS can possess 
different acylation states within the same or different species of gram-negative bacteria. The 
noncanonical inflammasome mediates inflammatory responses to intracellular LPS and is comprised of 
caspase-11 in mice, and the two putative orthologs in humans, caspase-4 and caspase-5. While tetra-
acylated LPS variants evade caspase-11 detection, caspase-4 was found to be activated by a tetra-
acylated LPS variant. However, it is still unclear whether caspase-4 and caspase-5 recognize different LPS 
variants and whether their activation is promoted by IFN-. Here, we use primary or THP-1-derived 
macrophages and CRISPR/Cas9 technology to test human noncanonical inflammasome responses to 
LPS variants from different bacteria and whether IFN- and human GBPs promote these responses in 
macrophages. Our findings elucidate aspects of human innate immune response to gram-negative 
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ELUCIDATING HUMAN INFLAMMASOME RESPONSES TO  
LEGIONELLA PNEUMOPHILA AND LIPOPOLYSACCHARIDE VARIANTS 
  
Antonia R. Bass 
Sunny Shin 
 
Host recognition of intracellular bacterial pathogens results in the formation 
of a multiprotein complex termed the inflammasome, which leads to the 
recruitment and activation of inflammatory caspases. These caspases promote IL-
1 family cytokine release and pyroptosis, a lytic form of cell death, which are critical 
for anti-bacterial defense. In mice, interferon-gamma (IFN-g) is a potent inducer of 
the both the noncanonical and canonical inflammasomes. Specifically, a family of 
IFN-inducible GTPases known as guanylate binding proteins (GBPs) promote 
inflammasome responses to a variety of bacteria in mice. The functions of the 
mouse GBPs include stimulating the rupture of pathogen-containing vacuoles and 
bacteriolysis of cytosolic bacteria in order to release pathogen-derived products, 
such lipopolysaccharide (LPS), into the cytosol for downstream host sensing and 
inflammasome activation. In contrast to mice, which possess 11 GBPs, humans 
have 7 GBPs and their role in inflammasome activation in human macrophages is 
poorly understood. Here, we use Legionella pneumophila, a vacuolar intracellular 
gram-negative bacterium, to elucidate the functions of human GBPs on 
 viii 
inflammasome responses in macrophages. We determined that human GBP1 is 
essential for maximal inflammasome responses to L. pneumophila as well as is 
important for disrupting the L. pneumophila-containing vacuole (LCV) in order to 
make this vacuolar bacterium more accessible for cytosolic sensing. In addition, 
LPS can possess different acylation states within the same or different species of 
gram-negative bacteria. The noncanonical inflammasome mediates inflammatory 
responses to intracellular LPS and is comprised of caspase-11 in mice, and the 
two putative orthologs in humans, caspase-4 and caspase-5. While tetra-acylated 
LPS variants evade caspase-11 detection, caspase-4 was found to be activated 
by a tetra-acylated LPS variant. However, it is still unclear whether caspase-4 and 
caspase-5 recognize different LPS variants and whether their activation is 
promoted by IFN-g. Here, we use primary or THP-1-derived macrophages and 
CRISPR/Cas9 technology to test human noncanonical inflammasome responses 
to LPS variants from different bacteria and whether IFN-g and human GBPs 
promote these responses in macrophages. Our findings elucidate aspects of 
human innate immune response to gram-negative bacterial pathogens and may 
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CHAPTER 1: INTRODUCTION 
Microbial organisms are all around us; some microbes can benefit the host 
by providing either a commensalism or mutualism relationship, while other 
microbes, known as pathogens, can be detrimental to the host and cause disease. 
Mammalian organisms have several lines of defense in order to combat invading 
pathogens. The initial protection mechanisms are the skin and mucous 
membranes, which provide physical and chemical barriers by preventing entry of 
pathogens into the underlying tissues as well as trapping unwanted organisms and 
destruction of them by antimicrobial enzymes. However, when these primary 
defenses are damaged the pathogen can now take advantage and enter the body, 
which is when the next host defense mechanism takes over—nonspecific innate 
immunity. The innate immune response is the second line of defense against 
microbial pathogens and is essential for the clearance of these pathogens and host 
survival. An array of host factors are involved in initial responses to invading 
bacteria, viruses, parasites and fungi and lead to downstream events including the 
production of antimicrobial peptides, proinflammatory cytokines, interferon, and/or 
initiation of cell death pathways. Interplay between these pathways may promote 
a greater response to combat infection. Additionally, some bacteria are able to 
evade innate immune pathways by using effector molecules or by altering their 
morphology to be unrecognizable by host sensors. Here, we highlight the 
importance of innate immune responses to gram-negative bacterial pathogens and 
how interferon (IFN) can promote these responses.  
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1.1. Pattern recognitions receptors and their ligands 
In order to detect pathogenic microbes, the host relies on its germline-
encoded sensors termed pattern recognition receptors (PRRs) (Janeway, 1989). 
PRRs function in the surveillance of conserved microbial structures known as 
pathogen-associated molecular patterns (PAMPs) or endogenous danger signals 
released from dying cells called damage-associated molecular patterns (DAMPs) 
(Krakauer, 2019). Recognition of these PAMPs and DAMPs by PRRs leads to 
downstream signaling events including the release of proinflammatory cytokines 
and cell death. Upon secretion of cytokines, many different immune responses 
occur including the recruitment of additional immune cells to the site of infection 
for host defense and clearance of pathogens as well as the production of host 
proteins such as interferons and antimicrobial peptides. Furthermore, activation of 
PRRs can lead to cell death, ultimately eliminating the replicative niche for the 
pathogen.  
There are currently five main classes of PRRs: Toll-like receptors (TLRs), 
C-type lectin receptors (CLRs), nucleotide-binding oligomerization domain-like 
receptors (NLRs), retinoic acid-inducible gene I (RIG-I)-like receptors (RLRs), and 
absent in melanoma 2 (AIM2)-like receptors (ALRs) (Jang et al., 2015). Within 
each family of PRRs, there are subfamilies of the receptors that each recognize a 
specific ligand or signal. This allows the host to initiate an immune response to 
multiple pathogenic components or danger signals for maximal defense against 
invading pathogens.  
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The first family of PRRs that was discovered is the membrane bound TLR 
family. The Toll pathway was initially identified in a genetic screen for genes that 
are important for early embryonic development of Drosophila melanogaster 
(Hashimoto, Hudson, & Anderson, 1988). However, it was eventually found that 
Toll was also essential for immune response in Drosophila and that this pathway 
is conserved in mammals (Wasserman, 1993). There are 10 TLRs in humans 
(TLR1-10) and 12 TLRs in mice (TLR1-9, TLR11-13), and each TLR recognizes a 
different stimulus (Broz & Monack, 2013). TLR1-9 are present in both mice and 
humans, whereas TLR11-13 are only expressed in mice and TLR10 is only 
expressed in humans since it is a pseudogene in mice. The structure of TLRs 
consists of an N-terminal leucine-rich repeat (LRR) domain important for ligand 
sensing, a hydrophobic transmembrane domain, and a cytoplasmic C-terminal Toll 
IL-1 receptor (TIR) domain essential for signaling (Botos, Segal, & Davies, 2011). 
TLRs have been shown to localize to two different sites within a cell such as a 
macrophage. TLR1, TLR2, TLR4, TLR5, and TLR6 mainly localize to the plasma 
membrane, whereas TLR3, TLR7, TLR8, TLR9, TLR11, TLR12, and TLR13 
localize to endosomal compartments (Broz & Monack, 2013). Regardless of their 
location, TLR activation leads to recruitment of adaptor molecules to the TIR 
domain for signaling; these adaptor proteins include myeloid differentiation primary 
response 88 (MyD88) and TIR-domain-containing adaptor protein inducing IFN-b 
(TRIF) which predominantly signal through NFkB to upregulate proinflammatory 
cytokine production and through IRF3 to induce IFN production (O'Neill, Bryant, & 
Doyle, 2009). 
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As previously mentioned, each TLR recognizes one or more specific 
microbial ligands. For the TLRs that come into contact with bacterial components 
in the extracellular milieu, TLR1 recognizes bacterial triacyl lipopeptides, TLR2 
recognizes lipoproteins, peptidoglycan, and lipotechoic acid (LTA), TLR4 
recognizes the gram-negative bacterial outer membrane component 
lipopolysaccharide (LPS), TLR5 recognizes flagellin, and TLR6 recognizes LTA 
and diacyl lipopeptides (Broz & Monack, 2013). In general for TLRs that recognize 
their corresponding ligands in endosomal compartments, TLR3, TLR7, TLR8, and 
TLR9 recognize nucleic acids. Until recently, the location and ligand for human 
TLR10 was unknown; it was reported that TLR10 localizes to endosomes and its 
ligand is dsRNA, like TLR3, and that TLR10 negatively regulates TLR3 by 
competing for dsRNA binding and upregulating the TLR3 signaling inhibitor 
SARM1 (S. M. Lee et al., 2018). For the remaining mice endosome-localized TLRs, 
TLR11 recognizes flagellin and profilin, an actin-binding protein found in the 
parasite Toxoplasma gondii as well as Escherichia coli, TLR12 recognizes profilin, 
and TLR13 recognizes bacterial ribosomal RNA (Broz & Monack, 2013).  
In order for downstream TLR signaling to occur, TLR monomers must first 
bind to their cognate ligand. This binding results in conformational change and 
formation of a dimer between two ligand-binding domains of TLRs bringing the 
transmembrane and cytoplasmic TIR domains of the two TLRs into close proximity, 
which leads to initiation of the signaling cascade (Botos et al., 2011). TLRs may 
either homodimerize or heterodimerize, depending on the type of TLR. For 
instance, TLR1 and TLR2 heterodimerize to recognize triacylated lipopeptides, as 
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well as TLR2 and TLR6 heterodimerize to recognize diacylated lipopeptides 
(Oliveira-Nascimento, Massari, & Wetzler, 2012). Once dimerization occurs 
between two TLR monomers, conformational change allows the TIR domains to 
recruit TIR-domain-containing adaptors. The five TLR adaptors are MyD88, TRIF, 
MyD88-adaptor-like (MAL), TRIF-related adaptor molecule (TRAM), and sterile a- 
and armadillo-motif-containing protein (SARM) (O'Neill et al., 2009). MAL and 
TRAM are ‘linking adaptors’ where MAL recruits MyD88 and TRAM recruits TRIF 
to the TLR TIR domains; however, these additional adaptors are not always 
required for signaling. Specifically, only TLR1, TLR2, TLR4, and TLR6 recruit MAL 
which further recruits MyD88 for downstream NFkB signaling to produce 
proinflammatory cytokines (O'Neill et al., 2009). TLR4 also recruits TRAM which 
recruits TRIF for downstream IRF3 signaling for production of IFN-b or other IFN-
inducible genes; nevertheless, it was also found that TLR4-TRIF-dependent 
signaling also activates NFkB for proinflammatory cytokine production. TLR3 does 
not signal through MyD88, but it recruits TRIF for IRF3 and NFkB signaling. The 
remaining TLRs (TLR5, TLR7, TLR8, TLR9, TLR11, TLR12, TLR13) recruit MyD88 
for NFkB activation and, in the case of the endosome-localized TLRs, for IRF7 
activation to upregulate IFN-a and IFN-inducible genes. More studies need to 
address the role of TLR10, but it is thought that its function is to negatively regulate 
MyD88 and TRIF signaling (Jiang, Li, Hess, Guan, & Tapping, 2016). Distinctive 
from the other four TIR-domain-containing adaptors, SARM is the negative 
regulator of MyD88- and TRIF-dependent signaling (Carlsson, Ding, & Byrne, 
2016; Carty et al., 2006).  
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CLRs are another family of membrane-bound PRRs that have been 
implicated in immune responses to microbial pathogens. CLRs are predominantly 
expressed in myeloid cells and they possess at least one C-type lectin-like domain 
(CTLD), which is important for binding carbohydrates (mannose, fucose, and 
glucan) located on bacteria, viruses, parasites, and fungi (Brown, Willment, & 
Whitehead, 2018). Importantly, CLRs are essential for both innate and adaptive 
immunity by production of inflammatory mediators and phagocytosis followed by 
antigen presentation to T lymphocytes, respectively (Chiffoleau, 2018). Examples 
of CLRs involved in intracellular signaling pathways are Dectin-1, Dectin-2, and 
macrophage-inducible C-type lectin (Mincle). Dectin-1 directly signals using its 
immunoreceptor tyrosine-based activation motif (ITAM) found on the cytoplasmic 
end of the receptor, whereas Dectin-2 and Mincle indirectly signal by associating 
with an ITAM-containing adaptor (Hoving, Wilson, & Brown, 2014). ITAM further 
recruits Syk tyrosine kinase for downstream NFkB and mitogen-activated protein 
kinase (MAPK) signaling. These signaling events lead to cellular responses such 
as the production of proinflammatory cytokines or activation of the adaptive 
immune system via cross-presentation.  
Some microbial pathogens are uptaken by a host cell through phagocytosis 
or receptor-mediated endocytosis, resulting in a vacuole-enclosed pathogen. The 
goal of the host cell is to destroy these phagosomes or endocytosed pathogens by 
lysosomal degradation. However, pathogens such as bacteria have quickly 
learned to evade these destructive pathways by using effector molecules either to 
escape the phagosome and survive in the cytosol or to live within the phagosome 
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by remodeling their vacuole. In addition, viruses have evolved to hijack the host 
cell’s endocytic machinery to invade the cell and initiate its replication. In response, 
host cells developed additional immune defenses within the cytosol that recognize 
PAMPs and DAMPs, similar to extracellular TLRs and CLRs. These cytosolic 
PRRs are the NLRs, RLRs, and ALRs and are essential for controlling intracellular 
infections and promoting host survival.  
NLRs are a family of intracellular PRRs that initiate immune responses to 
pathogenic microbes and cellular stress signals. All NLR proteins have 3 domains: 
an N-terminal effector domain, a central NACHT nucleotide-binding and 
oligomerization domain, and a C-terminal LRR domain (Y. K. Kim, Shin, & Nahm, 
2016). There are four subfamilies of NLRs based on the structure of the N-
terminus, which are the NLRA, NLRB, NLRC, and NLRP subfamilies. The NLRA 
subfamily has only one member known as MHC-II transactivator (CIITA), which 
possesses an N-terminal acidic transactivation domain and its function is to 
regulate the expression of MHC genes. The NLRB subfamily has one member in 
humans called the NLR Family Apoptosis Inhibitor Protein (NAIP), whereas mice 
have seven NAIPs (NAIP1-7) and they all contain three N-terminal baculoviral 
inhibition of apoptosis repeat (BIR)-like domains. The NLRC subfamily has six 
members, three of which have at least one caspase activation and recruitment 
domain (CARD) at the amino-terminus (NOD1, NOD2, NLRC4), whereas the 
remaining three members have an N-terminal domain that is still unknown but are 
placed in this subfamily due to their homology with the CARD-containing NLRC 
proteins (NLRC3, NLRC5, NLRX1). The largest NLR subfamily is the NLRP 
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subfamily containing 14 members which all have an N-terminal pyrin domain (PYD) 
(NLRP1-14). In general, NLRs are activated upon the binding of cytosolic ligands 
by the LRR domain, which leads to a conformational change and release of the 
NLR from its autoinhibitory state. Subsequently, the NACHT domain undergoes 
oligomerization, which forms an N-terminal scaffold for adaptor proteins followed 
by effectors to bind. Activation of these NLRs lead to immune responses including 
inflammasome formation, NFkB and MAPK signaling, and autophagy (Y. K. Kim 
et al., 2016). 
Different NLRs are activated in response to various stimuli such as bacterial 
flagellin, lethal toxins, and even cell stress responses (i.e. reactive oxygen species 
(ROS)). These specific ligands lead to the activation of NLRs involved in the 
formation of inflammasomes, which are cytosolic multimeric protein complexes 
that promote cell death and proinflammatory cytokine release. Some of the NLRs 
involved in inflammasome formation include NAIP, NLRC4, NLRP1, and NLRP3 
and will be discussed in detail in the ‘canonical inflammasome responses to 
bacterial components’ section.   
RLRs are another family of intracellular PRRs that predominantly recognize 
viral RNA. There are three members within the RLR family: RIG-I, MDA5 
(melanoma differentiation-associated 5), and LGB2 (laboratory of genetics and 
physiology 2) (Rehwinkel & Gack, 2020). All three members of the RLR family are 
comprised of a central helical domain followed by a carboxy-terminal domain, both 
of which are essential for RNA detection (Rehwinkel & Gack, 2020). RIG-I and 
MDA5 also contain two CARDs at their amino-terminus for signaling transduction, 
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while LGB2 does not possess these domains and is thought to regulate RIG-I and 
MDA5. Upon the sensing of viral RNA by RIG-I and MDA5, conformational change 
results in exposure of their CARDs for interaction with the adaptor mitochondrial 
antiviral-signaling protein (MAVS) and leads to NFkB activation for type I IFN 
production. Although RLRs detect nucleic acids derived from viruses, another 
identified PRR family recognizes nucleic acids from both viruses and bacteria and 
is known as the ALR family. 
The ALR family is the third known family of intracellular PRRs and are 
important for detecting cytosolic-exposed bacterial and viral DNA. The two 
members of the ALR family are AIM2 and interferon-inducible protein 16 (IFI16). 
Their structure is comprised of an N-terminal PYD domain followed by a C-terminal 
DNA sensing domain known as the 200-amino-acid domain (HIN) (Liao et al., 
2011). AIM2 consists of only one HIN-200 domain, while IFI16 contains two 
domains: HIN-A and HIN-B (Liao et al., 2011). AIM2 interaction with bacterial or 
viral DNA results in recruitment of the adaptor ASC via PYD-PYD interactions 
followed by caspase-1 recruitment and activation (Hornung et al., 2009; Rathinam 
et al., 2010). Caspase-1 activation results in inflammasome responses involving 
the maturation and release of IL-1 family cytokines and cell death. In contrast, 
IFI16 recruits the adaptor stimulator of interferon genes (STING) for IFN-b 
production to combat viral infections (Unterholzner et al., 2010). In addition, studies 
in murine macrophages showed that IFI204, the murine ortholog of IFI16, mediates 
IFN-b production in response to DNA from intracellular bacterial infections (Storek, 
Gertsvolf, Ohlson, & Monack, 2015; Unterholzner et al., 2010). Interestingly, IFI16 
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is not only important for IFN-b induction, but has also been found to interact with 
ASC and caspase-1 to initiate inflammasome responses to viral DNA infections as 
well (Kerur et al., 2011; Monroe et al., 2014). Therefore, AIM2 and IFI16 are 
considered to be the two inflammasome sensor proteins of the ALR family.  
 
1.2. Canonical inflammasome responses to bacterial components  
Upon recognition of intracellular bacterial pathogens, the host initiates the 
formation of a multimeric protein complex termed the inflammasome. In order for 
inflammasome activation to occur, a cytosolic sensor protein detects pathogen 
components or cellular stress signals and recruits an adaptor protein followed by 
the inactive cysteine protease, caspase-1 (CASP1). CASP1 undergoes 
oligomerization and autoproteolysis into its mature form which goes on to cleave 
IL-1b and IL-18 for their release from the cell. CASP1 also cleaves the cytosolic 
protein gasdermin-D (GSDMD), which is known as the initiator protein for inducing 
pyroptosis, a lytic form of cell death. GSDMD is made of an N-terminal and C-
terminal fragment and upon its cleavage by CASP1, the GSDMD N-terminal 
fragment translocates to the plasma membrane and oligomerizes to form a pore, 
allowing release of cellular components and rupture of the cell through osmotic 
influx. Thus, host cell death and proinflammatory cytokine release are key 
indicators of inflammasome response to microbial infections.  
The CASP1-containing inflammasomes are understood to be known as the 
canonical inflammasomes. There are six identified canonical inflammasomes: the 
NLRP1 inflammasome, the NLRP3 inflammasome, the NLRC4 inflammasome, the 
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AIM2 inflammasome, the IFI16 inflammasome, and the Pyrin inflammasome. 
Although inflammasome responses can be activated in response to bacterial, viral, 
parasitic, and fungal pathogens, here only inflammasome responses to bacterial 
components will be discussed.  
The NLRP1 inflammasome is activated by different ligands in humans and 
mice, although both engage in similar mechanism for downstream activation of the 
cysteine protease caspase-1. The murine ortholog to human NLRP1 is NLRP1b 
and it initiates an immune response upon sensing the enzymatic activity of lethal 
toxin from Bacillus anthracis and also recently determined upon the direct N-
terminal ubiquitination by E3 ubiquitin ligase IpaH7.8 encoded by Shigella flexneri 
(Sandstrom et al., 2019). The ligand of human NLRP1 is muramyl dipeptide (MDP), 
a bacterial cell wall component (Faustin et al., 2007). Both NLRP1 and NLRP1b 
have a C-terminal function-to-find domain (FIIND) followed by CARD. The 
mechanism of the NLRP1 inflammasome activation involves initial autoproteolysis 
of the FIIND which results in two fragments that are noncovalently linked and is 
essential for NLRP1 inflammasome activity (D'Osualdo et al., 2011; Finger et al., 
2012; Frew, Joag, & Mogridge, 2012). NLRP1 is subsequently activated by its 
respective ligands which result in cleavage and ubiquitination of the N-terminal 
NLRP1 fragment followed by its proteasomal degradation and release of the C-
terminal fragment, which contains the FIIND C-terminal portion and the CARD. 
This leads to the self-assembly of the C-terminal fragment, which recruits caspase-
1 to form the inflammasome complex. Some studies showed that the adaptor 
molecule apoptosis-associated speck-like protein containing a CARD (ASC) is 
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necessary for NLRP1 inflammasome activation by forming ASC dimers via their 
PYD-PYD interactions and their free CARD domains mediate CARD-CARD 
interactions between the NLRP1 CARD and caspase-1 CARD (Finger et al., 2012), 
while others say that ASC is not required but enhances the NLRP1 inflammasome 
response (Faustin et al., 2007).  
The NLRP3 inflammasome is one of the most studied inflammasomes. In 
order for this inflammasome activation to occur, two signaling events must happen: 
a priming signal and activation signal (Kelley, Jeltema, Duan, & He, 2019). A 
priming signal can include TLR ligands or endogenous cytokines including tumor 
necrosis factor alpha (TNFa) and interleukin 1 beta (IL-1b). The purpose of priming 
is to signal through NFkB to upregulate the expression of the NLRP3 protein and 
pro-IL-1b. Additionally, priming induces post-translational modifications such as 
phosphorylation and deubiquitylation important for regulating NLRP3 
inflammasome activation (Yang, Liu, & Xiao, 2017). The NLRP3 activation signal 
involves detection of cellular stress that is induced by diverse stimuli, rather than 
direct binding of ligands as other inflammasomes do. These diverse stimuli include 
bacterial and fungal toxins, viral DNA and RNA, ATP, nigericin, and alum (Kelley 
et al., 2019). Upon these stimuli entering the host cell, they can cause different cell 
stress responses including ion imbalances like potassium (K+) efflux, production of 
ROS, and lysosomal disruption. All of these cellular events result in activation of 
the NLRP3 inflammasome, which is then able to oligomerize through its NACHT 
domain and recruit the adaptor ASC to its N-terminal PYD. Recruitment of ASC 
leads to the formation of ASC filaments into a single helical structure known as an 
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ASC speck. Following speck formation, caspase-1 is recruited to ASC through 
homotypic CARD-CARD interactions, leading to cleavage and maturation of 
caspase-1 into its active p20 and p10 subunits, which form a heterotetramer that 
cleaves IL-18 and IL-1b. Although the NLRP3 inflammasome has been studied 
extensively, there are still many unknowns about how it becomes activated since 
it doesn’t directly bind to a ligand. Recent studies identified a member of the 
mammalian NIMA-related kinase family known as NEK7 to be essential for 
mediating NLRP3 inflammasome assembly and activation (He, Zeng, Yang, Motro, 
& Nunez, 2016; Schmid-Burgk et al., 2016). It is possible that NEK7 is the 
upstream sensor of NLRP3 and directly senses the cellular stress responses 
followed by binding to NLRP3 and facilitating its oligomerization. NEK7 and NLRP3 
interaction contributes to promoting pyroptosis in inflammatory bowel disease, thus 
NEK7 could be a potential therapeutic target for inflammatory disorders or other 
NLRP3-asssociated diseases (X. Chen et al., 2019; G. Liu, Chen, Wang, & Yuan, 
2020).  
 The inflammasome containing NLRC4 is unique in that NLRC4 is not the 
sensor NLR. Instead, NAIP is the sensor NLR and recognizes flagellin as well as 
the type III secretion system (T3SS) components, the inner rod and needle 
proteins. Specifically, for the murine NAIPs, NAIP1 recognizes the T3SS needle, 
NAIP2 recognizes the T3SS inner rod, and NAIP5/6 recognize flagellin through 
their NACHT domains (Franchi et al., 2006; Kofoed & Vance, 2011; Miao et al., 
2006; Yang, Zhao, Shi, & Shao, 2013; Zhao et al., 2011). In contrast, human NAIP 
acts broadly and recognizes all three of these bacterial ligands, indicating that mice 
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and human NAIPs function differently (Grandjean et al., 2017; Kortmann, 
Brubaker, & Monack, 2015; Reyes Ruiz et al., 2017; J. Yang et al., 2013). Based 
on cryo-EM structures, a single NAIP recruits NLRC4 and promotes the 
polymerization of NLRC4 to form a ring-like structure (Tenthorey et al., 2017; 
Zhang et al., 2015). NLRC4 interacts with caspase-1 directly via CARD-CARD 
interactions; however, it is thought that the adaptor ASC may also be recruited to 
stabilize the CARD-CARD interactions between NLRC4 and caspase-1, thus 
enhancing inflammasome activation. The NAIP/NLRC4 inflammasome mounts 
immune defense against a variety of bacterial pathogens such as Salmonella 
enterica serovar Typhimurium, Pseudomonas aeruginosa, and Legionella 
pneumophila. Although L. pneumophila does not have a T3SS, it has a type 4 
secretion system (T4SS) and flagellin, so it is thought that L. pneumophila 
activates the NAIP/NLRC4 inflammasome by inadvertently translocating flagellin 
through the T4SS into the cytosol.  
It is known that different inflammasomes form their own macromolecular 
complex in response to a specific ligand or signal. However, during a normal 
infection, multiple ligands can be released into the cytosol and various endogenous 
danger signals can be present within a host cell. Therefore, multiple different 
inflammasomes may be activated within the same cell in order to generate a 
greater host response to clear pathogens. Interestingly, one study found that, 
during infection with S. Typhimurium, the NLRC4 and NLRP3 inflammasomes are 
both recruited to the same macromolecular complex which contains ASC, 
caspase-1, as well as caspase-8 (Man et al., 2014). This shows two novel 
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mechanisms of inflammasome activation: the first being that two different 
inflammasome proteins are recruited to the same complex and the second that 
caspase-8 can also be recruited to the ASC speck. Additional studies determined 
that caspase-8 can be recruited to the NLRC4 inflammasome independent of 
caspase-1, but dependent on ASC, thus triggering an alternative pathway when 
caspase-1 is absent (Kumar, Radha, & Swarup, 2010; B. L. Lee, K. M. Mirrashidi, 
et al., 2018; Man et al., 2013; Mascarenhas et al., 2017; Rauch et al., 2017). 
Caspase-8 interaction with ASC PYD is facilitated by its death effector domain 
(DED) (Vajjhala et al., 2015). Caspase-8 has classically been known to be initiator 
caspase for apoptosis; however, these findings reveal that caspase-8 has a wide-
range of functions in different immune pathways. 
The AIM2 inflammasome is activated upon direct binding to double stranded 
DNA (dsDNA) followed by recruitment of ASC and caspase-1. Studies using 
macrophages from AIM2-knockout mice or gene silencing of murine macrophages 
by siRNA revealed that AIM2 is activated by a variety of bacteria including 
Mycobacterium tuberculosis, Mycobacterium bovis, Francisella tularensis, and 
Legionella pneumophila (Fernandes-Alnemri et al., 2010; Ge, Gong, Xu, & Shao, 
2012; Rathinam et al., 2010; Saiga et al., 2012; Y. Yang et al., 2013). Infection with 
these bacteria in AIM2-deficient or silenced murine macrophages resulted in 
decreased caspase-1 activation and IL-1b or IL-18 release compared to wild-type 
or untreated macrophages, indicating AIM2 is crucial for promoting inflammasome 
response. Furthermore, there are additional bacterial pathogens that activate both 
the AIM2 and NLRP3 inflammasomes in parallel to produce robust caspase-1 
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activation and IL-1b production; these bacteria include Brucella abortus, Listeria 
monocytogenes, and Porphyromonas gingivalis (Gomes et al., 2013; S. Kim et al., 
2010; E. Park et al., 2014). Therefore, it is most likely that multiple inflammasomes 
are needed to control many other bacterial infections as well due to the presence 
of various bacterial components that serve as ligands for different inflammasomes 
and the triggering of cellular stress which typically results in NLRP3 inflammasome 
activation. 
Similar to the AIM2 inflammasome, the IFI16 inflammasome recognizes 
genomic DNA as it is also within the ALR family. IFI16 was initially found to induce 
IFN-b in a STING-dependent manner in response to viral DNA (Unterholzner et al., 
2010). Later, studies involving gene silencing of IFI16 or its murine ortholog IFI204 
in human or murine macrophages, respectively, revealed that they had decreased 
IFN-b production compared to control-treated macrophages during infection with 
intracellular bacteria including L. monocytogenes, Francisella novicida, and M. 
bovis (Chunfa et al., 2017; Hansen et al., 2014; Storek et al., 2015). Thus, IFI16 
can recognize both viral and bacterial DNA to induce a type I IFN response. 
Intriguingly, another study found that IFI204/IFI16 was important for killing of the 
extracellular bacteria, Staphylococcus aureus, by enhancing bactericidal activity 
which is a novel finding of a DNA sensor (W. Chen et al., 2019). Although there 
are no reports of IFI16 involvement in caspase-1-dependent inflammasome 
activation in response to bacteria, there are findings that show IFI16 
inflammasome responses to viral infections that are dependent on ASC and 
caspase-1 (Ansari et al., 2015; Ansari et al., 2013; Kerur et al., 2011). This IFI16 
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inflammasome is initiated upon the binding of IFI16 to viral DNA in the nucleus, 
followed by formation of the ASC-caspase-1 inflammasome which is translocated 
into the cytoplasm for inflammasome activity.  
The pyrin inflammasome is indirectly activated upon detection of the 
inactivation of the Rho-GTPase, RhoA. Pyrin is composed of an N-terminal PYD, 
followed by a B-box and coiled-coil domain (Heilig & Broz, 2018). Human pyrin 
possesses a C-terminal B30.2 domain, which is absent in mice (Broz & Dixit, 
2016). RhoA activates protein kinase 1 (PKN1) and 2 (PKN2) for their 
phosphorylation of the N-terminal part of pyrin, leading to the binding of 14-3-3 
proteins at these phosphorylation sites in order to inhibit pyrin inflammasome 
activation (Y. H. Park, Wood, Kastner, & Chae, 2016). However, bacterial toxins 
target and inactivate RhoA, resulting in inactivation of PKN1 and PKN2 and loss 
of the interaction between pyrin and 14-3-3 proteins (Xu et al., 2014). This releases 
pyrin from its inhibited state and allows for inflammasome activation, which 
involves the recruitment of ASC followed by caspase-1 recruitment and activation. 
 
1.3. Noncanonical inflammasome responses to gram-negative bacteria 
Recently, an alternative mechanism of inflammasome activation, that does 
not directly recruit caspase-1, in response to gram-negative bacteria was 
discovered and is termed the noncanonical inflammasome. The noncanonical 
inflammasome is comprised of caspase-11 in mice and the two putative 
orthologous, caspase-4 and caspase-5 in humans (Vigano & Mortellaro, 2013). 
Caspase-11, caspase-4, and caspase-5 all possess N-terminal CARD domains 
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followed by large (p20) and small (p10) catalytic subunits (B. L. Lee, I. B. Stowe, 
et al., 2018). All of these inflammatory caspases bind to intracellular LPS through 
their CARD domains, which leads to the oligomerization and activation of caspase-
11 and caspase-4 (Shi et al., 2014). Although caspase-5 was shown to bind to 
LPS, it is unclear whether it oligomerizes and additional studies on the mechanism 
of caspase-5 function in response to gram-negative bacterial infections are 
needed. Studies in murine macrophages showed that the caspase-11 
noncanonical inflammasome is activated during infection with a number of gram-
negative bacteria including L. pneumophila, Escherichia coli, and S. Typhimurium 
(Aachoui et al., 2013; Broz et al., 2012; Case et al., 2013; Casson et al., 2013; 
Kayagaki et al., 2011). Human caspase-4 also induces inflammasome activation 
in response to L. pneumophila, S. Typhimurium, Yersinia pseudotuberculosis, 
Francisella novicida, and E. coli in macrophages (Casson et al., 2015; Goddard et 
al., 2019; Lagrange et al., 2018). In addition, murine and human epithelial cells 
induce noncanonical inflammasome responses to Burkholderia pseudomallei, 
Burkholderia thailandensis, and S. Typhimurium (Holly et al., 2020; Knodler et al., 
2014; Srisaowakarn, Pudla, Ponpuak, & Utaisincharoen, 2020; Wang et al., 2018). 
Thus, the noncanonical inflammasome can be activated in different cell types. 
Although there has been very little investigation focused on caspase-5, 
there are a couple of studies that found interesting results in human monocytes 
that were treated with LPS or infected with Pseudomonas aeruginosa membrane 
vesicles (Bitto et al., 2018; Vigano et al., 2015). In one study, primary human 
monocytes were treated with extracellular LPS, which led to the secretion of IL-1a 
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and IL-1b in a caspase-4- and caspase-5-dependent manner (Vigano et al., 2015). 
Intriguingly, only caspase-5 underwent processing in response to LPS 
internalization, whereas caspase-4 was left uncleaved. These findings may 
suggest that caspase-5 is differentially expressed in monocytes compared with 
macrophages and may be a reason of why caspase-5 can stimulate this one-step 
noncanonical inflammasome response to LPS. The other study found that only 
caspase-5 is activated in response to P. aeruginosa outer membrane vesicles 
(OMVs), which enter the monocytes via endocytosis (Bitto et al., 2018). In contrast, 
caspase-4 was activated upon transfection of P. aeruginosa LPS. These results 
indicate that caspase-4 and caspase-5 are differentially activated by LPS 
depending on the form of LPS as well as its mechanism of entry into the cell. 
Therefore, both of these caspase-5 studies highlight that extracellular treatment of 
LPS or OMVs result in caspase-5 activation, suggesting that caspase-5 responds 
to endocytosed vesicles containing LPS, rather than sensing LPS that is forcibly 
introduced into the cell.  
TLR4 was initially believed to be the sole LPS sensor, which recognizes 
extracellular LPS through a defined mechanism involving an array of proteins that 
present LPS directly to membrane-bound TLR4 (B. S. Park & Lee, 2013; Poltorak 
et al., 1998; Takeuchi et al., 1999). Excessive LPS stimulation of cells leads to 
endotoxic shock or sepsis. Two studies found that intracellular LPS can induce 
endotoxic shock independent of TLR4 (Hagar, Powell, Aachoui, Ernst, & Miao, 
2013; Kayagaki et al., 2013). These studies identified caspase-11 as the 
noncanonical inflammasome that responds to transfected LPS from different gram-
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negative bacteria including F. novicida, Yersinia pestis, and E. coli. Importantly, 
the caspase-11 noncanonical inflammasome as well as caspase-1-dependent 
inflammasomes require two signals for optimal inflammasome response to 
bacterial pathogens: the priming signal for upregulation of inflammasome proteins 
and proinflammatory cytokines and an activation signal involving recognition of 
bacterial components or cell stress by a sensor protein (Kayagaki et al., 2011; 
Mariathasan, 2007). In agreement with this general rule, these two studies found 
that LPS-induced lethal sepsis occurred only when wild-type (WT) mice were first 
primed with a TLR agonist followed by LPS challenge, whereas WT mice treated 
with either the TLR agonist or LPS alone did not trigger lethality. Furthermore, 
using these conditions, they showed that caspase-11 knockout (Casp11-/-) mice 
were rescued from LPS lethality, whereas TLR4 knockout (TLR4-/-) mice 
succumbed to the lethal dose of LPS; thus, these data conclude that caspase-11 
is the alternative mechanism of LPS sensing within the cytosol (Kayagaki et al., 
2013).  
In addition to TLR4, it was also previously thought that caspase-1, originally 
known as the IL-1b converting enzyme (ICE), was important for inducing LPS-
induced endotoxic shock in mice (Kuida et al., 1995; Li et al., 1995). However, 
these published studies generated caspase-1 knockout (Casp1-/-) mice using 129 
mouse strain embryonic stem cells, which have been found to produce an 
inactivating passenger mutation of caspase-11 upon the targeting of ICE using 
homologous recombination (Kenneth et al., 2012). Therefore, due to the close 
proximity of caspase-1 and caspase-11, these generated Casp1-/- mice are 
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actually deficient in both caspase-1 and caspase-11. In order to address this 
concern, one study generated Casp11-/- C57BL/6 mice, caspase-1 and caspase-
11 double knockout (Casp1/11-/-) C57BL/6 mice, and Casp1-/- C57BL/6 mice by 
injecting the caspase-11 transgene into Casp1/11-/- embryos (Kayagaki et al., 
2011). These mice helped to distinguish the roles of caspase-1 and caspase-11 
during infection of gram-negative bacteria or stimulation with canonical activators 
such as ATP. This study concluded that canonical stimuli did not activate caspase-
11, however non-canonical stimuli such as LPS and gram-negative bacteria led to 
caspase-11 inflammasome activation as well as caspase-1 inflammasome 
activation that was dependent on NLRP3 and ASC, but caspase-11 processing 
and cell death was not dependent on NLRP3 and ASC. Therefore, caspase-11 is 
upstream of caspase-1. Finally, they also found that caspase-11 deficiency, but 
not caspase-1 deficiency, protected mice from LPS-induced endotoxic shock.  
Since the NLRP3 and ASC proteins were required for inducing a caspase-
1-dependent inflammasome response to non-canonical stimuli and that caspase-
11 is upstream of caspase-1, it was unclear what the link was connecting caspase-
11 activation to downstream NLRP3 inflammasome activation (Kayagaki et al., 
2011). Activation of caspase-11 upon infection with various gram-negative bacteria 
leads to downstream pyroptosis, a lytic form of cell death, and release of IL-1 family 
cytokines (Hagar et al., 2013; Kayagaki et al., 2011; Kayagaki et al., 2013). 
However, the mechanism involving pyroptosis initiation was largely unknown. It 
was discovered that a 53 kDa protein known as gasdermin-D (GSDMD) was 
essential for inducing noncanonical inflammasome signaling as GSDMD knockout 
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(GSDMD-/-) murine macrophages had decreased cell death and IL-1b release and 
looked similar to Casp11-/- macrophages (Kayagaki et al., 2015). Specifically, this 
study found that caspase-11 cleaves GSDMD, which results in a p30 pro-
pyroptotic N-terminal fragment that also induces NLRP3-dependent caspase-1 
activation. Following this breakthrough finding, additional studies determined that 
the GSDMD N-terminal fragment binds to the plasma membrane to form a circular 
pore, which results in loss of membrane integrity and osmotic lysis of the cell 
(Aglietti et al., 2016; Sborgi et al., 2016). The GSDMD pore also disrupts ionic 
gradients and can lead to potassium (K+) efflux, which is a trigger of the NLRP3 
inflammasome. This idea was confirmed in a study that showed caspase-11 
activated NLRP3 inflammasome by stimulating K+ efflux (Ruhl & Broz, 2015). 
Thus, this provides a model in which intracellular LPS activates caspase-11 to 
cleave GSDMD, resulting in its N-terminal fragment to oligomerize and form a pore 
in the plasma membrane, which induces pyroptosis as well as K+ efflux for NLRP3-
ASC-caspase-1 inflammasome activation. This process is now well known as the 
noncanonical NLRP3 inflammasome, which is essential for IL-1 cytokine release 
due to the cleavage and activation of caspase-1.  
Most of these noncanonical inflammasome studies regarding GSDMD and 
downstream NLRP3 inflammasome have been conducted using mice or murine 
macrophages, however there are studies that investigated the human 
noncanonical inflammasome involved in these processes as well. Caspase-4 and 
caspase-5 mediate downstream NLRP3 inflammasome activation upon the 
recognition of intracellular LPS (Baker et al., 2015; Schmid-Burgk et al., 2015). 
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Furthermore, all of the murine and human inflammatory caspases (caspase-1, 
caspase-11, caspase-4, and caspase-5) were found to cleave GSDMD, which is 
crucial for induction of pyroptosis (Shi et al., 2015). Therefore, downstream NLRP3 
inflammasome activation by caspase-11/4/5 results in caspase-1-mediated 
maturation of IL-1 family cytokines as well as cleavage of GSDMD, which further 
promotes pyroptosis of the infected cell.  
Intriguingly, the noncanonical inflammasome has been shown to respond 
to other stimuli in addition to LPS. Caspase-4 is activated by the Shiga toxin 2 
(Stx2)/LPS complex derived from pathogenic E. coli and caspase-11 detects 
lipophosphoglycan (LPG) from Leishmania parasites (de Carvalho et al., 2019; 
Platnich et al., 2018). In addition, the caspase-4 study also determined that 
caspase-4-dependent GSDMD cleavage leads to N-terminal GSDMD fragment 
enriched at the mitochondria, which resulted in mitochondrial ROS production for 
NLRP3 inflammasome activation (Platnich et al., 2018). These data indicate that 
GSDMD can activate the NLRP3 inflammasome in multiple ways including 
induction of K+ efflux and ROS production.  
 
1.4. Type I and II Interferon signaling 
Interferons (IFNs) are cytokines that are classically known for their ability to 
induce an antiviral gene program in response to viral infections. IFNs were named 
so due to their ability to “interfere” with viral replication, resulting in host defense 
against viruses (Isaacs & Lindenmann, 1957). There are three main classes within 
the IFN family: type I, type II, and type III IFNs. Together, they induce the 
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expression of hundreds of IFN stimulated genes (ISGs) (Platanias, 2005; Stanifer, 
Pervolaraki, & Boulant, 2019). 
Type I IFNs are produced by almost all cell types and are comprised of eight 
different types: 13 subtypes of IFN-a (alpha), IFN-b (beta), IFN-d (delta), IFN-e 
(epsilon), IFN-k (kappa), IFN-w (omega), IFN-z (zeta), and IFN-t (tau) (Platanias, 
2005). All of the type I IFNs signal through the type I interferon receptor also known 
as IFN a/b receptor (IFNAR), which is comprised of two subunits: IFNAR1 and 
IFNAR2. Upon binding to type I IFNs, the cytoplasmic end of IFNAR1/2 interact 
with the Janus activated kinase (JAK) family members, JAK1 and TYK2, leading 
to the phosphorylation of STAT1 and STAT2 for complex formation with IFN-
regulatory factor 9 (IRF9). The following STAT1-STAT2-IRF9 complex binds to the 
IFN-stimulated response element (ISRE) for transcription of hundreds of IFN-
stimulated genes. Although type I IFNs were primarily thought to control viral 
infections, type I IFNs have been shown to promote host defense against bacteria 
and parasites as well (Boxx & Cheng, 2016; Silva-Barrios & Stager, 2017).   
Similar to the type I IFN signaling pathway, type II IFN also signals through 
the JAK-STAT pathway and is essential for controlling bacterial and parasitic 
infections in addition to viral infections (Czarniecki & Sonnenfeld, 1993; Lykens et 
al., 2010; Platanias, 2005). In contrast to type I IFNs, type II IFNs consist of only 
one type, IFN-g, which are primarily produced by NK cells, activated T cells, and 
macrophages. IFN-g binding to its receptor made up of IFN gamma receptor 1 
(IFNGR1) and IFN gamma receptor 2 (IFNGR2) leads to JAK1 and JAK2 
association, followed by phosphorylation of STAT1 and production of STAT1-
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STAT1 homodimers, which bind to the IFN-g activated site (GAS) for gene 
transcription. Type I IFN signaling can also lead to STAT1 homodimers for GAS 
gene activation. Therefore, type I IFNs can upregulate different genes depending 
on the combination of STAT complexes for binding either GAS, ISRE, or both.  
Type III IFNs are a new class of IFNs and are known as IFN-ls (lambdas) 
(Stanifer et al., 2019). They have four family members including IFN-l1, IFN-l2, 
IFN-l3, and IFN-l4 that signal through a heterodimeric receptor IFNLR1 and IL-
10R2 that undergoes JAK-STAT signaling similar to type I IFN signaling through 
GAS and ISRE elements, however their function is restricted to epithelial cells 
(Stanifer et al., 2019). These IFNs also protect epithelial barriers from bacterial 
immunity, further highlighting that type I, II, and III IFNs are essential for host 
defense against bacterial infections (Odendall, Voak, & Kagan, 2017).       
 
1.5. Interferon-inducible GTPases: Guanylate binding proteins 
As it was previously mentioned, type I and II IFNs upregulate a vast 
repertoire of genes in response to viruses, bacteria, and parasites. Among the 
most notable family of ISGs are the IFN-inducible GTPase superfamily, which 
includes the 65-73 kDa guanylate binding proteins (GBPs), 21-47 kDa immunity 
related GTPases (IRGs), 72-82 kDa myxoma (Mx) resistance proteins, and 200-
285 kDa very large inducible GTPases (B. H. Kim, Shenoy, Kumar, Bradfield, & 
MacMicking, 2012). Specifically, GBPs and IRGs are the two subfamilies involved 
in cell-autonomous immune responses against intracellular bacterial pathogens.  
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GBPs are upregulated by type I and II IFNs, however they are more robustly 
induced by the type II IFN, IFN-g (Man, Place, Kuriakose, & Kanneganti, 2017). 
Mice possess 11 GBPs and 2 pseudogenes located on chromosomes 3 and 5. 
Mouse chromosome 3 contains Gbp1, Gbp2, Gbp3, Gbp5, Gbp7, and one 
pseudogene, while chromosome 5 has Gbp4, Gbp6, Gbp8, Gbp9, Gbp10, Gbp11, 
and the second pseudogene (Olszewski, Gray, & Vestal, 2006). In contrast, 
humans only have seven GBPs located on chromosome 1. Structural and 
biochemical analysis revealed that GBPs are part of the dynamin superfamily and 
therefore undergo nucleotide-dependent oligomerization and GTPase activity 
(Vestal & Jeyaratnam, 2011). Based on the structure of human GBP1, all GBPs 
are comprised of an N-terminal globular large G domain, which is important for 
nucleotide binding and GTPase effector activity, followed by an a-helical C-
terminal domain (Prakash, Praefcke, Renault, Wittinghofer, & Herrmann, 2000). 
The N-terminal LG domain is connected by the C-terminal domain by an 
intermediate region made up of an a-helical domain and two b-sheets.   
The C-terminal amphipathic a helices mediate protein-protein and protein-
lipid interactions (B. H. Kim et al., 2012). In addition, human and mouse GBP1, 
GBP2, and GBP5 possess a C-terminal ‘CaaX’ isoprenylation motif important for 
facilitating protein-protein interactions as well as membrane binding. The ‘C’ 
signifies a cysteine amino acid residue, ‘aa’ indicates any aliphatic amino acids, 
and ‘X’ signifies the amino acid that determines which lipid moiety is added, either 
a leucine or serine. The terminal amino acid for human GBP1 and murine Gbp5 is 
serine, therefore a C-15 farnesyl group is added at their CaaX motif. In contrast, 
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human GBP2 and GBP5 as well as murine Gbp1 and Gbp2 have a terminal 
leucine, which results in addition of a C-20 geranylgeranyl lipid. One study found 
that membrane binding of human GBP1, GBP2, and GBP5 is dependent not only 
on prenylation of the CaaX motif, but also dependent on oligomerization of the 
GBPs (Britzen-Laurent et al., 2010). Here, they found that GBPs are able to 
homodimerize or heterodimerize and that prenylated GBPs can recruit non-
prenylated GBPs to their intracellular compartments. Specifically, human GBP1 
localizes to the plasma membrane, GBP2 localizes to the perinuclear membrane, 
and GBP5 to the Golgi. Heterodimerization between prenylated GBPs results in a 
hierarchical positioning effect of GBPs; for instance, human GBP1 recruits GBP2 
and GBP5 to the plasma membrane, whereas GBP5 repositions GBP2 to the 
Golgi. These findings suggest that GBP1 is the primary recruiter for the remaining 
GBPs in uninfected IFN-g-primed cells. However, infection studies have shown to 
alter the positioning effects of GBPs to the pathogen directly, presumably to induce 
host defense mechanisms.   
 
1.6. GBPs role in inflammasome responses to bacteria 
Studies in macrophages have proven that GBPs employ a variety of 
functions in a pathogen-specific manner. Initial murine GBP findings showed that 
GBPs can promote rupture of the pathogen-containing vacuole (PCV) or 
bacteriolysis of cytosolic bacteria (B. C. Liu et al., 2018; Meunier et al., 2014; 
Meunier et al., 2015). Upon infection with the vacuolar pathogen S. Typhimurium, 
murine macrophages lacking GBPs on chromosome 3 (Gbpchr3-/-) showed 
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decreased cell death and IL-1b release compared to WT macrophages, and more 
specifically after conducting siRNA-mediated knockdown of individual GBPs, 
found that Gbp2 is the sole GBP important for mediating this caspase-11-
dependent inflammasome response (Meunier et al., 2014). In addition, they 
determined that Gbpchr3-/- macrophages had a decreased amount of galectin-8-
positive S. Typhimurium. Galectins are b-galactoside-binding lectins that bind to 
the carbohydrates found in the inner leaflet of vacuolar membranes and therefore 
serve as a marker of ruptured vacuoles. As expected due to this finding, they 
further showed that Gbpchr3-/- or Gbp2-deficient (Gbp2-/-) macrophages had 
decreased presence of cytosolic S. Typhimurium, indicating that GBPs mediate 
lysis of the PCV of S. Typhimurium. In contrast, two studies revealed that murine 
GBPs localize to the outer membrane of cytosolic F. novicida and L. pneumophila 
DsdhA mutant. Specifically, murine Gbp2 and Gbp5 individually promote AIM2 
inflammasome activation through their direct binding and lysis of F. novicida’s 
outer membrane (Meunier et al., 2015). Additionally, the cytosolic DsdhA mutant 
of L. pneumophila was shown to have lost its rod-like appearance in IFN-b-primed 
WT murine macrophages, but retained the rod shape in Gbpchr3-/- macrophages, 
indicating that murine GBPs induce bacteriolysis of cytosolic exposed bacteria (B. 
C. Liu et al., 2018). They further reveal that GBPs on chromosome 3 are essential 
for mediating the release of DNA from the DsdhA mutant. Interestingly, this study 
also found that IFN-b priming resulted in destabilization of the vacuole of WT L. 
pneumophila in both WT and Gbpchr3-/- macrophages, suggesting that there are 
additional IFN-induced factors other than GBPs that are rupturing L. pneumophila’s 
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vacuole. It is interesting that murine GBPs rupture the PCV of S. Typhimurium, but 
not of L. pneumophila; thus, GBPs may take on different roles in a bacterium-
specific manner. Nevertheless, all three of these murine GBP studies discussed 
so far conclude that GBPs control bacterial burden within the host.  
In addition to promoting inflammasome responses to bacterial pathogens, 
GBPs can initiate inflammasome activation in response to bacterial components 
as well. GBPs promote caspase-11-dependent pyroptosis in response to 
cytoplasmic LPS from E. coli, Salmonella minnesota, and L. pneumophila, 
although the specific mechanism of how GBPs do this was unclear (Pilla et al., 
2014). It was revealed that murine and human GBP5 can form a tetramer that 
binds to NLRP3 to promote ASC-caspase-1 inflammasome assembly in response 
to pathogenic bacteria and bacterial components including LPS and muramyl 
dipeptide (MDP) (Shenoy et al., 2012). Therefore, GBPs may similarly oligomerize 
in response to LPS to enhance caspase-11 activation, possibly through binding 
LPS and transporting it directly to caspase-11, acting in a similar manner as the 
LPS binding protein (LBP) during TLR4 activation. Furthermore, GBPs on 
chromosome 3 and more specifically Gbp2 are required for inflammasome 
activation in response to OMVs derived from E. coli (Finethy et al., 2017). It was 
later found that GBPs associate with OMVs and transfected LPS, indicating that 
GBP binding to LPS is the main factor regulating GBP recruitment to OMVs 
(Santos et al., 2018).   
The precise mechanism that governs GBP recruitment to PCVs is poorly 
understood. We know that GBPs bind to LPS on the outer membrane of bacteria, 
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but whether there are specific microbial signatures on pathogenic vacuoles is 
unclear. Two studies determined that murine GBPs are recruited to vacuolar 
pathogens that contain bacterial secretion systems (E. M. Feeley et al., 2017; 
Zwack et al., 2017). Specifically, GBPs are delivered to the pathogen-containing 
vacuoles of L. pneumophila and Yersinia pseudotuberculosis in a manner 
dependent on the presence of the Dot/Icm type IV secretion system and 
hypersecretion of the Yersinia type III secretion system, respectively (E. M. Feeley 
et al., 2017). However, it was determined that the presence of bacterial secretion 
systems result in vacuolar membrane damage leading to initial recruitment of 
galectin-3, the damaged vacuole marker, followed by recruitment of GBPs. 
Galectin-3-deficient cells had a decreased amount of murine Gbp1 and Gbp2 to 
the L. pneumophila-containing vacuoles and Yersinia-containing vacuoles, 
indicating that galectin-3 controls GBP recruitment to PCVs. Furthermore, another 
study showed that hyperinjection of the Yersinia translocon protein, YopD, leads 
to its association with galectin-3 and Gbp2 and that GBPs on chromosome 3 
contribute to Yersinia T3SS-induced inflammasome activation (Zwack et al., 
2017). Therefore, these findings provide a model wherein Yersinia translocon 
proteins localize to the PCV resulting in galectin-3 recruitment followed by GBP 
recruitment for promoting noncanonical inflammasome responses to Yersinia. 
Besides the presence of bacterial secretion systems, there may be additional ways 
in which GBPs are recruited to non-self vacuolar membranes.  
The GBP research discussed so far has focused on murine GBPs. Since 
mice have 11 GBPs and humans have 7 GBPs, there may be differences in the 
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role that human GBPs play in response to bacterial infections. Recently, 
investigation on human GBPs have revealed seminal findings on human cell-
autonomous immune responses on various bacterial pathogens. Initial studies on 
the cytosolic bacterium Shigella flexneri highlighted that human GBPs are recruited 
to the outer membrane in order to inhibit S. flexneri’s actin motility (Li et al., 2017; 
Piro et al., 2017; Wandel et al., 2017). Human GBP1 is first recruited to S. flexneri, 
followed by GBP2-4 and GBP6 to form a GBP coat around the bacteria (Piro et al., 
2017; Wandel et al., 2017). S. flexneri has developed mechanisms to counter host 
cell defense by using their IpaH family of E3 ubiquitin ligases. Specifically, IpaH9.8 
was found to ubiquitylate and degrade GBPs to allow for cell-to-cell spread, while 
S. flexneri lacking IpaH9.8 maintained their GBP coats and were unable to undergo 
actin-based motility (Li et al., 2017; Wandel et al., 2017). Thus, human GBP1 
prevents bacterial spread of S. flexneri, which is a novel function of GBPs. 
Additional findings on this process showed that GBP1 localization with S. flexneri 
is dependent on its CaaX motif, GTPase activity, and triple arginine motif at the C-
terminus. Human GBP1 also binds to the S. flexneri rough mutant which lacks the 
O-antigen at a lower affinity compared to the WT S. flexneri, indicating that GBP1 
binds directly to LPS on the outer membrane of S. flexneri (Piro et al., 2017). 
Moreover, human GBP2 colocalizes with F. novicida to promote caspase-4-
dependent inflammasome responses (Lagrange et al., 2018). These findings show 
that human GBPs can take on different roles in a bacterium-specific manner. 
Human GBP1 not only is important for inhibiting the bacterial spread of S. 
flexneri, but also plays an essential role in promoting caspase-4 inflammasome 
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activation during infection with cytosolic exposed S. Typhimurium and S. flexneri 
mutant that lacks the effectors IpaH9.8 and OspC3 as well (Fisch et al., 2019; 
Kutsch et al., 2020; Santos et al., 2020; Wandel et al., 2020). GBP1 was initially 
shown to promote the caspase-4 inflammasome in response to S. Typhimurium in 
a GTPase and isoprenylation dependent manner (Fisch et al., 2019). In addition, 
GBP1 localizes to S. Typhimurium and recruits caspase-4. However, this study 
was not clear on whether GBP1 localizes to the vacuole or outer membrane of S. 
Typhimurium. A recent study determined that GBP1 is recruited to the outer 
membrane of cytosolic exposed S. Typhimurium in a CaaX motif and GTPase-
dependent manner and does not colocalize with galectin-3+ ruptured vacuolar 
membranes (Santos et al., 2020). Intriguingly, in contrast to murine GBPs that 
induce bacteriolysis of cytosolic F. novicida and L. pneumophila, human GBP1 
does not induce bacteriolysis of S. Typhimurium but rather controls inflammasome 
assembly at the bacterial surface. Furthermore, similar to the S. flexneri studies, 
upon binding LPS on S. Typhimurium, GBP1 recruits GBP2-4 to form a complex, 
which recruits caspase-4 for its activation. Although it was not clear how caspase-
4 is being activated, it could be due to a number of possibilities including a scenario 
where the GBP complex transfers LPS to caspase-4 or that the GBP complex 
weakens the bacterial membrane so that caspase-4 can directly target LPS. Two 
studies investigate how caspase-4 is activated and it seems like latter of these two 
possibilities is happening (Kutsch et al., 2020; Wandel et al., 2020). While GBP1 
is the initiator GBP that recruits GBP2-4, the functions of these recruited GBPs 
were finally established. GBP2 and GBP4 participate in caspase-4 recruitment, 
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whereas GBP3 is essential for caspase-4 activation in response to cytosolic S. 
Typhimurium as well as to S. flexneri that lacks the effectors IpaH9.8 and OspC3, 
due to their inhibition of the caspase-4 inflammasome (Wandel et al., 2020). 
Specifically, GBP1-4 assemble into a polyvalent protein array on the outer 
membrane bacterial surface and leads to an LPS-dependent complex formation 
with caspase-4. Thus, this investigation provides a model where the GBP complex 
disrupts the membrane integrity for allowing access of capsase-4 to bind LPS. 
Furthermore, another study looking at the mechanism of caspase-4 activation 
showed that GBP1 polymers dock to the outer membrane of S. flexneri through 
binding to the O-antigen of its LPS, resulting in GBP1 protein coats surrounding 
the bacteria (Kutsch et al., 2020). They further conclude that GBP1 becomes 
anchored in the bacterial membrane via their farnesyl tails, which disrupts the LPS 
barrier and reveals lipid A for caspase-4 detection. Thus, rather than lysing the 
cytosolic bacteria for release of bacterial components such as LPS for 
inflammasome activation, human GBPs respond to cytosolic bacteria by 
orchestrating an organized complex platform for direct access of caspase-4.  
Human GBP1 has been involved in microbial restriction of other bacteria 
and parasites as well. Human GBP1 localizes to the parasite Toxoplasma gondii 
vacuole to restrict its infection in mesenchymal stromal cells and also mediates 
restriction of C. trachomatis in THP-1 macrophages (Qin et al., 2017; Xavier, Al-
Zeer, Meyer, & Daumke, 2020). Interestingly, GBP1 does not always interact with 
the pathogen in order to control infection, since it was found that GBP1 does not 
localize to vacuoles of T. gondii, C. trachomatis, or S. Typhimurium but restricts T. 
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gondii replication in A549 lung epithelial cells (Johnston et al., 2016). Therefore, 
human GBPs may have different functions in a cell-type-specific manner. 
  
1.7. Interferon-inducible GTPases: Immunity related GTPases 
Another IFN-inducible GTPase family that has been implicated in vacuolar 
rupture and bacteriolysis are the IRGs. Mice possess 23 IRG proteins, whereas 
humans possess two IRG proteins, IRGM and IRGC (Bekpen et al., 2005). In 
contrast to murine IRGs, human IRGs are not IFN-inducible due to the loss of 
interferon response elements upstream of their transcriptional start site. Therefore, 
human IRGs would not be involved in IFN-dependent host defense pathways. The 
murine IRGs are divided into two subfamilies: the GMS and GKS proteins, which 
are named so because of the presence of either a GMS or GKS amino acid motif 
on the first nucleotide-binding site (Hunn, Feng, Sher, & Howard, 2011). The GMS 
proteins include the IRGM subfamily, while the GKS proteins contain the IRGA, 
IRGB, IRGC, and IRGD subfamilies. The IRGMs are guanine nucleotide 
dissociation inhibitors that control the localization of other IFN-inducible GTPases 
including the GKS subfamily of IRGs and GBPs. The presence of IRGMs on 
membranes prevents the binding of GBPs and GKS IRGs, and therefore the 
IRGMs serve as regulators for IFN-inducible GTPases involved in vacuolar rupture 
or bacteriolysis to determine “self” versus “non-self” (Ngo & Man, 2017). Indeed, 
one study found that Irgm1 and Irgm3 did not localize to “non-self” pathogen-
containing vacuoles, but instead localized to “self” organelles, such as lipid 
droplets (Haldar et al., 2013). They found that when the IRGM proteins were 
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knocked out, the GKS proteins Irga6 and Irgb6 localized to the lipid droplets, 
indicating that IRGs and GBPs target membranes that are missing “self” IRGM 
proteins.  
 
1.8. IRGs role in inflammasome responses to bacteria 
IRGs have been shown to destabilize vacuoles of pathogens and in one 
case have been essential for mediating bacteriolysis of cytoplasmic bacteria. The 
murine IRGs Irgm1 and Irgm3 are critical for directing Irga6, Irgb6 and Irgb10 to 
the C. trachomatis inclusions to control bacterial replication (Coers et al., 2008; 
Haldar et al., 2013). In addition, Irgm1 is important for controlling Mycobacterium 
tuberculosis infection in the lungs (Tischler, Leistikow, Kirksey, Voskuil, & 
McKinney, 2013). Although not in the context of bacterial infection, murine IRGs 
have also been reported to localize to the parasitophorous vacuole of T. gondii in 
a hierarchal manner in the order of Irgb6, Irgb10, Irga6, Irgm2, and Irgd in order to 
disrupt the vacuole for killing of the intracellular parasite (Khaminets et al., 2010; 
Martens et al., 2005).  
Irgb10 is the only known murine IRG that has been implicated in inducing 
bacteriolysis of cytoplasmic bacteria in order to liberate ligands for inflammasome 
sensing (Man et al., 2016). Specifically, Irgb10 targets the intracellular bacteria F. 
novicida and E. coli in a GBP dependent manner. Following bacterial targeting, 
Irgb10 mediates bacteriolysis, which results in the release of bacterial components 
including DNA for AIM2 inflammasome activation and LPS for noncanonical 
capsase-11 inflammasome activation.  Humans do not possess an ortholog of 
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mouse Irgb10; however, human IRGM has been shown to be important for 
controlling M. tuberculosis and S. Typhimurium infections through autophagy 
induction (McCarroll et al., 2008; Singh, Davis, Taylor, & Deretic, 2006). While not 
in the context of inflammasome activation, these findings show that IRGM is 
important for activating alternative host defense pathways.  
 
1.9. Legionella pneumophila infection in macrophages 
My primary thesis project focuses on investigating IFN-induced innate 
immune responses to Legionella pneumophila in order to gain an understanding 
of human GBPs role during infection with this vacuolar pathogen. Legionella 
pneumophila is a gram-negative, opportunistic intracellular bacterial pathogen that 
is the causative agent for Legionnaires’ disease, a severe pneumonia that primarily 
affects immunocompromised hosts, or to a lesser extent can cause Pontiac Fever, 
a flu-like illness (Fields, Benson, & Besser, 2002; Fraser et al., 1977). L. 
pneumophila was first identified during an outbreak that occurred in 1976 at the 
56th annual American Legion Convention in Philadelphia (Fraser et al., 1977). 
There was a total of 182 individuals diagnosed with severe pneumonia and 29 
people died from the illness, revealing the detrimental effects of this intracellular 
pathogen. L. pneumophila persists in aquatic environments and replicates within 
their natural hosts, which are free-living amoebae. However, L. pneumophila can 
also be found as a contaminant in freshwater reservoirs including water towers, 
hot tubs, and air condition units and, therefore, can become an accidental 
pathogen to humans upon the inhalation of aerosolized water droplets that are 
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contaminated with L. pneumophila. Upon inhalation, these intracellular bacteria 
gain access to the lungs where they infect and replicate in alveolar macrophages, 
although it was determined that L. pneumophila can also replicate within 
neutrophils as well (Copenhaver et al., 2014).  
Upon uptake by macrophages, L. pneumophila resides within a specialized 
compartment termed the L. pneumophila-containing vacuole (LCV) (Horwitz, 
1983). However, in order to survive and replicate within the LCV, L. pneumophila 
relies on its Dot/Icm type IVb secretion system (T4SS) (Berger & Isberg, 1993; 
Berger, Merriam, & Isberg, 1994; Brand, Sadosky, & Shuman, 1994; Ensminger & 
Isberg, 2009; Roy & Isberg, 1997). The T4SS translocates over 300 bacterial 
effectors that are essential for manipulation of host cell processes as well as for 
vacuolar remodeling (Hubber & Roy, 2010). Specifically, these effectors allow L. 
pneumophila to evade the endocytic pathway by avoiding endosome-lysosome 
fusion and to remodel the vacuole by recruiting ER-derived vesicles to the LCV 
membrane (Ensminger & Isberg, 2009; Hubber & Roy, 2010). Modification of the 
LCV with ER-derived vesicles results the establishment of an ER-like organelle 
that is maintained by the host cell and, therefore, supports the replication of L. 
pneumophila within this specialized vacuole (Roy, 2002). L. pneumophila begin to 
replicate in the LCV at 4-6 hours upon initial uptake by a host cell. At around 14 
hours post-uptake, L. pneumophila has replicated to large numbers and at this 
point escape the LCV and rupture the host cell in order for L. pneumophila progeny 
to infect additional neighboring cells. Although the T4SS is essential for the survival 
of L. pneumophila within the LCV, the T4SS makes L. pneumophila susceptible to 
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host sensing and can activate innate immune pathways in the cytosol, such as the 
inflammasome (Casson et al., 2013; Casson et al., 2015; Molofsky et al., 2006).  
Most of the studies conducted involving L. pneumophila use strains that are 
derived from the serogroup 1 clinical isolate Philadelphia-1, which was collected 
from the 1976 outbreak. The two strains that were derived from the Philadelphia-
1 isolate are the JR32 strain and LP01 strain, both of which are replicative strains 
(Rao, Benhabib, & Ensminger, 2013). Additional strains were produced 
downstream from the LP01 strain. LP02 was derived from LP01 and is a thymidine 
auxotroph; thus, it requires thymidine in order to undergo replication. Using this 
strain is instrumental in understanding L. pneumophila’s influence on the immune 
response without the confounding variable of replication. Furthermore, LP02 was 
used to derive LP03, also known as the avirulent dotA mutant, which is a thymidine 
auxotroph that lacks the dot/icm translocation system and is defective for 
intracellular replication (Berger & Isberg, 1993; Berger et al., 1994). In my studies, 
I use a flagellin deficient LP02 strain, DflaA, in order to investigate inflammasome 
responses that are NAIP/NLRC4 inflammasome independent (Ren, Zamboni, Roy, 
Dietrich, & Vance, 2006), as well as use DdotA LP03 strain and a dsRED-
expressing JR32 strain. L. pneumophila has been shown to activate canonical 
caspase-1 containing inflammasomes as well as noncanonical inflammasome 
pathways (Case et al., 2013; Casson et al., 2013; Casson et al., 2015; Ge et al., 
2012; Miao et al., 2010; Zhao et al., 2011). However, whether IFN-g or human 
GBPs promote inflammasome responses to L. pneumophila in human 
macrophages has not been studied.     
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1.10. Lipopolysaccharide (LPS): immunological consequence of acylation 
state in macrophages  
Lipopolysaccharide (LPS) is the major outer membrane lipid component of 
gram-negative bacteria. It is composed made up of three components: the lipid A 
moiety, core oligosaccharide, and O-antigen. LPS is an amphiphilic molecule 
where the lipid A comprises the hydrophobic part and the polysaccharides within 
the core and O-antigen make up the hydrophilic portion. The lipid A moiety is the 
portion of LPS that is directly recognized by the extracellular and intracellular LPS 
sensors, TLR4 and noncanonical inflammatory caspases 11, 4 and 5, respectively. 
Specifically, lipid A is has two glucosamine residues that are connected by a β1’-
6 linkage that can be phosphorylated at the 1 and 4’ positions and are acylated at 
the 2,3,2’, and 3’ positions (Bertani & Ruiz, 2018).  
Intriguingly, LPS can possess different acylation or phosphorylation states 
in various bacteria as well as within the same bacterial species. For instance, lipid 
A can have different numbers and lengths of acyl chains and usually have either 
one or two phosphate groups. Gram-negative bacteria’s ability to remodel their 
LPS is important for their pathogenesis as it can allow these particular bacteria to 
evade immune detection, including TLR4 and the noncanonical inflammatory 
caspases. In particular for Helicobacter pylori, it has a tetra-acylated LPS and the 
ability to remove phosphoryl groups from its 1 and 4’ positions through the use of 
its phosphatases lpxE and lpxF, respectively, which lead to the attenuation of 
TLR4-MD2 activation (Cullen et al., 2011). This in contrast to E. coli LPS, which is 
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hexa-acylated and contains two phosphate groups and robustly activates the 
TLR4-MD2 complex. Another gram-negative bacteria species that has the ability 
to modify its LPS is Francisella novicida. F. novicida initially synthesizes a penta-
acylated LPS with two phosphates and uses its phosphatase lpxF to remove the 
4’-phosphate group and a deacylase to remove the 3’-hydroxyacyl chain (Raetz et 
al., 2009). This process results in a tetra-acylated and monophosphorylated F. 
novicida LPS, which evades the murine noncanonical inflammasome (Hagar et al., 
2013). Additionally, bacteria can switch between acyl states in response to its 
surrounding environment. Specifically, Yersinia pestis can switch between being 
tetra-acylated and hexa-acylated. Y. pestis is hexa-acylated when grown at 25°C, 
the temperature of a flea vector, however it removes two acyl chains to become 
tetra-acylated upon being grown at 37°C, which is the temperature of a mammalian 
host (Rebeil, Ernst, Gowen, Miller, & Hinnebusch, 2004). Similar to tetra-acylated 
F. novicida LPS, it was discovered that tetra-acylated Y. pestis evades murine 
caspase-11 detection, whereas Y. pestis in its hexa-acylated form activates 
caspase-11 (Hagar et al., 2013). These results are in agreement with another 
study that found tetra-acylated H. pylori or lipid IVa, the precursor to E. coli LPS, 
failed to activate the mouse noncanonical inflammasome as well as TLR4, while 
hexa-acylated LPS from E. coli or S. Typhimurium robustly activates caspase-11 
and TLR4 (Kayagaki et al., 2013). In contrast to what was found in mouse 
macrophages, a recent study determined that tetra-acylated F. novicida LPS 
activates capsase-4, suggesting that human noncanonical inflammasome can 
recognizes under-acylated LPS (Lagrange et al., 2018). This data along with other 
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human caspase-4 inflammasome studies indicates that caspase-4 can recognize 
different types of LPS variants with different numbers of acyl chains (Casson et al., 
2015; Goddard et al., 2019; Knodler et al., 2014; Lagrange et al., 2018; 
Srisaowakarn et al., 2020). However, there are no further studies that investigate 
human noncanonical inflammasome responses to LPS variants that are 
differentially phosphorylated or acylated.    
 
1.11. Dissertation Aims 
Gram-negative bacterial pathogens are responsible for a significant number 
of hospital-acquired infections, making them a major public health concern. 
Additionally, antibiotic resistance is on the rise, making it difficult to control many 
bacterial infections. Inability to control these bacterial infections can lead to sepsis, 
an overwhelming systemic immune response, and ultimately death if left untreated. 
Although there are successful treatments for sepsis in mice using 
immunomodulators, these treatments fail to alleviate sepsis in humans. The 
reasons for these failures are poorly understood, but one possible reason could be 
due to the differences between mouse and human innate immune genes that may 
play a role in the responses to gram-negative bacterial infections. Importantly, 
mouse studies do not always translate to what happens in humans. Therefore, it 
is important to understand human innate immune responses to gram-negative 
bacterial infections in order to gain insight into the cellular components or signaling 
pathways that can be targeted to enhance or limit the immune response. L. 
pneumophila is a gram-negative, vacuolar pathogen that replicates in 
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macrophages and serves as a valuable model pathogen as it robustly activates 
immune response pathways including the inflammasome. IFN-priming promotes 
murine inflammasome responses to L. pneumophila, but whether and how IFN 
influences human inflammasome responses to L. pneumophila has not been 
investigated. Additionally, LPS from gram-negative bacteria is a potent activator of 
the intracellular noncanonical inflammasome; however, it appears that murine 
caspase-11 is differentially activated depending on the LPS variant, while it is 
unclear whether human caspase-4 is activated by different LPS variants. To better 
understand human inflammasome responses to L. pneumophila in the context of 
IFN-g or to different LPS variants, this dissertation will focus on the following aims 
(Fig. 1.1): 
 
Figure 1.1. Human inflammasome responses to L. pneumophila and LPS 
variants. This dissertation will focus on the role of IFN-g and GBPs on human 
inflammasome responses to L. pneumophila as well as the roles of caspase-4 and 
caspase-5 responses to LPS variants. 
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Aim 1: Determine how IFN-g promotes human inflammasome responses 
during L. pneumophila infection   
IFN-treatment in mice leads to upregulated inflammasome response to a 
variety of bacteria, including L. pneumophila. Specifically, there are unknown IFN-
induced factors that promote the rupture of the LCV, while murine GBPs induce 
bacteriolysis for the release of DNA and LPS into the cytosol for inflammasome 
sensing and activation. Mice and humans differ in the number of GBPs, and recent 
findings indicate that human GBP2 promotes caspase-4 inflammasome in 
response to the cytosolic bacteria, F. novicida. However, whether human GBPs 
contribute to inflammasome responses to vacuolar pathogens is poorly 
understood. In CHAPTER 2, we investigate whether IFN-g and human GBPs 
promote inflammasome response to the vacuolar pathogen, L. pneumophila, and 
found that human GBP1 mediates maximal inflammasome response and 
promotes the rupture of the pathogen vacuole during L. pneumophila infection. 
 
Aim 2: Determine human noncanonical inflammasome responses to 
different LPS variants 
Based on studies testing LPS from different gram-negative bacteria, under-
acylated variants evade caspase-11 detection in mice, while one study showed 
that tetra-acylated LPS activates caspase-4 in humans. Whether the number, 
position, or length of acyl chains on LPS as well as the number of phosphate 
groups determines activation of the human noncanonical inflammasome has not 
been studied. In CHAPTER 3, we investigate the activation of caspase-4 and 
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caspase-5 in response to different lipooligosaccharide variants derived from Y. 
pestis in order to determine whether there are differences or similarities in their 
activation. Additionally, we employed CRISPR/Cas9 to knock out caspase-4, 
caspase-5, GBP1, and GBP2 in THP-1 cell lines. Our preliminary results suggest 
that caspase-4, but not caspase-5, is activated in response to E. coli LPS. Future 
studies with these cell lines are needed to determine the role caspase-4 and -5 in 
response to the Y. pestis LOS, as well as to determine the role of human GBPs 
(GBP1 and GBP2) in response to LPS or LOS derived from L. pneumophila, E. 



















CHAPTER  2 
 
Human GBP1 promotes pathogen vacuole rupture and inflammasome 






































This chapter contains large portions of a submitted manuscript titled “Human 
GBP1 promotes pathogen vacuole rupture and inflammasome activation during 
Legionella pneumophila infection” by Antonia. R. Bass and Sunny Shin.  
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2.1.  Abstract 
The inflammasome is an essential component of host defense against 
intracellular bacterial pathogens, such as Legionella pneumophila, the causative 
agent of the severe pneumonia Legionnaires’ disease. Inflammasome activation 
leads to recruitment and activation of caspases, which promote IL-1 family cytokine 
release and pyroptosis. In mice, interferon (IFN) signaling promotes 
inflammasome responses against L. pneumophila, in part through the functions of 
a family of IFN-inducible GTPases known as guanylate binding proteins (GBPs). 
Within murine macrophages, IFN signaling promotes rupture of the L. 
pneumophila-containing vacuole (LCV), whereas GBPs are dispensable for 
vacuole rupture. Instead, GBPs facilitate the lysis of cytosol-exposed L. 
pneumophila. In contrast to mouse GBPs, the functions of human GBPs in 
inflammasome responses to L. pneumophila are poorly understood. Here, we 
show that IFN-g promotes caspase-1, caspase-4, and caspase-5 inflammasome 
activation during L. pneumophila infection and upregulates GBP expression in 
primary human macrophages. We find that human GBP1 is important for maximal 
IFN-g-driven inflammasome responses to L. pneumophila. Furthermore, IFN-g 
signaling promotes the rupture of LCVs. Similar to murine GBPs, human GBP1 
and GBP2 target LCVs in a T4SS-dependent manner. However, in contrast to 
murine GBPs, human GBP1 promotes vacuolar lysis of the LCV, resulting in 
increased bacterial access to the host cell cytosol. Our findings show a key role 
for human GBP1 in targeting and disrupting pathogen-containing vacuoles and 
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reveal mechanistic differences in how mouse and human GBPs promote 
inflammasome responses to L. pneumophila.  
 
 
2.2. Significance Statement 
The bacterial pathogen Legionella pneumophila, the causative agent of the 
severe pneumonia Legionnaires’ disease, resides within a host-derived vacuole 
inside macrophages. In response, the macrophage directs assembly of a 
multiprotein signaling complex termed the inflammasome, which mediates cell 
death and release of cytokines important for antibacterial defense. The cytokine 
interferon-gamma (IFN-g) potentiates inflammasome responses by inducing 
expression of host factors, including guanylate-binding proteins (GBPs). In mice, 
IFN signaling promotes rupture of the L. pneumophila-containing vacuole (LCV). 
Mouse GBPs do not mediate LCV disruption, but instead facilitate lysis of cytosol-
exposed bacteria. In contrast, the functions of human GBPs are poorly understood. 
Here, we show that human GBP1 promotes inflammasome responses to L. 
pneumophila. In contrast to mouse GBPs, we find that human GBP1 targets and 
disrupts the LCV. These findings provide insight into the role of human GBPs in 




The innate immune response to bacterial pathogens is essential for 
mediating host defense and bacterial clearance. This response is initiated through 
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the recognition of conserved microbial components known as pathogen-
associated molecular patterns (PAMPs) by host pattern recognition receptors 
(PRRs) (Janeway, 1989; Takeuchi & Akira, 2010). In particular for intracellular 
bacteria, a subset of cytoplasmic PRRs that detect bacterial components 
contaminating the host cell cytosol and other activities associated with invading 
pathogens has been implicated in host defense. Upon activation, host sensors 
such as the nucleotide-binding oligomerization domain-like receptors (NLRs) 
mediate the formation of a multimeric protein complex termed the inflammasome. 
Inflammasome activation triggers a cascade of immune responses that culminate 
in the release of IL-1 family cytokines and an inflammatory form of cell death 
termed pyroptosis. This response alerts the body of the infection and recruits other 
innate immune cells to the site of infection, thereby promoting bacterial control and 
clearance.   
The two inflammasomes that have been described are the canonical and 
noncanonical inflammasomes. In response to a diverse range of ligands, canonical 
inflammasomes recruit and activate the cysteine protease caspase-1 to promote 
the processing and secretion of the proinflammatory cytokines IL-1b and IL-18 
(Martinon, Burns, & Tschopp, 2002; Ting, Willingham, & Bergstralh, 2008). 
Additionally, an alternative caspase-1-independent inflammasome termed the 
noncanonical inflammasome mediates inflammatory responses to gram-negative 
bacteria (Aachoui et al., 2013; Broz et al., 2012; Case et al., 2013; Casson et al., 
2013; Kayagaki et al., 2011; Lamkanfi & Dixit, 2014; Rathinam et al., 2012). The 
noncanonical inflammasome is formed by caspase-11 in mice and two orthologs 
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in humans, caspase-4 and caspase-5; these caspases are activated upon binding 
bacterial lipopolysaccharide (LPS), a potent PAMP and major outer membrane 
lipid component of gram-negative bacteria (Hagar et al., 2013; Kayagaki et al., 
2013; Shi et al., 2014). Following their activation, these inflammatory caspases 
cleave the substrate gasdermin-D (GSDMD). Upon cleavage, the GSDMD N-
terminal fragment translocates to the plasma membrane and oligomerizes to form 
a pore, leading to pyroptosis (Kayagaki et al., 2015; Shi et al., 2015). Death of the 
infected cell eliminates the replicative niche for intracellular pathogens and leads 
to the clearance of bacteria through various mechanisms including the uptake of 
the bacteria within pore-induced intracellular traps (PITs) by neutrophils and 
clearance by efferocytosis (Jorgensen, Zhang, Krantz, & Miao, 2016).   
 Inflammasome responses are potentiated by priming signals recognized by 
plasma membrane receptors that upregulate the production of inflammatory 
cytokines and inflammasome components. During an infection, toll-like receptors 
play a major role in promoting the expression of innate immune genes. 
Additionally, type I and type II IFNs produced during infection promote 
inflammasome responses in mice. A subfamily of IFN-upregulated GTPases called 
GBPs are particularly important in promoting inflammasome responses to gram-
negative bacteria in mice (Balakrishnan, Karki, Berwin, Yamamoto, & Kanneganti, 
2018; Finethy et al., 2017; B. H. Kim et al., 2016; B. C. Liu et al., 2018; MacMicking, 
2004; Meunier et al., 2014; Meunier et al., 2015; Pilla et al., 2014; Shenoy et al., 
2012; Zwack et al., 2017). Mouse GBPs can localize to pathogen-containing 
vacuoles or bacterial membranes of cytosol exposed bacteria (B. H. Kim et al., 
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2011; Man et al., 2016; Meunier et al., 2015; Piro et al., 2017; Santos et al., 2018; 
Wandel et al., 2017). However, the precise steps regulated by GBPs in promoting 
inflammasome activation are unclear. A study using Salmonella Typhimurium 
indicated that mouse GBPs promote rupture of pathogen-containing vacuoles 
(PCVs), whereas other studies with Francisella novicida and L. pneumophila 
indicate that GBPs function downstream of PCV rupture and facilitate bacteriolysis, 
resulting in cytosolic release of bacterial components that subsequently trigger 
inflammasome activation (B. C. Liu et al., 2018; Man et al., 2015; Man et al., 2016; 
Meunier et al., 2014; Meunier et al., 2015). Additionally, GBPs were found to 
promote caspase-11 activation in response to transfected LPS and, therefore, 
revealed that GBPs can operate downstream of vacuolar and outer membrane 
lysis (Pilla et al., 2014). Mouse GBPs can also promote inflammasome responses 
in the absence of targeting the PCV, as is the case with the vacuolar pathogen 
Chlamydia muridarum (Finethy et al., 2015). It is still unclear how mouse GBPs 
mediate these various functions, although one study showed that GBPs recruit the 
immunity-related GTPase (IRG) IRGB10 to mediate bacteriolysis (Man et al., 
2016).  
While studies in mice have linked the functions of IFN signaling and GBPs 
to inflammasome activation, the degree to which the function of murine GBPs 
mirror their human counterparts is unknown, as the significant differences in 
immune genes between mice and humans, including in the GBP superfamily, could 
translate into differences in immune mechanisms. Notably, mice have 11 GBPs, 
whereas humans only have seven GBPs (Olszewski et al., 2006). The functions of 
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human GBPs in host defense against gram-negative bacteria, particularly whether 
human GBPs play a role in PCV rupture or bacteriolysis, is unclear. Human GBP1 
colocalizes to the outer membrane of the cytosolic pathogen Shigella flexneri and 
further recruits additional GBPs, specifically GBP2, 3, 4, and 6, to inhibit the actin-
based motility of S. flexneri (Piro et al., 2017; Wandel et al., 2017). Additionally, 
human GBP1 and GBP5 promote inflammasome responses to S. Typhimurium, 
which can reside within a specialized vacuole or in the cytosol, while human GBP2 
promotes inflammasome responses to the cytosolic pathogen F. novicida (Fisch 
et al., 2019; Lagrange et al., 2018; Shenoy et al., 2012). These findings indicate 
that different human GBPs function in a bacterium-specific manner. Furthermore, 
human GBP1 associates with sterilely lysed host vacuoles, and therefore, it may 
be possible that human GBPs can also associate with bacteria-containing 
vacuoles that are host derived, similar to mouse GBPs (E. M. Feeley et al., 2017; 
Piro et al., 2017). 
Here, we sought to define the role of IFN-g signaling and human GBPs in 
human inflammasome responses to the vacuolar pathogen L. pneumophila. L. 
pneumophila is a gram-negative intracellular bacterial pathogen that infects 
alveolar macrophages and is the causative agent of the severe pneumonia known 
as Legionnaires’ Disease (Fraser et al., 1977). Upon uptake, L. pneumophila 
resides within a L. pneumophila-containing vacuole (LCV) and relies on the 
Dot/Icm type IV secretion system (T4SS) to survive within the LCV (Berger & 
Isberg, 1993; Berger et al., 1994; Brand et al., 1994; Horwitz, 1983; X. Liu & Shin, 
2019; Roy & Isberg, 1997). The T4SS injects over 300 effector proteins, many of 
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which enable L. pneumophila to evade the endolysosomal pathway and modify its 
LCV into an ER-derived replicative compartment (Ensminger & Isberg, 2009; 
Hubber & Roy, 2010; Isaac & Isberg, 2014; Ninio & Roy, 2007; Roy, 2002; Vogel 
& Isberg, 1999). Despite being essential for L. pneumophila virulence, T4SS 
activity triggers robust canonical and noncanonical inflammasome activation in 
human macrophages (Casson et al., 2015). The role of IFN signaling and GBPs in 
promoting human inflammasome responses to L. pneumophila is unknown. A 
recent study found that human GBP1 directly binds to L. pneumophila as well as 
other gram-negative bacterial pathogens (Kutsch et al., 2020); however, this study 
did not clarify whether GBP1 binds to the LCV or outer membrane.  
In this study, we found that IFN-g promotes inflammasome responses to L. 
pneumophila in a T4SS-dependent manner in both immortalized and primary 
human macrophages. We further determined that human GBP1 was essential for 
maximal inflammasome activation and that IFN-g-primed macrophages had a 
significant increase in GBP1 and GBP2 localization to the LCV and/or outer 
membrane of L. pneumophila compared to unprimed macrophages. GBP1 and 
GBP2 were recruited to L. pneumophila’s vacuole and/or outer membrane in a 
T4SS-dependent manner, indicating that human GBPs detect pathogen-
containing vacuoles containing virulence-associated bacterial secretion systems. 
Additionally, IFN-g treatment led to the increased rupture of LCVs and exposure of 
L. pneumophila to the host cell cytosol, in part through a mechanism involving 
GBP1. Overall, our findings indicate that IFN-g-dependent human GBP1 
responses promote rupture of the LCV, facilitating bacterial detection in the cytosol 
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to enhance inflammasome activation. Furthermore, as human GBP1 facilitates 
LCV rupture, in contrast to mouse GBPs, which are dispensable for LCV rupture, 
our findings suggest that mouse and human GBPs have evolved distinct functions. 
 
2.4. Results 
2.4.1. IFN-g promotes inflammasome activation in human macrophages 
during L. pneumophila infection. 
IFN-g promotes human inflammasome responses to the cytosolic pathogen 
F. novicida (Lagrange et al., 2018). However, whether IFN-g upregulates 
inflammasome responses to a vacuolar pathogen in human macrophages is poorly 
understood; therefore, we sought to test this with L. pneumophila. To determine 
whether IFN signaling increases inflammasome activation in response to L. 
pneumophila, we primed macrophages with IFN-g prior to infection with L. 
pneumophila. L. pneumophila requires a T4SS to translocate bacterial products 
into the host cell cytosol; therefore, we also investigated whether IFN-g-mediated 
inflammasome responses to L. pneumophila are dependent on its T4SS. Unprimed 
or IFN-g-primed phorbol 12-myristate 13-acetate (PMA)-differentiated THP-1 
macrophages were infected with a L. pneumophila dotA mutant lacking a functional 
T4SS (T4SS-) or a T4SS-sufficient (T4SS+) strain lacking flagellin (DflaA) in order 
to focus on NAIP-independent inflammasome responses. Unprimed THP-1 cells 
infected with T4SS- Lp or mock infected exhibited little to no cell death, whereas 
cells infected with T4SS+ Lp underwent increased cell death and IL-1 family 
cytokine release (Fig. 2.1 A and B), consistent with previous findings showing that 
 54 
L. pneumophila induces T4SS-dependent inflammasome responses in THP-1 
cells (Casson et al., 2015). THP-1 macrophages that were primed with IFN-g and 
infected with T4SS+ Lp had a significant increase in cell death compared to 
unprimed macrophages (Fig. 2.1 A and 2.2 A). We observed a notable difference 
in the amount of cell death for THP-1 cells depending on the assay used. 
Specifically, we found that IFN-g-primed THP-1 cells infected with T4SS+ Lp 
resulted in around 10% cell death by measurement of LDH at 2 hpi (Fig. 2.1 A), 
whereas these same cells led to 75% cell death when measuring propidium iodide 
(PI) uptake (Fig. 2.2 A). This difference may be due to the size of the GSDMD 
pores in these THP-1 cells, which may be wide enough to allow PI to be easily 
released due to its smaller size compared to the LDH molecule. IFN-g-primed 
macrophages infected with T4SS+ Lp also had significantly elevated levels of IL-
1b and IL-18 secretion compared to unprimed macrophages (Fig. 2.1 B). 
Interestingly, we noticed significantly increased secretion of IL-1b and IL-18 levels 
in T4SS- Lp-infected THP-1 cells primed with IFN-g compared to unprimed cells. 
However, unprimed and IFN-g-primed THP-1 cells infected with T4SS- Lp showed 
significantly lower levels of cytokine release compared to their T4SS+ Lp infected 
counterparts. This indicates that there is a T4SS-dependent cytokine release in 
both unprimed and IFN-g-primed THP-1 cells, where the latter shows a more 
dominant phenotype. Furthermore, we observed processing of IL-1b into its mature 
p17 form in the supernatant of both T4SS- and T4SS+ Lp-infected THP-1 cells 
primed with IFN-g (Fig. 2.1 C). These data indicate that IFN-g priming promotes 
inflammasome responses to both T4SS- and T4SS+ L. pneumophila in THP-1 
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cells, although maximal inflammasome activation occurs in primed cells infected 
with bacteria that harbor a functional T4SS. 
We next asked whether IFN-g also enhances inflammasome responses to 
L. pneumophila in primary human monocyte-derived macrophages (hMDMs) 
derived from healthy human donors. IFN-g-primed hMDMs infected with T4SS+ Lp 
also exhibited significantly increased levels of cell death (Fig. 2.1 D), as well as IL-
1b and IL-18 release (Fig. 2.1 E), compared to unprimed or IFN-g-primed hMDMs 
that were uninfected or infected with T4SS- Lp. Overall, our data indicate that IFN-
g promotes inflammasome responses and IL-1 family cytokine release in response 
to L. pneumophila infection in both PMA-differentiated THP-1 cells and primary 
hMDMs.  
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Figure 2.1. IFN-g promotes inflammasome activation in response to L. 
pneumophila in human macrophages. Phorbol 12-myristate 13-acetate (PMA)-
differentiated THP-1 cells (A, B, C)  or primary human monocyte-derived 
macrophages (hMDMs) (D, E, F) were either left unprimed or primed with IFN-g 
(100 U/ml) overnight and infected with T4SS- Lp, T4SS+ Lp, or mock-infected with 
























































































































































































































































































lactate dehydrogenase release assay and normalized to mock-infected cells. (B 
and E) IL-1b and IL-18 levels in the supernatant were measured by ELISA. (C, F) 
Immunoblot analysis was conducted on supernatants (sup) and lysates from THP-
1 cells (C) or hMDMs (F) for full-length IL-1b (pro-IL-1b), cleaved IL-1b (mature IL-
1b), full length caspase-1 (pro-casp1), cleaved casp1 (casp1 p20), pro-casp4, 
cleaved caspase-4 (casp4 p32), pro-casp5, casp5 p35, full-length Gasdermin-D 
(GSDMD), intermediate and cleaved GSDMD (GSDMD int. and GSDMD p30), and 
b-actin. Western blots are representative of three independent experiments. (A and 
B) Shown are the results representative of three independent experiments. *P< 
0.05, **P< 0.01, and ***P< 0.001 by unpaired t-test. (D and E) Shown are the 
pooled results of six independent experiments using hMDMs from different healthy 
human donors. Each data point represents the mean of triplicate infected wells 
from an individual donor. *P< 0.05, **P<0.01, and ***P< 0.001 by paired t-test.  
 
2.4.2. Caspase-1, caspase-8, and additional caspases promote 
inflammasome activation in response to L. pneumophila. 
We next investigated which caspases are involved in promoting 
inflammasome activation in response to L. pneumophila following IFN-g priming. 
L. pneumophila activates the human noncanonical caspase-4 inflammasome in 
macrophages that were not initially primed (Casson et al., 2015), but whether IFN-
g priming affects canonical or noncanonical inflammasome activation in L. 
pneumophila-infected human macrophages has not been studied. We observed 
caspase-1 processing into its mature p20 form in T4SS+ Lp-infected hMDMs 
primed with IFN-g (Fig. 2.1 F). Both caspase-4 and caspase-5 were upregulated at 
the RNA and protein level following IFN-g priming of THP-1 cells and hMDMs (Fig. 
2.1 F and 2.2 B-D). Additionally, we observed release of full-length and processed 
forms of caspase-4 and caspase-5, as well as GSDMD processing and release, 
into the supernatants of IFN-g-primed hMDMs infected with T4SS+ Lp (Fig. 2.1 F). 
Intriguingly, we noticed that the lysates of unprimed primary hMDMs either mock-
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infected or infected with T4SS- Lp showed caspase-5 expression, suggesting that 
it may be constitutively expressed in these cells (Fig. 2.1 F). Additionally, IFN-g 
treatment resulted in the generation of processed caspase-5 p35 subunit in 
primary hMDMs and THP-1 cells and indicates that caspase-5 is undergoing 
autoprocessing in the presence or absence of infection. The upregulation of 
caspase-4 and caspase-5 by IFN-g treatment in THP-1 cells and primary hMDMs 
as well as the released processed forms of these caspases in the supernatant of 
IFN-g-primed hMDMs may account for the observed increase in cell death and 
cytokine release during L. pneumophila infection. Together, these data 
demonstrate that caspase-1, -4, and -5 are processed into their mature forms upon 
IFN-g priming and infection with T4SS+ Lp (Fig. 2.1 F). 
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Figure 2.2. IFN-g promotes inflammasome activation in response to L. 
pneumophila in human macrophages and upregulates caspase-4 and 
caspase-5. (A) PI uptake time course of PMA-differentiated THP-1 cells that were 
either left unprimed or primed with IFN-g (100 U/ml) for 24 h and infected with 
T4SS+ Lp MOI=50. Data are representative of three independent experiments with 
each data point representing the mean of triplicate infected wells. *P< 0.05, **P< 
0.01, ***P< 0.001 by unpaired t-test. PMA-differentiated THP-1 cells (B) or primary 
hMDMs (D) were either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20 
hours, respectively. Transcript levels of caspase-4 (CASP4) and caspase-5 
(CASP5) were determined by quantitative RT-PCR. Fold change was calculated 
by normalizing to the housekeeping gene HPRT for each sample and then to the 
unprimed sample. Relative expression of each gene was calculated by normalizing 
to the housekeeping gene HPRT. Shown are pooled results of three independent 
experiments (B) or six independent experiments using hMDMs from different 
healthy human donors (D), with each data point representing the value for each 
experiment (B) or an individual donor (D). *P< 0.05, **P< 0.01, and ****P< 0.0001 
by paired t-test. (C) PMA-differentiated THP-1 cells were either left unprimed or 
primed with IFN-g (100 U/ml) overnight and infected with T4SS- Lp, T4SS+ Lp, or 
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PMA-differentiated THP-1 lysates for full-length caspase-4 (pro-casp4), full-length 
caspase-5 (pro-casp5), caspase-5 intermediates (casp5 p44 and casp5 p35), and 
b-actin (same b-actin blot as shown in Fig. 2.1C since from same experiment). 
Western blots are representative of three independent experiments.  
 
We next tested whether caspase activity is required for inflammasome 
responses to L. pneumophila in the presence or absence of IFN-g. Our previous 
data indicated that caspase-1 is cleaved and activated upon IFN-g priming and 
infection with T4SS+ Lp (Fig. 2.1 F). Therefore, we wanted to confirm that caspase-
1 is involved in inflammasome responses to L. pneumophila through inhibitor 
treatment. Additionally, recent studies have found novel functions of caspase-8 
being implicated in inflammasome responses to a variety of bacteria 
(Antonopoulos et al., 2015; Man et al., 2014; Man et al., 2013; Sarhan et al., 2018); 
thus, we wanted to determine whether caspase-8 is also promoting inflammasome 
responses to L. pneumophila. Cell death was significantly decreased in either 
unprimed or IFN-g-primed hMDMs that were treated with the pan-caspase inhibitor 
ZVAD prior to infection with T4SS+ Lp, compared to the levels of cell death 
observed in vehicle control-treated cells (Fig. 2.3 A). Intriguingly, we observed 
higher cell death in unprimed and IFN-g-primed hMDMs that were treated with 
DMSO and infected with T4SS+ Lp compared to the unprimed and IFN-g-primed 
hMDMs that were only infected with T4SS+ Lp in Fig. 2.1 D. This may suggest that 
DMSO propagates cell death in the presence of T4SS+ Lp through additional 
activation of cell stress pathways or inflammasomes, such as the NLRP3 
inflammasome.  IL-1b and IL-18 secretion was also significantly decreased in IFN-
g-primed hMDMs treated with ZVAD, compared to DMSO-treated hMDMs (Fig. 2.3 
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B and C). In addition, IL-18 secretion was significantly decreased in unprimed 
hMDMs treated with ZVAD. Importantly, treatment with the caspase-1-specific 
inhibitor YVAD or the caspase-8-specific inhibitor IETD significantly reduced cell 
death and IL-1b and IL-18 secretion in IFN-g-primed hMDMs, compared to DMSO-
treated hMDMs. Similar to ZVAD treated cells, YVAD and IETD also significantly 
reduced cell death and IL-18 release in unprimed hMDMs. Interestingly, we 
observed lower amounts of cell death and IL-1 family cytokine release in hMDMs 
treated with the broader-spectrum inhibitor ZVAD compared to treatment with the 
caspase-1 or caspase-8 selective inhibitors. These data indicate that caspase-1, 
caspase-8, and likely additional caspases are involved in promoting 
inflammasome responses to L. pneumophila. Furthermore, we noticed that 
unprimed and IFN-g-primed hMDMs infected with T4SS+ Lp had comparable 
levels of IL-1b, which may be due to donor variability as well as to the low levels 
of IL-1b production from lack of TLR priming. As both caspase-4 and caspase-5 
are processed in IFN-g-primed T4SS+ Lp-infected hMDMs (Fig. 2.1 F), these 
noncanonical inflammatory caspases may play a role together with caspase-1 and 




Figure 2.3. Caspase-1, caspase-8, and additional caspases promote 
inflammasome activation in response to L. pneumophila. (A, B, C) Primary 
hMDMs were left unprimed or primed with IFN-g (100 U/mL) overnight and treated 
with the inhibitors ZVAD, YVAD, IETD, MCC950, or DMSO control for one hour 
followed by infection with T4SS+ Lp for four hours. (A) Cell death was measured 
using lactate dehydrogenase release assay and normalized to mock-infected cells. 
(B and C) IL-1b and IL-18 levels in the supernatant were measured by ELISA. 
Shown are the pooled results of four to six independent experiments using hMDMs 
from different healthy human donors. Each data point represents the mean of 
triplicate infected wells from an individual donor. *P< 0.05, **P< 0.01, and ***P< 























































































































































































































We also wanted to determine whether the NLRP3 inflammasome plays a 
role in response to L. pneumophila during IFN-g treatment, since it has been shown 
that the NLRP3 inflammasome can be activated downstream of caspase-11 during 
L. pneumophila infection (Case et al., 2013; Casson et al., 2013). While the NLRP3 
inhibitor MCC950 did suppress inflammasome responses upon LPS and nigericin 
treatment, the inhibitor had no effect on cell death or IL-1b and IL-18 levels in both 
unprimed and IFN-g-primed hMDMs infected with L. pneumophila (Fig. 2.4). In 
addition, ZVAD, YVAD, and IETD treatments significantly decreased IL-18 levels 
in hMDMs treated with LPS and nigericin. These results suggest that the NLRP3 
inflammasome does not play a role in response to L. pneumophila in the context 
of IFN-g priming. However, it is still possible that the NLRP3 inflammasome 
contributes to controlling L. pneumophila infection in human macrophages at a 
later timepoint, since we only looked four hours after infection. Collectively, our 
data show that caspase-1, caspase-8, and likely caspase-4 and caspase-5 
participate in inflammasome responses to L. pneumophila infection in IFN-g-










Figure 2.4. NLRP3 inflammasome activation is inhibited by MCC950, YVAD, 
ZVAD, and IETD. (A) Primary hMDMs were primed with E. coli LPS (0.5 µg/mL) 
for four hours and treated with nigericin (10 µM) for four hours. Inhibitors were 
added one hour before addition of nigericin. IL-1b and IL-18 levels in the 
supernatant were measured by ELISA. Shown are the results representative of 
three independent experiments. *P< 0.05, ***P< 0.001, ****P< 0.0001 by unpaired 
t-test.  
 
2.4.3. IFN-g upregulates human GBPs.  
IFN-g induces expression of a large number of genes that contribute to 
antimicrobial defense. In mice, two IFN-inducible gene families that promote 
inflammasome activation in macrophages are the GBPs and IRGs. Their assigned 
functions include binding and rupturing the phagosome of vacuolar pathogens, as 
well as directly lysing bacteria that escape the phagosome and enter the cytosol 
(B. C. Liu et al., 2018; Man et al., 2016; Meunier et al., 2014; Meunier et al., 2015). 
These activities lead to release of pathogen-derived products such as 
lipopolysaccharide (LPS) and DNA into the cytosol, resulting in downstream 
inflammasome activation. Mice have 11 GBPs and 23 IRGs, whereas humans 
have seven GBPs and two IRG genes (Bekpen et al., 2005). Human GBPs, like 










































their murine counterparts, are IFN-inducible, whereas human IRGs are not induced 
by IFN stimulation (Bekpen et al., 2005; Lagrange et al., 2018; Qin et al., 2017).  
Thus, we chose to test whether human GBPs might play a role in the 
enhanced inflammasome responses of IFN-g-primed cells to L. pneumophila. We 
first asked whether GBP expression is upregulated by IFN-g in THP-1-derived 
macrophages and hMDMs. In THP-1 cells, we found that expression of all GBPs 
was induced in response to IFN-g, and GBP1-5 mRNA levels were significantly 
upregulated in hMDMs following IFN-g treatment (Fig. 2.5 A and B). Following IFN-
g-priming, we observed high relative expression of GBP1, GBP2, GBP3, GBP4, 
and GBP5, whereas there was very low relative expression of GBP6 and GBP7 in 
THP-1 cells (Fig. 2.6 A) and hMDMs (Fig. 2.6 B), in agreement with previous 
findings (Lagrange et al., 2018). Furthermore, priming hMDMs with increasing 
amounts of IFN-g led to a dose-dependent increase in GBP mRNA levels (Fig. 2.5 
C and 2.6 C). Protein levels of GBP1, GBP2, GBP4, and GBP5 were also 
increased in a dose-dependent manner in response to IFN-g (Fig. 2.5 D). Thus, 
human GBPs are transcriptionally and translationally induced by IFN-g in 
macrophages, in agreement with previous findings (Lagrange et al., 2018; Qin et 















































Figure 2.5. Human GBPs are transcriptionally and translationally 
upregulated in response to IFN-g. PMA-differentiated THP-1 cells (A) or primary  
hMDMs (B) were either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20 
hours, respectively. (C and D) hMDMs were left unprimed or primed with IFN-g at 
the indicated concentrations for 20 hours. (A, B, C) Transcript levels of GBP1-7 
were determined by quantitative RT-PCR and fold change was calculated by 
normalizing to the housekeeping gene HPRT for each sample and then to the 
unprimed sample. Shown are the pooled results of three independent experiments 
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(B), with each data point representing the value for each experiment (A) or an 
individual donor (B). *P< 0.05, **P< 0.01, and ***P< 0.001 by paired t-test. (C) 
Shown are the pooled results of four independent experiments using hMDMs from 
different healthy human donors and each data point represents the value of an 
individual donor. (D) Immunoblot analysis was conducted on lysates for GBP1, 
GBP2, GBP4, GBP5, and b-actin. Western blot is representative of four 


































Figure 2.6. Human GBPs are transcriptionally upregulated by IFN-g in 
macrophages. PMA-differentiated THP-1 cells (A) or primary hMDMs (B) were 
either left unprimed or primed with IFN-g (100 U/mL) for 18 or 20 hours, 
respectively. (C) hMDMs were left unprimed or primed with IFN-g at the indicated 
concentrations for 20 hours. (A, B, C) Transcript levels of GBP1-7 were determined 
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normalizing to the housekeeping gene HPRT. Shown are the pooled results of 
three independent experiments (A) or six independent experiments using hMDMs 
from different healthy human donors (B), with each data point representing the 
value for each experiment (A) or an individual donor (B). *P< 0.05 and **P< 0.01 
by paired t-test. (C) Shown are the pooled results of four independent experiments 
using hMDMs from different healthy human donors and each data point represents 
the value of an individual donor.  
 
2.4.4. Human GBP1 contributes to maximal IFN-g-dependent inflammasome 
responses to L. pneumophila.  
Since GBP1-5 were significantly upregulated in hMDMs, we next wanted to 
test whether these GBPs play a role in human inflammasome responses to L. 
pneumophila. We therefore individually silenced expression of GBP1-5 prior to 
IFN-g treatment and T4SS+ Lp infection in hMDMs. Notably, specific knockdown 
of GBP1 significantly decreased cell death and IL-1b and IL-18 secretion following 
L. pneumophila infection in IFN-g-primed hMDMs, indicating that GBP1 plays a 
non-redundant role in inflammasome responses against L. pneumophila infection 
(Fig. 2.7 A and B). Importantly, we do not observe complete decrease of cell death 
and cytokine release upon knockdown of human GBP1. This indicates that human 
GBP1 plays a partial role in promoting inflammasome responses during L. 
pneumophila infection, possibly through rupture of the LCV or bacteriolysis of the 
outer membrane in order for release of L. pneumophila components into the 
cytosol for inflammasome sensing. Additionally, we notice that the cell death is 
around 20% upon GBP1 knockdown of IFN-g-primed hMDMs (Fig. 2.7 A), which is 
comparable to the amount of cell death we observe in unprimed hMDMs (Fig. 2.1 
D). Thus, the remaining cell death observed is most likely due to inflammasome 
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activation by secreted T4SS effector molecules as well as cell stress signals that 
are typically activated upon detection of L. pneumophila. GBP3 knockdown 
resulted in significantly decreased IL-1b release but did not affect cell death or IL-
18 release. In contrast, knockdown with siRNAs against GBP2, 4, and 5 did not 
decrease cell death or cytokine secretion. Furthermore, we examined the 
knockdown efficiencies for hMDMs treated with siRNA for each GBP and found 
that siRNA knockdown was specific for each GBP and did not affect the expression 
levels of the remaining GBPs (Fig. 2.7 C). Collectively, these data indicate that 
human GBP1 is important for promoting maximal cell death and IL-1 family 
cytokine release.  
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Figure 2.7. GBP1 is required for maximal inflammasome activation. Primary 
hMDMs were transfected with 30 nM siRNA specific for individual GBP or 
scrambled control siRNA (siControl), primed with IFN-g (100 U/mL) overnight, and 
infected with T4SS+ Lp for four hours. (A) Cell death was measured using lactate 
dehydrogenase release assay and normalized to mock infected cells. (B) IL-1b and 
IL-18 levels in the supernatant were measured by ELISA. (C) Transcript levels of 
GBP1-5 in ‘mock’ samples were determined by quantitative RT-PCR and fold 
change was calculated by normalizing to the housekeeping gene HPRT for each 












































































































































































































































































































































































































































































































































































































of three independent experiments using hMDMs from different healthy human 
donors. (A and B) Each data point represents the mean of triplicate infected wells 
from an individual donor. *P< 0.05, **P< 0.01, and ***P< 0.001 by paired t-test. (C) 
Each data point represents the value of an individual donor.      
 
2.4.5. IFN-g promotes GBP localization to L. pneumophila in a T4SS-
dependent manner.  
Since our data indicated that human GBP1 is required for maximal 
inflammasome activation during infection with L. pneumophila, we next wanted to 
elucidate how GBP1 could be promoting this response. Mouse Gbp2 colocalizes 
with S. Typhimurium and promotes the rupture of the Salmonella-containing 
vacuole (SCV), while its predicted human ortholog, GBP1, was recently shown to 
target and bind the outer membrane of S. Typhimurium to form a GBP complex 
and disrupt the membrane integrity for recruitment and activation of caspase-4 
(Fisch et al., 2019; Fisch et al., 2020; Kutsch et al., 2020; Meunier et al., 2014; 
Santos et al., 2020; Wandel et al., 2020). In addition, recent findings showed that 
human GBP1 directly binds to gram-negative bacteria including L. pneumophila, 
although they did not determine whether GBP1 binds to the LCV or outer 
membrane (Kutsch et al., 2020). We hypothesized that human GBP1 might play a 
similar role as mouse Gbp2 during S. Typhimurium infection and would be 
predicted to colocalize with the LCV for vacuolar rupture in IFN-g-primed 
macrophages. To test this hypothesis, we infected IFN-g-primed and unprimed 
hMDMs with dsRED-expressing T4SS+ Lp and stained for GBP1. While there was 
little to no GBP1 expression or colocalization with L. pneumophila in unprimed 
cells, there was a significant increase in the percentage of infected cells containing 
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GBP1-positive L. pneumophila following IFN-g priming (Fig. 2.8 A and B). 
Approximately 60% of infected cells contained L. pneumophila that colocalized 
with GBP1. In contrast, GBP1 was distributed throughout the cytoplasm in 
uninfected IFN-g-primed hMDMs (Fig. 2.9 A). The secondary antibodies used for 
anti-GBP1 staining did not associate with L. pneumophila when used alone and 
only stained cells when primary anti-GBP1 antibodies were used (Fig. 2.9 B). 
These data indicate that GBP1 is recruited to L. pneumophila and/or the LCV within 
IFN-g-primed hMDMs.    
While it is unclear whether GBP1 binds to the LCV or the bacterial outer 
membrane, human GBP1 colocalizes with the outer membrane of the cytosolic 
bacterium, S. flexneri, and additional GBPs are also recruited to inhibit its actin 
motility (Piro et al., 2017; Wandel et al., 2017). Thus, we tested whether GBP2 
also localized to L. pneumophila. We also observed a significantly increased 
percentage of hMDMs harboring GBP2+ L. pneumophila following IFN-g priming 
compared to unprimed cells (Fig. 2.8 C and D), although to a lower extent 
compared to GBP1+ L. pneumophila. Furthermore, secondary antibodies used for 
anti-GBP2 staining did not stain when used alone and only colocalized with L. 
pneumophila when primary anti-GBP2 antibodies were used (Fig. 2.9 C). 
Collectively, these findings show that both GBP1 and GBP2 are recruited to L. 
pneumophila and/or the LCV in IFN-g-primed hMDMs. 
In mouse macrophages, colocalization of GBPs with L. pneumophila is 
dependent on the T4SS, while GBP colocalization with Yersinia 
pseudotuberculosis requires the presence of type III secretion system translocon 
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components (E. M. Feeley et al., 2017; Zwack et al., 2017). These findings indicate 
that murine GBPs respond to secretion systems that are key signatures of bacterial 
virulence. It is also possible that GBPs associate with the virulence factors 
secreted by these pathogens to aid in the process of PCV rupture and bacterial 
access to the cytosol. However, whether human GBPs also detect PCVs that 
contain bacteria expressing virulence-associated secretion systems is unclear. 
Notably, only T4SS+ Lp, but not T4SS- Lp, exhibited robust colocalization with 
GBP1 and GBP2 in IFN-g-primed hMDMs (Fig. 2.8 E-H). Collectively, these data 
suggest that GBP1 and GBP2 are upregulated in response to IFN-g priming and 





Figure 2.8. IFN-g promotes the colocalization of GBP1 and GBP2 with L. 
pneumophila in a T4SS-dependent manner. (A-D) Primary hMDMs were either 
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expressing T4SS+ Lp for two hours. Representative fluorescence micrographs of 
anti-GBP1 (A) or anti-GBP2 (C) antibody staining in dsRED-T4SS+ Lp-infected 
hMDMs and quantification of the percentage of hMDMs containing GBP1+ Lp (B) 
or GBP2+ Lp (D) out of total infected hMDMs. Graphs show the mean and s.d. of 
technical triplicates and data are representative of three independent experiments 
using hMDMs from different healthy human donors. **P< 0.01 by unpaired t-test. 
(E-H) Primary hMDMs were primed with IFN-g (100 U/mL) overnight and infected 
with dsRED-expressing T4SS- Lp or T4SS+ Lp for two hours. Representative 
fluorescence micrographs of anti-GBP1 (E) or anti-GBP2 (G) antibody staining in 
dsRED-T4SS- or dsRED-T4SS+ Lp-infected hMDMs and quantification of the 
percentage of hMDMs containing GBP1+ Lp (F) or GBP2+ Lp (H) out of total 
infected hMDMs. Graphs show the mean and s.d. of technical triplicates and data 
are representative of two independent experiments using hMDMs from different 
























Figure 2.9. GBP1 is distributed throughout the cytoplasm in uninfected 
hMDMs. Primary hMDMs were either left unprimed or primed with IFN-g (100 
U/mL) overnight and infected with dsRED-expressing T4SS+ Lp or left uninfected 
for two hours. (A) Representative fluorescence micrographs of anti-GBP1 staining 
in uninfected hMDMs. (B and C) Representative fluorescence micrographs of 
dsRED-T4SS+ Lp-infected hMDMs stained with only secondary-antibody anti-
rabbit (B) or anti-mouse (C) Alexa Fluor 488. (A, B, C) Images are representative 

































2.4.6. IFN-g and GBP1 promote the rupture of LCVs.  
We next wanted to determine how IFN-g and GBP1 promote increased 
inflammasome activation during L. pneumophila infection. We first tested whether 
IFN-g treatment results in an increase of ruptured LCVs, which would allow L. 
pneumophila to become more accessible for recognition by cytosolic 
inflammasome sensors. We utilized a differential permeabilization assay to 
distinguish between vacuolar and cytosolic L. pneumophila in the presence and 
absence of IFN-g priming (Meunier & Broz, 2015). We compared unprimed and 
IFN-g-primed hMDMs that were infected with dsRED-expressing T4SS+ Lp and 
then treated with the detergent digitonin, which selectively permeabilizes the 
plasma membrane while leaving intracellular membranes intact. The cells were 
then immunostained with an antibody for L. pneumophila, followed by staining with 
an Alexa 488-labeled secondary antibody that fluoresces green. Thus, dsRED-
expressing L. pneumophila contained within an intact vacuole only fluoresce red, 
while dsRED-expressing L. pneumophila within a ruptured vacuole will fluoresce 
both green and red (Fig. 2.10 A). We found that a significantly increased 
percentage of hMDMs primed with IFN-g contained L. pneumophila that stained 
with anti-L. pneumophila antibody and fluoresced green compared to unprimed 
cells (Fig. 2.10 B and C). We observed around 25% of unprimed hMDMs contained 
cytosolic L. pneumophila, which may be due to additional IFN-independent host 
factors that contribute to the targeting and destabilization of the LCV. Treatment 
with the detergent saponin, which permeabilizes all cell membranes, resulted in 
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similar percentages of unprimed and IFN-g-primed hMDMs containing bacteria that 
were stained by anti-L. pneumophila antibody (Fig. 2.11 A and B). The secondary 
antibody stained only in the presence of anti-L. pneumophila antibody (Fig. 2.11 
C), indicating that the secondary antibody does not bind to L. pneumophila directly. 
These results indicate that IFN-inducible host factors promote rupture of the LCV, 
resulting in increased L. pneumophila exposure to the host cell cytosol. 
Since GBP1 colocalizes with L. pneumophila (Fig. 2.8 A and B) and GBP1 
is important for maximal inflammasome responses to L. pneumophila in IFN-g-
primed hMDMs (Fig. 2.7), we hypothesized that GBP1 might contribute to the 
disruption of LCV integrity. Therefore, we conducted the phagosome integrity 
assay in GBP1-silenced IFN-g-primed hMDMs. We confirmed efficient and specific 
GBP1 knockdown at the mRNA and protein levels compared to control siRNA 
treatment (Fig. 2.10 D and E). Additionally, a significantly lower percentage of 
infected hMDMs treated with GBP1 siRNA contained GBP1+ L. pneumophila 
compared to control siRNA-treated hMDMs (Fig. 2.11 D and E). Interestingly, a 
significantly decreased percentage of GBP1 siRNA-treated hMDMs contained 
bacteria that were stained by anti-L. pneumophila antibody following digitonin 
permeabilization compared to hMDMs treated with control siRNA (Fig. 2.10 F and 
G), indicating that there is a significant decrease in the percentage of cells 
containing ruptured LCVs following GBP1 knockdown. In contrast, following 
saponin permeabilization of all cellular membranes, a similar percentage of 
hMDMs contained bacteria that stained positive for anti-L. pneumophila antibody 
following control or GBP1 siRNA treatment (Fig. 2.11 G and H), whereas staining 
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with secondary antibody alone revealed negligible background staining (Fig. 2.11 
F and I). Collectively, these findings indicate that GBP1 plays a key role in IFN-g-
dependent disruption of the LCV in primary human macrophages, thus allowing for  
increased access of L. pneumophila to the host cell cytosol.  
 
Figure 2.10. IFN-g and GBP1 promote the rupture of LCVs in hMDMs. (A) 
Schematic of vacuolar Lp, which fluoresces red, and cytosolic Lp, which is stained 
green and fluoresces red. (B and C) Primary hMDMs were either left unprimed or 
primed with IFN-g (100 U/mL) overnight and infected with dsRED-expressing 
T4SS+ Lp for two hours. (B) Representative fluorescence micrographs of anti-Lp 
antibody staining followed by Alexa 488-conjugated secondary antibody staining 
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of the percentage of hMDMs harboring cytosolic Lp out of total infected hMDMs. 
(D-G) Primary hMDMs were transfected with 5 pmol siRNA specific for GBP1 
(siGBP1) or scrambled control siRNA (siControl) for at least 48 h, primed with IFN-
g (100 U/mL) overnight, and infected with dsRED-expressing T4SS+ Lp for two 
hours. (D) GBP1 transcript levels in ‘mock’ samples were determined by 
quantitative RT-PCR. Fold change was calculated by normalizing to the 
housekeeping gene HPRT and then to the siControl sample. (E) Immunoblot 
analysis was conducted on ‘mock’ lysates for GBP1, GBP2, and b-actin. (F) 
Representative fluorescence micrographs of anti-Lp antibody staining followed by 
Alexa 488-conjugated secondary antibody staining in digitonin-permeabilized 
dsRED-T4SS+ Lp-infected hMDMs. (G) Quantification of the percentage of 
hMDMs harboring cytosolic Lp out of total infected hMDMs. Graphs show the mean 
and s.d. of technical triplicates and data are representative of three independent 
experiments using hMDMs from different healthy human donors. *P<0.05 and **P< 
0.01 by unpaired t-test. (D and E) Data are representative of three independent 









Figure 2.11. Controls for phagosome integrity assay and GBP1 
immunostaining assay. (A-C) Primary hMDMs were either left unprimed or 
primed with IFN-g (100 U/mL) overnight and infected with dsRED-expressing 
T4SS+ Lp for two hours. (A) Representative fluorescence micrographs of anti-Lp 
primary antibody and Alexa Fluor 488-conjugated anti-rabbit secondary antibody 
staining in saponin-permeabilized unprimed and IFN-g-primed dsRED-T4SS+ Lp-
infected hMDMs and (B) quantification of the percentage of anti-Lp antibody (Ab) 
positive hMDMs out of total infected hMDMs. (C) Representative fluorescence 
micrographs of unprimed and IFN-g-primed dsRED-T4SS+ Lp-infected hMDMs 
stained with only secondary-antibody anti-rabbit Alexa Fluor 488 as a control for 
digitonin phagosome integrity assay. (D-I) Primary hMDMs were transfected with 
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for at least 48 h, primed with IFN-g (100 U/mL) overnight, and infected with dsRED-
expressing T4SS+ Lp for two hours. (D) Representative fluorescence micrographs 
of anti-GBP1 antibody staining in dsRED-T4SS+ Lp-infected hMDMs. (E) 
Quantification of the percentage of hMDMs containing GBP1+ Lp out of total 
infected hMDMs. (F) Representative fluorescence micrographs of IFN-g-primed 
siControl and siGBP1 dsRED-T4SS+ Lp-infected hMDMs stained with only Alexa 
Fluor 488-conjugated anti-rabbit secondary antibody as a control for GBP1 
immunostaining assay. (G) Representative fluorescence micrographs of anti-Lp 
primary antibody and Alexa Fluor 488-conjugated anti-rabbit secondary antibody 
staining in saponin-permeabilized IFN-g-primed siControl and siGBP1 dsRED-
T4SS+ Lp-infected hMDMs and (H) quantification of the percentage of anti-Lp Ab 
positive hMDMs out of total infected hMDMs. (I) Representative fluorescence 
micrographs of IFN-g-primed siControl and siGBP1 dsRED-T4SS+ Lp-infected 
hMDMs stained with only Alexa Fluor 488-conjugated anti-rabbit secondary 
antibody as a control for digitonin phagosome integrity assay. (A-I) Data and 
images are representative of three independent experiments using hMDMs from 




Our data reveal that human GBP1 is crucial for robust inflammasome 
activation in response to L. pneumophila infection in IFN-g-primed primary human 
macrophages. These findings are the first to report the role of human GBPs in 
inflammasome activation in response to L. pneumophila infection. We show that 
IFN-g leads to enhanced cell death and proinflammatory cytokine release during 
L. pneumophila infection and that this inflammasome response involves caspase-
1, capsase-4, caspase-5, and GSDMD processing. Although we conclude that 
IFN-g-primed cells lead to a T4SS-dependent inflammasome response to L. 
pneumophila, we did observe a small but significant amount of cytokine release in 
IFN-g-primed THP-1 cells that were infected with T4SS- Lp compared to unprimed 
cells. However, IFN-g-primed THP-1 cells infected with T4SS- Lp showed 
significantly decreased cell death and cytokine release compared to cells infected 
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with T4SS+ Lp, indicating that there is a T4SS-dependent inflammasome 
response. The reason for release of cytokines upon infection with T4SS- Lp may 
be due to an alternative IFN-dependent innate immune pathway that is 
independent of GBPs, since we did not observe GBP localization to T4SS- Lp, and 
would be of interest to investigate in the future. We also find that GBP1 colocalizes 
with L. pneumophila in a T4SS-dependent manner and promotes increased access 
of L. pneumophila to the host cell cytosol, indicating that GBP1 facilitates disruption 
of the LCV. Our findings suggest a model in which human GBP1 promotes the 
liberation of L. pneumophila components into the host cell cytosol to allow for 
increased inflammasome sensing and activation. Intriguingly, murine GBPs do not 
disrupt the LCV, but rather promote outer membrane disruption of cytosolic L. 
pneumophila (B. C. Liu et al., 2018). Together, these findings suggest that human 
and murine GBPs play distinct roles in mediating inflammasome responses against 
L. pneumophila. 
Although mice encode 11 GBPs and humans encode seven GBPs, there 
are some GBPs shared between mice and humans, with mouse Gbp2 and Gbp5 
thought to be the orthologs of human GBP1 and GBP5, respectively (Olszewski et 
al., 2006). These murine orthologs may provide insight into the functions of human 
GBPs, since most experimental studies aimed at elucidating GBP functions have 
been conducted in mice. Mouse GBPs colocalize with pathogens that harbor 
bacterial secretion systems or bacterial translocon components (E. M. Feeley et 
al., 2017; Zwack et al., 2017). Mouse Gbp2 promotes lysis of the SCV and 
activation of the noncanonical inflammasome, while its ortholog human GBP1 
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colocalizes with S. Typhimurium and promotes caspase-4-mediated pyroptosis 
(Fisch et al., 2019; Meunier et al., 2014). Mouse GBPs do not mediate vacuole 
disruption for other bacterial pathogens, but instead facilitate lysis of cytosolic 
bacteria (B. C. Liu et al., 2018; Meunier et al., 2014; Meunier et al., 2015). Whether 
human GBP1 is recruited to pathogen-containing vacuoles and whether it 
promotes lysis of pathogen-containing vacuoles or bacteria was unknown. 
Importantly, our findings reveal that GBP1 targets the LCV in a T4SS-dependent 
manner and furthermore, that GBP1 promotes vacuolar disruption and increased 
exposure of L. pneumophila to the host cell cytosol. Thus, human and mouse 
orthologs may have both distinct and overlapping functions. Additional studies will 
further elucidate the roles of human GBPs in response to other bacterial infections.  
Our data show that human GBP1 and GBP2 colocalize with L. pneumophila 
in a T4SS-dependent manner, but whether and how these GBPs are recruited and 
bound to the LCV and/or bacterial outer membrane still remains to be determined. 
Mouse Gbp2 colocalizes with bacterial pathogens containing bacterial secretion 
systems in a galectin-3-dependent manner (E. M. Feeley et al., 2017). Whether 
galectins facilitate human GBP1 recruitment to pathogen-containing vacuoles is 
unknown. Furthermore, human and mouse GBP1, GBP2, and GBP5 have a C-
terminal CaaX prenylation motif that facilitates membrane binding and 
oligomerization with other GBPs (Vestal & Jeyaratnam, 2011). Human GBP1 
colocalizes to the outer membrane of S. flexneri and colocalizes with S. 
Typhimurium in a manner dependent on its isoprenylation and GTPase activity 
(Fisch et al., 2019; Piro et al., 2017; Wandel et al., 2017). In addition, human GBP1 
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colocalizes with a S. flexneri mutant lacking the O-antigen less frequently than with 
the wild-type strain, indicating that host recognition of O-antigen enables GBP1 
targeting to S. flexneri (Piro et al., 2017). It would be of interest to determine 
whether the CaaX motif in human GBP1 and GBP2 are necessary for 
colocalization with L. pneumophila and what bacterial or vacuolar components they 
are binding to. Although we found that GBP2 colocalized with L. pneumophila, 
siRNA-mediated silencing of GBP2 did not have an effect on inflammasome 
activation. It is possible that GBP2 is not required for inflammasome responses to 
L. pneumophila or that siRNA-mediated knockdown in primary hMDMs was not 
efficient enough to reveal a role for GBP2. Further studies will discern between 
these possibilities. Since we found that GBP1 promotes inflammasome activation, 
it would also be of interest to determine whether GBP1 may act as an initiator GBP 
that recruits additional GBPs, similar to what has been observed with S. flexneri 
(Li et al., 2017; Piro et al., 2017; Wandel et al., 2017), and whether there is a 
synergistic role for human GBPs. 
Inflammasome activation is triggered in response to sensing of bacterial 
products within the cytosol. Vacuolar localization of L. pneumophila within its ER-
derived vacuole would presumably limit the ability of host cells to recognize L. 
pneumophila components. However, when the integrity of the LCV is 
compromised, either by host factors or in the case of bacterial mutants that cannot 
maintain vacuolar integrity L. pneumophila becomes more accessible for 
recognition by host cytosolic sensors (B. C. Liu et al., 2018). We show that IFN-g 
priming in primary human macrophages results in an increased frequency of 
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ruptured LCVs, indicating that IFN-inducible host cell factors promote disruption of 
the LCV. Our data indicate that GBP1 is one such factor. While we cannot formally 
conclude that GBP1-mediated rupture of the LCV is the proximal cause of 
downstream inflammasome activation, this rupture likely results in increased 
exposure of L. pneumophila products to the host cell cytosol, thus making the 
bacteria vulnerable to inflammasome sensing. Human GBPs may also target and 
promote destabilization of the outer membrane of L. pneumophila to enable the 
release of bacterial components, including LPS and DNA, for inflammasome 
sensing. Murine GBPs encoded on chromosome 3 promote the disruption of the 
outer membrane of the cytosolic L. pneumophila mutant lacking the effector SdhA, 
which is important for maintaining the vacuole integrity of the LCV (B. C. Liu et al., 
2018). Mouse macrophages lacking chromosome 3 GBPs that were infected with 
the DsdhA mutant showed a decrease in pyroptosis and release of DNA into the 
cytosol, indicating that one or more chromosome 3 GBPs contribute to 
inflammasome activation in response to cytosolic bacteria. Since mouse GBPs 
mediate the disruption of cytosolic L. pneumophila, it is possible that human GBP1 
or other GBPs may also enable disruption of the L. pneumophila outer membrane 
to release bacterial components that subsequently lead to inflammasome 
activation.  
Overall, our findings reveal a critical role for IFN-g and human GBP1 in 
promoting human inflammasome responses against L. pneumophila. In particular, 
our study illuminates a key function for human GBP1 in disrupting the pathogen-
containing vacuole. These findings indicate that human GBPs have distinct roles 
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compared to mouse GBPs in promoting inflammasome responses to L. 
pneumophila and provide insight into human cell-autonomous responses to a 
vacuolar bacterial pathogen.  
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2.7. Materials and Methods 
2.7.1. Primary Human Samples 
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All studies on primary human monocyte-derived macrophages (hMDMs) 
were performed in compliance with the requirements of the US Department of 
Health and Human Services and the principles expressed in the Declaration of 
Helsinki. Samples obtained from the University of Pennsylvania Human 
Immunology Core are considered to be a secondary use of deidentified human 
specimens and are exempt via Title 55 Part 46, Subpart A of 46.101 (b) of the 
Code of Federal Regulations. 
 
2.7.2. Cell Culture 
THP-1 cells (TIB-202; American Type Culture Collection) were maintained 
in RPMI supplemented with 10% (vol/vol) heat-inactivated FBS, 0.05 nM b-
mercaptoethanol, 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37°C in a 
humidified incubator. The day before stimulation, cells were replated in media 
without antibiotics in a 48-well plate at a concentration of 2 × 105 cells per well or 
in a 96-well plate at a concentration of 1 × 105 cells per well and incubated with 
phorbol 12-myristate 13-acetate (PMA) for 24 hours to allow differentiation into 
macrophages. Media was replaced with RPMI without serum for infections in 48-
well plate. 
Primary human monocytes from deidentified healthy human donors were 
obtained from the University of Pennsylvania Human Immunology Core. 
Monocytes were cultured in RPMI supplemented with 10% (vol/vol) heat-
inactivated FBS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin, 
and 50 ng/mL recombinant human M-CSF (Gemini Bio Products). Cells were 
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cultured for 4 days in 10 mL of media in 10 cm-dishes at 4-5 × 105 cells/mL, 
followed by addition of 10 mL of fresh growth media for an additional 2 days for 
complete differentiation into macrophages. The day before macrophage 
stimulation, cells were rinsed with cold PBS, gently detached with trypsin-EDTA 
(0.05%) and replated in media without antibiotics and with 25 ng/mL M-CSF in a 
48-well plate at a concentration of 1 × 105 cells per well or in a 24-well plate at a 
concentration of 2 × 105 cells per well.  
 
2.7.3. Macrophage Stimulation 
In infection experiments, PMA-differentiated THP-1 cells and primary 
human monocyte-derived macrophages (hMDMs) were either left unprimed or 
were primed overnight with recombinant human IFN-g (R&D Systems) at a 
concentration of 100 U/mL. In dose-response experiments, hMDMs were either left 
unprimed or primed with 0.1, 1, 10, or 100 U/mL of IFN-g for 20 hours. 
 
2.7.4. Bacterial Strains and Macrophage Infection 
All Legionella pneumophila infections used strains derived from the serogroup 1 
clinical isolate Philadelphia-1. Where indicated, strains utilized were derived from 
the Lp02 strain (rpsL, hsdR, thyA), which is a thymidine auxotroph. The isogenic 
Lp02 (rpsL, hsdR, thyA) flagellin mutant, DflaA (T4SS+ Lp), and avirulent dotA 
mutant, Lp03 (T4SS- Lp), which are both thymidine auxotrophs, were used to infect 
PMA-differentiated THP-1 cells and primary hMDMs (Berger & Isberg, 1993; 
Berger et al., 1994; Ren et al., 2006). DflaA (T4SS+) or DdotA (T4SS-) L. 
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pneumophila strains on the JR32 background (rpsL, hsdR) carrying pSW001, 
which allows for constitutive dsRED expression, were used in 
immunofluorescence experiments (Mampel et al., 2006; Marra & Shuman, 1989). 
All L. pneumophila strains were grown as a stationary patch for 48 hours on 
charcoal yeast extract agar plates at 37°C (J. C. Feeley et al., 1979). Bacteria were 
resuspended in PBS and added to the cells at a multiplicity of infection (MOI) of 10 
in 48-well and 24-well plate experiments. Infected cells were then centrifuged at 
290 × g for 10 min and incubated at 37°C. For immunofluorescence experiments, 
primary hMDMs were infected for 2 hours. For infection experiments involving 
THP-1-derived macrophages, cells were infected for 2 hours. For additional 
infection experiments involving primary hMDMs, cells were infected for 4 hours. 
For all experiments, mock-infected cells were treated with PBS.  
 
2.7.5. Inhibitor Treatments  
25 µM of caspase-1 inhibitor Ac-YVAD-cmk (Sigma-Aldrich SML0429), 20 
µM of caspase-8 inhibitor Z-IETD-FMK (SM Biochemicals SMFMK004), 20 µM of 
pan-caspase inhibitor Z-VAD(Gomes et al.)-FMK (SM Biochemicals SMFMK001), 
and 1 µM of NLRP3 inhibitor MCC950 (Sigma-Aldrich PZ0280) were added to 
primary hMDMs 1 hour before infection.  
 
2.7.6. NLRP3 Inflammasome Assay 
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The NLRP3 inflammasome was activated by priming primary hMDMs with 
0.5 µg/mL E. coli LPS (055:B5;Sigma) for 4 hours followed by 10 µM nigericin 
treatment for 4 hours. 
 
2.7.7. siRNA-Mediated Knockdown 
All of the Silencer Select siRNA oligos targeting human GBP mRNA were 
purchased from Thermo Fisher Scientific. Individual siRNA targeting GBP1 
(s5620), GBP2 (s5623), GBP3 (5628), GBP4 (s41805), and GBP5 (s41810) were 
used. The two Silencer Select negative control siRNAs (Silencer Select Negative 
Control No. 1 siRNA and Silencer Select Negative Control No. 2 siRNA) were 
purchased from Life Technologies (Ambion). In experiments where GBP1-5 were 
individually knocked down, primary hMDMs were replated in media without 
antibiotics in a 48-well plate, as described above, three days before infection. Two 
days before infection, 30 nM of total siRNA were transfected into macrophages 
using HiPerFect transfection reagent (Qiagen) following the manufacturer’s 
protocol. 16 hours before infection, media was replaced with fresh antibiotic-free 
media containing 100 U/mL IFN-g. In immunofluorescence experiments where 
GBP1 was knocked down, primary hMDMs were replated in media without 
antibiotics on glass coverslips in a 24-well plate as described above four days 
before infection. Three days before infection, 5 pmol of total siRNA were 
transfected into macrophages using Lipofectamine RNAiMAX transfection reagent 
(Thermo Fisher Scientific) following the manufacturer’s protocol. 16 hours before 
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infection, media was replaced with fresh antibiotic-free media containing 100 U/mL 
IFN-g. 
 
2.7.8. Quantitative RT-PCR Analysis 
RNA was isolated using the Rneasy Plus Mini Kit (Qiagen) following the 
manufacturer’s protocol. Cells were lysed in 350 µL RLT buffer with b-
mercaptoethanol and centrifuged through a QIAshredder spin column (Qiagen). 
cDNA was synthesized from isolated RNA using SuperScript II Reverse 
Transcriptase (Invitrogen) following the manufacturer’s protocol. Quantitative PCR 
was conducted with the CFX96 real-time system from Bio-Rad using the SsoFast 
EvaGreen Supermix with Low ROX (Bio-Rad). Transcript levels for each gene 
were normalized to the housekeeping gene HPRT for each sample, and samples 
were normalized to unprimed sample or to control siRNA-treated sample using the 
2-DDCt (cycle threshold) method to calculate fold change. Relative expression was 
calculated by normalizing gene-specific transcript levels to HPRT transcript levels 
for each sample using the 2-DCt method. Primer sequences from primer bank used 
for HPRT1, GBP1-6, CASP4, and CASP5 or from Lagrange, et al. for GBP7 are 
the following (all 5’ à 3’):  
HPRT1 forward: CCTGGCGTCGTGATTAGTGAT 
HPRT1 reverse: AGACGTTCAGTCCTGTCCATAA 
GBP1 forward: AGGAGTTCCTTCAAAGATGTGGA 
GBP1 reverse: GCAACTGGACCCTGTCGTT 
GBP2 forward: CTATCTGCAATTACGCAGCCT 
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GBP2 reverse: TGTTCTGGCTTCTTGGGATGA 
GBP3 forward: ATTCCCTGAAGCTAACGCAAG 
GBP3 reverse: GGGCAGATCGAAGACAAAACATT 
GBP4 forward: ATGGGTGAGAGAACTCTTCACG 
GBP4 reverse: TGCGGTATAGCCCTACAATGG 
GBP5 forward: CCATGTGCCTCATCGAGAACT 
GBP5 reverse: ACAGGTTGCGTAATGGCAGAC 
GBP6 forward: ATGGAATCTGGACCCAAAATGTT 
GBP6 reverse: GCTGGTTCACCAATAGCTGCT 
GBP7 forward: TGCCTTCTTACCAAGTCCAGA 
GBP7 reverse: TCTCTGATGCCATGTTCAGG 
CASP4 forward: TCTGCGGAACTGTGCATGATG 
CASP4 reverse: TGTGTGATGAAGATAGAGCCCAT 
CASP5 forward: TCACCTGCCTGCAAGGAATG 
CASP5 reverse: TCTTTTCGTCAACCACAGTGTAG 
 
2.7.9. LDH Cytotoxicity Assay 
Macrophages were infected in a 48-well plate as described above and 
harvested supernatants were assayed for cell death by measuring loss of cellular 
membrane integrity via lactate dehydrogenase (LDH) activity. LDH release was 
quantified using an LDH Cytotoxicity Detection Kit (Clontech) according to the 
manufacturer’s instructions and normalized to mock-infected cells.  
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2.7.10. Real-Time Propidium Iodide Uptake Assay 
To measure live kinetics of cell membrane permeability, THP-1 cells were 
plated as described above in a black, flat-bottom 96-well plate (Cellstar), primed 
with 100 U/mL IFN-g for 24 hours, and infected with T4SS+ Lp at an MOI of 50 in 
media containing 1X HBSS without phenol red, 20 mM HEPES, and 10% (vol/vol) 
heat-inactivated FBS. Infected cells were centrifuged at 290 × g for 10 min. The 
cells were supplemented with 5 µM propidium iodide (PI, P3566, Invitrogen) and 
incubated for 10 min at 37°C to allow the cells to equilibrate. Then, the plate was 
sealed with adhesive optical plate sealing film (Microseal, Bio-Rad) and placed in 
a Synergy H1 microplate reader (BioTek) pre-heated to 37°C. PI fluorescence was 
measured every hour for 4 hours.  
 
2.7.11. ELISA 
Macrophages were infected in a 48-well plate as described above and 
harvested supernatants were assayed for cytokine levels using ELISA kits for 
human IL-1b (BD Biosciences) and IL-18 (R&D Systems). 
 
2.7.12. Immunoblot Analysis 
In experiments where macrophages were plated in a 48-well plate, cells 
were lysed in 1X SDS/PAGE sample buffer, and low-volume supernatants (90 µL 
media per well of a 48-well plate) were mixed 1:1 with 2× SDS/PAGE sample buffer 
containing Complete Mini EDTA-free Protease Inhibitor Mixture (Roche). In 
experiments where primary hMDMs were plated in a 24-well plate and infected 
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with T4SS- Lp, T4SS+ Lp, or mock infected with PBS, cells were lysed in 1X 
SDS/PAGE sample buffer, and supernatants were treated with trichloroacetic acid 
(TCA) overnight at 4°C and centrifuged at maximum speed for 15 min. Precipitated 
supernatant pellets were washed with ice-cold acetone, centrifuged at maximum 
speed for 10 min, and resuspended in 1X SDS/PAGE sample buffer. Protein 
samples were boiled for 5 min, separated by SDS/PAGE on a 12% (vol/vol) 
acrylamide gel, and transferred to PVDF Immobilon-P membranes (Millipore). 
Primary antibodies specific for human IL-1b (clone 8516; R&D Systems), caspase-
1 (2225S; Cell Signaling), caspase-4 (4450S; Cell Signaling), caspase-5 (D3G4W; 
46680S; Cell Signaling), Gasdermin-D (126-138; G7422; Sigma-Aldrich), GBP1 
(ab131255, Abcam), GBP2 (sc-271568, Santa Cruz), GBP4 (17746-1-AP, 
Proteintech), GBP5 (D3A5O, 67798S; Cell Signaling) and b-actin (4967L; Cell 
Signaling) were used. HRP-conjugated secondary antibodies anti-rabbit IgG 
(7074S; Cell Signaling) and anti-mouse IgG (7076S; Cell Signaling) were used. 
For detection, ECL Western Blotting Substrate or SuperSignal West Femto (both 
from Pierce Thermo Scientific) were used as the HRP substrate.  
 
2.7.13. Immunofluorescence Microscopy  
Primary hMDMs were plated on glass coverslips in a 24-well plate as 
described above. After 2 hours of infection with dsRED-Lp, cells were washed 2 
times with PBS and fixed with 4% paraformaldehyde for 10 min at 37°C. Following 
fixation, cells were washed and permeabilized with 0.2% Triton X-100 for 10 min. 
Cells were washed, blocked with 10% BSA for 1 hour, and stained with primary 
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antibodies (identified below) for 1 hour. Cells were washed with PBS and incubated 
with the appropriate Alexa-Fluor-conjugated secondary antibodies (identified 
below) for 1 hour, followed by washes and mounted on glass slides with DAPI 
mounting medium (Sigma Fluoroshield). Primary antibodies used were rabbit anti-
GBP1 (1:100 dilution; Abcam) and mouse anti-GBP2 (1:50 dilution; Santa Cruz). 
Secondary antibodies used at a dilution of 1:4000 were goat anti-rabbit conjugated 
to Alexa Fluor 488 (4412S; Cell Signaling) and goat anti-mouse conjugated to 
Alexa Fluor 488 (A11029; Life Technologies). Coverslips were imaged on a Leica 
SP5 FLIM confocal microscope at a magnification of 63× and the percentage of 
infected cells containing GBP1+ or GBP2+ intracellular bacteria out of the total 
number of infected cells were quantified.   
 
2.7.14. Phagosome Integrity Assay 
The phagosome integrity assay was performed as previously published  
(Meunier & Broz, 2015), with some modifications. To distinguish between cytosolic 
and vacuolar bacteria, primary hMDMs were plated on glass coverslips in a 24-
well plate as described above and infected with dsRED-Lp. After 2 hours of 
infection, cells were washed 3 times with KHM buffer (110 mM potassium acetate, 
20 mM HEPES, and 2mM MgCl2, pH 7.3) and incubated for 1 min in KHM buffer 
with 50 µg/mL digitonin (Sigma-Aldrich). Cells were washed 3 times with KHM 
buffer and stained for 15 min at 37°C with primary antibody to L. pneumophila 
(1:1000 dilution; gift from Craig Roy) in KHM buffer with 3% BSA. Cells were 
washed with PBS, fixed, and quenched with 0.1 M glycine for 10 min. Cells were 
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washed and incubated with secondary antibody anti-rabbit Alexa Fluor 488 for 1 
hour, followed by washes and mounted on glass slides with DAPI mounting 
medium. Cells were analyzed by microscopy. 0.1% saponin in KHM buffer was 
used as a positive control for this assay. The percentage of infected cells harboring 
cytosolic bacteria out of the total number of infected cells were quantified.  
 
2.7.15. Statistical Analysis 
GraphPad Prism software was used for graphing of data and all statistical 
analyses. Statistical significance for experiments with THP-1 cells was determined 
using the unpaired two-way Student’s t test. Statistical significance for hMDMs was 
determined using the paired two-way t test in experiments comparing multiple 
donors and the unpaired two-way t test in experiments involving infections with 
dsRED-expressing Lp for immunofluorescence assay. In hMDM experiments that 
compare cells from multiple donors, data are graphed so that each data point 
represents the mean of triplicate wells for each donor, and all statistical analysis 
was conducted comparing the means of each experiment. Differences were 
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3.1. Abstract 
Cytosolic detection of lipopolysaccharide (LPS), the major outer membrane 
lipid component of gram-negative bacteria, is accomplished by the noncanonical 
inflammasome and leads to gasdermin-D (GSDMD)-mediated inflammatory cell 
death known as pyroptosis as well as downstream IL-1 family cytokine release. 
The noncanonical inflammasome is comprised of the cysteine protease caspase-
11 in mice, while humans possess the two putative orthologs caspase-4 and 
caspase-5. Intriguingly, LPS can vary in its acylation and phosphorylation state 
contingent on the bacterial species and its environment. Gram-negative bacteria 
containing under-acylated LPS has been shown to evade murine caspase-11 
detection in macrophages, while hexa-acylated LPS variants robustly activate the 
noncanonical inflammasome. In contrast to mice, a recent study found that LPS 
with a lower acylation state can activate the human caspase-4 noncanonical 
inflammasome. However, the role of caspase-5 still remains unclear and whether 
caspase-4 or caspase-5 can be activated in response to LPS variants with 
differential acylation and phosphorylation states has not been investigated. 
Furthermore, IFN-inducible GBPs promote noncanonical inflammasome 
responses in murine macrophages and also recently found in human 
macrophages. Whether IFN-g and human GBPs promote caspase-4 and caspase-
5 activation in response to LPS from different bacteria is unknown. Here, we test 
the human noncanonical inflammasome response to LPS variants isolated from 
Yersinia pestis that vary in the number and position of acyl chains as well as the 
number of phosphate groups in primary human macrophages. We also use THP-
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1-derived macrophages and CRISPR/Cas9 technology to delineate the roles of 
caspase-4, caspase-5, GBP1, and GBP2 in inflammasome responses to 
Legionella pneumophila or Escherichia coli LPS. We determine that caspase-4 
plays a major role in detecting E. coli LPS, whereas caspase-5 does not and that 
human GBP1 may be important for cell death in response to L. pneumophila and 
E. coli LPS. This study provides a better understanding of the distinct roles that 
caspase-4 and caspase-5 have upon sensing different LPS variants. Additionally, 
the CRISPR/Cas9 knockout clones developed in this study offer useful tools in 
order to further investigate the functions of the human noncanonical inflammasome 
and GBPs in the context of other LPS variants or bacterial infections.   
 
3.2. Significance Statement 
 Gram-negative bacterial LPS is recognized by two innate immune sensors: 
the extracellular sensor, TLR4, and the intracellular sensor, the noncanonical 
inflammasome. Detection of LPS by these sensors is crucial for combating host 
defense against gram-negative bacterial pathogens. However, overactivation of 
these pathways can lead to detrimental outcomes including sepsis, an 
overwhelming inflammatory response that can result in organ failure and ultimately 
death. As there are treatments for sepsis in mice, there are no successful approved 
treatments for sepsis in humans. In addition, the mouse noncanonical 
inflammasome is comprised of only one inflammatory caspase, caspase-11, 
whereas the human noncanonical inflammasome is made up of two inflammatory 
caspases, caspase-4 and caspase-5, and their functions are relatively poorly 
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understood. Our study focuses on determining the specific roles of caspase-4 and 
caspase-5 in response to LPS variants from different bacteria, as well as 
examining whether IFN-inducible GBPs play a role in noncanonical inflammasome 
responses. This study elucidates aspects of human innate immune responses to 
gram-negative bacterial pathogens and provides insight into identifying potential 
therapeutic targets for treating gram-negative sepsis.  
 
3.3. Introduction   
 Gram-negative bacteria cause more than 30% of hospital-acquired 
infections in the US, making them a major public health concern (Peleg & Hooper, 
2010). Additionally, antibiotic-resistance is on the rise among gram-negative 
bacterial pathogens, further highlighting the need for more therapeutic approaches 
to controlling these infections (Exner et al., 2017). Uncontrolled gram-negative 
bacterial infections can lead to detrimental outcomes including sepsis, which is an 
overwhelming systemic inflammatory immune response to an infection. If left 
untreated, the host will succumb to organ failure and ultimately death. Preclinical 
studies in mice showed successful treatments for sepsis using immunomodulators 
that functioned by neutralizing either host inflammatory mediators or microbial 
products (Marshall, 2014). However, over 100 clinical trials testing these 
immunomodulators in sepsis patients have failed. The reasons for these clinical 
trial failures are unclear but may be due to differences between murine and human 
innate immune genes that play a role in responses to gram-negative bacterial 
infections. Therefore, it is important to understand human innate immune 
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responses to gram-negative bacterial pathogens in order to identify potential novel 
therapeutic targets for the treatment of gram-negative sepsis.  
Gram-negative sepsis is caused by the bacterial endotoxin, 
lipopolysaccharide (LPS), which is the major lipid component in the outer 
membrane of gram-negative bacteria. LPS activates innate immune sensors and 
subsequently leads to host defense signaling events including inflammatory 
cytokine release as well as cell death of the infected cell. The first identified LPS 
sensor is toll-like receptor 4 (TLR4), a membrane-bound receptor located on the 
plasma membrane or endosomal compartment membrane and recognizes 
extracellular LPS (Takeuchi et al., 1999). Although TLR4 is essential for regulating 
responses to gram-negative bacteria, its dysregulation can lead to sepsis. Studies 
in mice identified an alternative LPS sensor that leads to TLR4-independent 
endotoxic shock (Hagar et al., 2013; Kayagaki et al., 2013). This second LPS 
sensor is known as the noncanonical inflammasome and recognizes LPS within 
the cytosol.  
The noncanonical inflammasome is formed by the cysteine protease 
caspase-11 in mice and the two putative orthologs, caspase-4 and caspase-5 in 
humans (Kayagaki et al., 2011; Shi et al., 2014). These inflammatory caspases 
recognize and bind LPS through their caspase activation and recruitment domain 
(CARD) resulting in their oligomerization and activation (Shi et al., 2014). Active 
caspase-11, -4, and -5 mediate cleavage of gasdermin-D (GSDMD), the initiator 
protein of pyroptosis. The N-terminal fragment of GSDMD translocates to the 
plasma membrane and oligomerizes to form a pore resulting in osmotic influx and 
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cell lysis. This GSDMD pore also leads to potassium (K+) efflux which triggers 
activation of the canonical NLRP3 inflammasome. The NLRP3 inflammasome 
involves activation of caspase-1, which also cleaves GSDMD as well as cleaves 
IL-1 family cytokines into their mature forms for their release to signal bystander 
cells, which are then activated and recruited to the site of infection. This 
noncanonical inflammasome response is crucial for controlling intracellular 
bacterial infections, but similar to TLR4, its overactivation can result in LPS-
induced septic shock. Intriguingly, humans are among the most sensitive to 
endotoxins, whereas mice are more resistant (Kajiwara et al., 2014). One 
possibility as to why humans are more sensitive to the endotoxin LPS may be due 
to the presence of two intracellular LPS sensors compared to mice that contain 
only one intracellular LPS sensor. Humans evolved to develop caspase-4 and 
caspase-5 most likely due to a gene duplication of the ancestral caspase-11 gene 
in order to recognize and respond to a variety of gram-negative bacterial 
pathogens they come into contact with. The functions of caspase-4 and caspase-
5 in response to LPS are relatively poorly understood. Therefore, we aim to 
determine how these inflammatory caspases contribute to the human 
noncanonical inflammasome response to LPS. 
LPS is made up of three distinct components: the lipid A moiety, core 
oligosaccharide, and O-antigen polysaccharide. Specifically, the lipid A moiety is 
the component that is directly recognized and bound to by the CARD domain. Lipid 
A is comprised of two glucosamine residues that contain hydrophobic acyl chains 
that vary in number, position and length depending on the bacterial species. Also 
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contingent on the bacterial species, lipid A possesses either one or two phosphate 
groups located on the 1 and/or 4’ positions of the two glucosamine residues, 
respectively, and these phosphate groups provide a negative charge that help to 
facilitate binding to the positively charged amino acid residues in the CARD 
domains of caspase-11, -4, and -5. Interestingly, some bacteria within the same 
species are able to modify their acylation and phosphorylation states, suggesting 
that changing these vital features is important for their pathogenesis and may allow 
these bacteria to evade immune detection.  
The murine noncanonical inflammasome varies in response to different LPS 
variants. It has been determined that LPS with a lower quantity of acyl chains (i.e. 
tetra-acylated) evade caspase-11 immune detection, whereas LPS containing 
higher number of acyl chains (i.e. hexa-acylated) activate caspase-11 for 
downstream pyroptosis and release of inflammatory cytokines (Hagar et al., 2013; 
Kayagaki et al., 2013). Interestingly, some penta-acylated LPS variants, such as 
Francisella novicida lpxF mutant, can activate caspase-11 (Hagar et al., 2013), 
while other penta-acylated LPS variants, like Rhizobium galegae, evade caspase-
11 detection (Kayagaki et al., 2013). This brings up the question of whether the 
number of acyl chains is the only factor involved in promoting noncanonical 
inflammasome responses. It was newly discovered that the human noncanonical 
inflammasome functions differently than the murine system. The human 
noncanonical inflammasome is activated in response to tetra-acylated LPS 
variants, including the tetra-acylated F. novicida LPS, as well as penta- and hexa-
acylated LPS variants, which indicates that the human noncanonical 
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inflammasome is activated by LPS with different acylation states (Lagrange et al., 
2018). Surprisingly, there are no other studies that further explore the human 
noncanonical inflammasome response to different LPS variants. Whether the 
position of acyl chains or the number of phosphoryl groups on lipid A play a role in 
human noncanonical inflammasome response has not been studied. 
Furthermore, IFN promotes inflammasome activation in murine 
macrophages in response to gram-negative bacteria as well as to bacterial 
components including LPS and outer membrane vesicles (OMVs) (Finethy et al., 
2017; B. C. Liu et al., 2018; Meunier et al., 2014; Meunier et al., 2015; Pilla et al., 
2014; Santos et al., 2018). Specifically, the IFN-inducible family of GTPases known 
as guanylate bindings proteins (GBPs) facilitate these enhanced inflammasome 
responses by different functions, including the rupture of pathogen-containing 
vacuoles and disruption of the outer membrane of cytosol exposed bacteria. It was 
recently determined that human GBP2 promotes noncanonical inflammasome 
responses to the tetra-acylated LPS derived from F. novicida as well (Lagrange et 
al., 2018). However, there are no additional studies that investigate whether IFN 
and GBPs promote human noncanonical inflammasome responses to other LPS 
variants from different bacteria.  
Here, we investigate the activation of the human noncanonical 
inflammasome in response to seven lipooligosaccharide variants, which lack the 
O-antigen, that were derived from Y. pestis in order to determine whether its 
activation differs in response to each LOS variant. Specifically, we explore whether 
the number of acyl chains, number of phosphoryl groups, or position of acyl chains 
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can influence human noncanonical inflammasome activation and if IFN-g can 
promote this response. Additionally, we utilize CRISPR/Cas9 technology to 
knockout either caspase-4 (CASP4), caspase-5 (CASP5), human GBP1, or 
human GBP2 in the immortalized monocytic cell line, THP-1, in order to determine 
the roles of these host proteins in response to LPS variants derived from L. 
pneumophila and E. coli. Overall, this study provides a better understanding of 
caspase-4 and caspase-5 and how IFN-g and GBPs contribute to human 




3.4.1. The human noncanonical inflammasome is activated by different LOS 
variants.  
Caspase-4 was shown to be activated in response to tetra-acylated LPS 
derived from F. novicida, as well as to penta- and hexa-acylated LPS variants from 
other bacteria (Lagrange et al., 2018). However, whether the human noncanonical 
inflammasome can be activated in response to additional LPS variants that have 
differential acylation and phosphorylation states has not been studied. To 
determine whether the human noncanonical inflammasome responds to other LPS 
variants, we tested seven different LOS variants, which lack the O-antigen, that 
were isolated from wild-type (WT) Y. pestis or different mutants of Y. pestis that 
were grown at 26°C. The variants tested include four hexa-acylated LOS, two 
penta-acylated LOS, and one tetra-acylated LOS. Specifically, the hexa-acylated 
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LOS include LOS from WT Y. pestis (358@26), a mutant that lacks one phosphate 
group at the 4’ position (468@26), a mutant that is missing an acyl chain at the 3’ 
position but has an added acyl chain at the 2 position (438@26), and a mutant that 
lacks a phosphate group at the 4’ position as well as has a missing acyl chain at 
the 2’ position and an added acyl chain at the 2 position (470@26) (Fig. 3.1 A). 
The penta-acylated LOS variants are missing an acyl chain at either the 2’ position 
(47@26) or at the 3’ position (46@26). Finally, the tetra-acylated LOS variant lacks 
the two acyl chains at the 2’ and 3’ positions (48@26). Upon transfection with these 
seven LOS variants in primary human monocyte-derived macrophages (hMDMs), 
we determined that all of the variants promote cell death and IL-1b release; 
however, it does appear that transfection of the tetra-acylated LOS, 48@26, shows 
a lower inflammasome response compared to all of the other variants (Fig. 3.1 B 
and C). This may indicate that the presence of either the 2’ or 3’ acyl chains that 
are missing in this LOS variant help to promote maximal noncanonical 
inflammasome responses in human macrophages. Overall, these data suggest 
that Y. pestis LOS variants containing different number and position of acyl chains 
as well as different number of phosphate groups all activate the human 








Figure 3.1. Yersinia pestis LOS variants of different acylation and 
phosphorylation states activate the human noncanonical inflammasome. (A) 
Schematic representations of the seven Y. pestis LOS variants. The two 
glucosamine residues, which are represented by hexagons, can have one or two 
phosphate groups (orange circles) and have either four, five, or six acyl chains 
attached that can vary in position. LOS mutants that have missing phosphate 
groups or acyl chains or have added acyl chains in a different position compared 
to the WT Y. pestis LOS (358@26) are outlined in red circles. (B and C) Primary 
hMDMs were primed with Pam3CSK4 (1 µg/mL) for four h and either mock 
transfected with FuGENE HD alone or transfected with FuGENE HD and 2 µg/mL 
LPS for 20 h. (B) Cell death was measured using lactate dehydrogenase release 




Figure 3.1. Yersinia pestis LPS variants of different acylation states activate the 
human noncanonical inflammasome. Primary hMDMs were primed with Pa 3CSK4 (1 
µg/mL) for four h and either mock transfected with FuGENE HD alone or transfected with 
FuGENE HD and 2 µg/mL LPS for 20 h. (A) Cell death was measured using lactate 
dehydrogenase release assay and normalized to mock-infected cells. (B) IL-1β levels in the 
















































were measured by ELISA. (B and C) Shown are pooled results of two to three 
independent experiments using hMDMs from different healthy human donors. 
Each data point represents the mean of duplicate wells from an individual donor. 
Bar graphs are color coated based on the number of acyl chains (Green=Hexa-
acylated, Blue=Penta-acylated, Pink=Tetra-acylated).  
 
3.4.2. IFN-g upregulates human noncanonical inflammasome responses to E. 
coli and Y. pestis LOS variants. 
IFN has been shown to promote inflammasome responses in both mouse 
and human macrophages infected with a variety of bacteria including S. 
Typhimurium, L. pneumophila, and F. novicida (Lagrange et al., 2018; B. C. Liu et 
al., 2018; Meunier et al., 2014; Meunier et al., 2015). In particular, the family of 
IFN-inducible GTPases known as GBPs are upregulated by both type I and II IFNs, 
but more robustly upregulated by the type II IFN, IFN-g, and are the key players in 
promoting these inflammasome responses. Here, we investigated whether IFN-g 
promotes human noncanonical inflammasome responses to a hexa-acylated or 
tetra-acylated LOS derived from Y. pestis. The 470@26 LOS variant produced a 
robust inflammasome response in primary human macrophages (Fig. 3.1 B and 
C); therefore, we used this hexa-acylated LOS variant to determine how IFN-g 
affects this response along with the tetra-acylated variant that did not produce as 
strong of a response. As a control, we looked at human noncanonical 
inflammasome activation in response to the hexa-acylated LOS derived from the 
W3110 E. coli strain in unprimed and IFN-g-primed THP-1-derived macrophages. 
Upon transfection of these three LOS variants in THP-1-derived macrophages, we 
observed that IFN-g priming led to a significant increase in IL-1b release compared 
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to unprimed cells (Fig. 3.2). Moreover, all of the IFN-g-primed cells have similar 
amount of IL-1b release in response to the two hexa-acylated LOS variants and 
the tetra-acylated variant. This indicates that IFN-g enhances human noncanonical 
inflammasome activation in response to differentially acylated LOS.   
Figure 3.2. IFN-g promotes human noncanonical inflammasome responses 
to E. coli and Y. pestis LOS variants. Phorbol 12-myristate 13-acetate (PMA)-
differentiated THP-1 cells were either primed overnight with IFN-g (100 U/mL) or 
left unprimed, then primed with Pam3CSK4 (1 µg/mL) for 4 h, and either mock 
transfected with FuGENE HD alone or transfected with FuGENE HD and 2 µg/mL 
LPS for 20 h. IL-1b levels in the supernatant were measured by ELISA. **P<0.01 
and ***P<0.001 by unpaired t-test.  
 
3.4.3. Development of CASP4 or CASP5 knockout THP-1 clones using 
CRISPR/Cas9 technology. 
Caspase-4 and caspase-5 comprise the human noncanonical 
inflammasome. While most studies of the noncanonical inflammasome have been 
conducted using mice and murine macrophages, there are a few studies that 
investigated caspase-4 inflammasome activation in response to different gram-
negative bacteria including L. pneumophila, E. coli, and F. novicida (Casson et al., 
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2015; Goddard et al., 2019; Lagrange et al., 2018). Very little research has looked 
into the role of caspase-5 in macrophages, which may be due to its low relative 
expression level in macrophages. However, one study using primary human 
macrophages determined that caspase-5 did not undergo processing in response 
to transfected E. coli LPS or infection with L. pneumophila, S. Typhimurium, or Y. 
pseudotuberculosis, but did undergo proteolytic cleavage in response to treatment 
with extracellular E. coli LPS (Casson et al., 2015). In contrast, this study showed 
that caspase-4 undergoes processing in response to infection with L. pneumophila 
and S. Typhimurium. These results suggest that caspase-4 and caspase-5 may 
be activated through different pathways in response to gram-negative bacteria or 
LPS. Interestingly, additional studies using human monocytes found that caspase-
5 undergoes processing in response to extracellular LPS and activation in 
response to treatment with Pseudomonas aeruginosa outer membrane vesicles 
(OMVs) (Bitto et al., 2018; Vigano et al., 2015). Thus, these results in addition to 
the primary human macrophage results indicate that caspase-5 activation may be 
initiated through an external pathway, but this has not been thoroughly 
investigated. Since caspase-5 has been shown to directly bind LPS via its CARD 
domain (Shi et al., 2014), similar to caspase-11 and caspase-4, it is likely that 
caspase-5 can be activated in response to intracellular LPS. Therefore, in order to 
investigate the distinct roles of caspase-4 (CASP4) and caspase-5 (CASP5) in 
response to intracellular LPS variants, we used the Clustered Regularly 
Interspaced Short Palindromic Repeat (CRISPR) system together with the RNA-
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guided exonuclease Cas9 to disrupt the CASP4 and CASP5 genes in the 
immortalized monocytic THP-1 cell line.  
We generated lentivirus using a lentiCRISPR version 2 plasmid, which 
contains the Cas9 protein and the guide RNA (gRNA) target sequence for either 
CASP4 or CASP5, VSV-G envelope plasmid, and psPAX2 packaging plasmid. The 
gRNA sequences for CASP4 or CASP5 are located within exonic regions of the 
gene in order to promote a double-stranded break (DSB) at the target DNA site 
within the protein coding area. Specifically, the CASP4 gRNA targets exon 3 and 
the CASP5 gRNA targets exon 5, both of which targeted sequences are 
highlighted in Fig. 3.3 A and B. This DSB results in either non-homologous end 
joining (NHEJ) or homology directed repair (HDR), which can cause base-pair 
insertions, deletions, or frameshift mutations and lead to a premature stop codon 
and nonfunctional gene. After infecting the THP-1 monocytic cell lines with the 
generated lentivirus containing either CASP4 or CASP5 gRNA and Cas9 protein, 
followed by puromycin selection and clonal selection, we expanded 12 single cell 
clones to determine whether their RNA and protein levels of CASP4 or CASP5 
were absent. Based on the decreased gene and protein expression we chose three 
clones to validate and ensure that they were clones that originated from a single 
cell. THP-1 cells are a human monocytic cell line that are derived from an acute 
monocytic leukemia patient; however, they possess a diploid karyotype, unlike 
other leukemia cell lines (Fleit & Kobasiuk, 1991). Therefore, a single cell clone 
should therefore contain only two allelic mutations at the target sequence. Of the 
three clones chosen for the CASP5 gene, we validated two clones for CASP5, 
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clone 1 and clone 8, both of which possess two distinct allelic mutations (Fig. 3.3 
C and D). The sequencing electropherogram for the DNA target sequence and 
surrounding regions for both CASP5 alleles of each clone are shown. The 
sequence alignment comparing WT THP-1 and CASP5-/- THP-1 clones are also 
shown, and the nucleotide deletions within the CASP5 target sequence are 
indicated by red boxes. The CASP5 alleles in clone 1 have either 10 or 13 
nucleotides deleted, which result in premature stop codons (Fig. 3.3 C). The 
CASP5 alleles in clone 8 have either two or four nucleotide deletions and also 
result in premature stop codons and therefore nonfunctional CASP5 protein (Fig. 
3.3 D). qPCR analyses and western blots revealed decreased RNA and absent 
protein expression levels of CASP4-/- clones 2 and 6 (Fig. 3.4 A-B and E). Future 
























Figure 3.3. Validation of CASP4 and CASP5 knockout THP-1 clones 
generated using CRISPR/Cas9 technology. Schematic representations of the 
CASP4 gene (A) or the CASP5 gene (B) with exons (filled boxes) and introns 
(lines). The respective guide RNA target sequences for CASP4 and CASP5 are 
highlighted in red. Shown are the mutations of the two alleles for CASP5-/- clone 1 
(C) or CASP5-/- clone 8 (D) THP-1 genomic DNA by electropherogram and 
sequence alignment with WT THP-1 genomic DNA. The CASP5 target sequence 
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Figure 3.3. Validation of 
CASP4 and CASP5
knockout THP-1 clones 
generated using 
CRISPR/Cas9 technology. 
Schematic representations of 
the CASP4 gene (A) or the 
CASP5 gene (B) with exons 
(filled boxes) and introns 
(lines). The respective guide 
RNA target sequences for 
CASP4 and CASP5 are 
highlighted in red. Shown are 
the mutations of the two 
alleles for CASP5 clone 1 (C) 
or CASP5 clone 8 (D) THP-1 
genomic DNA by 
electropherogram and 
sequence alignment with WT 
THP-1 genomic DNA. The 
CASP5 target sequence is 
underlined and nucleotide 
deletions are indicated by the 
red boxes. The mutation 
starting point of missing 
nucleotide is indicated in the 









































is underlined and nucleotide deletions are indicated by the red boxes. The mutation 
starting point of missing nucleotide is indicated in the electropherogram by a black 
line.   
 
Besides one study that showed caspase-4-dependent inflammasome 
activation in response to F. novicida in IFN-g-primed human macrophages 
(Lagrange et al., 2018), no other studies have investigated the roles of caspase-4 
or caspase-5 in IFN-g-primed human macrophages in response to LPS variants 
from different bacteria. We compared caspase-4 and caspase-5 RNA and protein 
expression levels in WT THP-1 cells as well as the CASP4-/- and CASP5-/- THP-1 
clones (Fig. 3.4). This is to confirm that knockout of either gene did not cross react 
and lead to unintentional knockout of the other gene. For instance, CASP4-/- THP-
1 clones 2 and 6 present a decreased fold change and relative expression of 
CASP4, but CASP5-/- THP-1 clones 1,6, and 8 have normal CASP4 gene 
expression similar to WT THP-1 cells (Fig 3.4 A and B). CASP5-/- THP-1 clone 6 
was examined because it initially showed decrease CASP5 expression and absent 
protein expression when comparing the original 12 expanded clones; however, 
after conducting validation experiments it was revealed that it was not a single cell 
clone and had more than two allelic mutations. Additionally, CASP5-/- THP-1 clones 
1, 6, and 8 have decreased RNA fold change and relative expression levels of 
CASP5, while  CASP4-/- THP-1 clones 2 and 6 have higher CASP5 RNA 
expression, although CASP4-/- clone 6 show slightly lower CASP5 RNA expression 
compared to WT THP-1 cells (Fig. 3.4 C and D). Finally, we compared the CASP4 
and CASP5 protein levels in unprimed and IFN-g-primed WT THP-1 cells and the 
 115 
CASP4 and CASP5 knockout clones. Unprimed or IFN-g-primed CASP4-/- THP-1 
clones 2 and 6 show no CASP4 protein expression, whereas WT THP-1 and 
CASP5-/- THP-1 clones 1 and 8 have CASP4 expressed (Fig. 3.4 E). Notably, IFN-
g-primed WT THP-1 and CASP5-/- THP-1 clones have increased CASP4 protein 
expression compared to unprimed cells. Furthermore, unprimed WT THP-1 cells 
as well as the CASP4 and CASP5 knockout clones do not show any CASP5 
protein expression (Fig. 3.4 F). CASP5 is not constitutively expressed, unlike 
CASP4, and requires a priming signal for its upregulation. In addition, CASP5 has 
a very low relative expression compared to CASP4 (Fig. 3.4 B and D). IFN-g-
primed WT THP-1 and CASP4-/- THP-1 clones 2 and 6 present CASP5 protein 
expression, while CASP5-/- THP-1 clones 1 and 8 do not express CASP5 (Fig. 3.4 
F). These results indicate that disruption of the CASP4 gene does not affect 
CASP5 expression levels and that mutation of the CASP5 gene does not abrogate 
CASP4 expression. Thus, these THP-1 knockout clones can be used to distinguish 
the functions of caspase-4 and caspase-5 in response to intracellular LPS variants.   





Figure 3.4. Expression of CASP4 and CASP5 in CASP4 or CASP5 knockout 
THP-1 clones. (A-D) PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones, 
and CASP5-/- THP-1 clones were primed with IFN-g (100 U/mL) for 16 h. CASP4 
and CASP5 transcript levels were determined by quantitative RT-PCR and relative 
expression was calculated by normalizing to the housekeeping gene HPRT. Fold 
change was further calculated by normalizing to the WT THP-1 sample. (E-F) 
PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones, and CASP5-/- THP-1 
clones were either left unprimed or primed with IFN-g (100 U/mL) for 18 h. 
Immunoblot analysis was conducted on lysates for full length caspase-4 (pro-
casp4), full length caspase-5 (pro-casp5), and caspase-5 intermediates (casp5 
p44 and casp5 p35). Blots were stripped and reprobed for b-actin.  
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Figure 3.4. Expression of CASP4 and CASP5 in CASP4 or CASP5 knockout THP-1 
clones. (A-D) PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones, and CASP5-/-
THP-1 clones were primed with IFN-γ (100 U/mL) for 16 h. CASP4 and CASP5 transcript 
levels were determined by quantitative RT-PCR and relative expression was calculated by 
normalizing to the housekeeping gene HPRT. Fold change was further calculated by 
normalizing to the WT THP-1 sample. (E-F) PMA-differentiated WT THP-1 cells, CASP4-/-
THP-1 clones, and CASP5-/- THP-1 clones were either left unprimed or primed with IFN-γ
(100 U/mL) for 18 h. Immunoblot analysis was conducted on lysates for full length caspase-
4 (pro-casp4), full length caspase-5 (pro-casp5), and caspase-5 intermediates (casp5 p44 
and casp5 p35). Blots were stripped and reprobed for β-actin. Shown are the results 




















































































































































































































































































































































3.4.4. CASP4 is activated in response to E. coli LPS, while CASP5 may not 
play a role in response to E. coli or L. pneumophila LPS. 
The role of caspase-4 and caspase-5 in response to different LPS variants 
is not well defined. In addition, whether IFN-g promotes human caspase-4 or 
caspase-5 responses to different hexa-acylated LPS variants, including LPS 
derived from L. pneumophila or E. coli has not been studied. Here, we use WT, 
CASP4-/-, and CASP5-/- THP-1-derived macrophages to define the distinct roles of 
caspase-4 and caspase-5. Inflammasomes require an initial priming signal to 
upregulate sensor proteins, such as caspase-4 and caspase-5.  First, we either 
left the THP-1 cells unprimed or primed them with IFN-g in order to compare the 
roles of caspase-4 and caspase-5 in these distinguished cell types. Next, we 
primed all of the THP-1 cells with the TLR1/2 ligand, Pam3CSK4, which not only 
promotes the expression of sensor proteins but also of IL-1 family cytokines 
including IL-1b. The noncanonical inflammasome is characterized by cleaving 
GSDMD, which is the initiator of pyroptosis, followed by K+ efflux, which activates 
the NLRP3 capsase-1-containing inflammasome for IL-1 processing and release. 
Upon transfection with E. coli LPS and not L. pneumophila LPS, both CASP4-/- and 
CASP5-/- THP-1 cells show a significant decrease in cell death compared to WT 
THP-1 cells in the Pam3CSK4-primed only condition (Fig. 3.5 A). Notably, CASP4-
/- THP-1 cells show a much greater decrease compared to when CASP5 is 
knocked out. This indicates that caspase-4 plays an essential role in cell death in 
response to E. coli LPS, while caspase-5 may play a small role. Furthermore, when 
these cells are additionally primed with IFN-g and transfected with E. coli LPS, 
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CASP4-/- THP-1 cells have significantly reduced cell death, while CASP5-/- THP-1 
cells do not (Fig. 3.5 B). This could be due to an upregulated expression of 
caspase-4 in the CASP5-/- THP-1 cells upon the treatment of IFN-g. Similar to the 
Pam3CSK4-primed cells, additional treatment of IFN-g does not result in a 
caspase-4- or caspase-5-dependent cell death in response to L. pneumophila LPS 
(Fig. 3.5 B). Interestingly, both CASP4-/- THP-1 clones either primed with 
Pam3CSK4 alone or primed with IFN-g and Pam3CSK4, showed significantly 
decreased IL-1b release in response to E. coli, while the CASP5-/- THP-1 clones 
do not have a reduction (Fig. 3.5 C and D). In addition, for both primed conditions, 
only CASP4-/- clone 6 THP-1 cells have a significant reduction in IL-1b release in 
response to L. pneumophila LPS. This may suggest that caspase-4 is important 
for downstream IL-1b secretion in response to L. pneumophila LPS, but not cell 
death. These results are perplexing since cell death is upstream of IL-1 cytokine 
release for noncanonical inflammasome activation. Since these experiments were 
only conducted two times, repeated experiments are necessary and additional 
future experiments involving different timepoints and LPS treatment conditions are 
crucial to determine the role of caspase-4 and caspase-5 responses to L. 
pneumophila and E. coli LPS. It would be interesting to observe the inflammasome 
responses of caspase-4 and caspase-5 to treatment of extracellular LPS. Based 
on these results, we conclude that capsase-4 promotes noncanonical 
inflammasome responses to E. coli LPS and that caspase-5 may not play a role in 
response to E. coli or L. pneumophila LPS.  
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Figure 3.5. CASP4 promotes noncanonical inflammasome responses to E. 
coli LPS, while CASP5 may not play a role in detecting E. coli or L. 
pneumophila LPS. PMA-differentiated WT THP-1 cells, CASP4-/- THP-1 clones, 
and CASP5-/- THP-1 clones were either left unprimed (A and C) or primed 
overnight with IFN-g (100 U/mL) (B and D), then primed with Pam3CSK4 (1 µg/mL) 
for 4 h and either mock transfected with FuGENE HD alone or transfected with 
FuGENE HD and 10 µg/mL L. pneumophila LPS or 2 µg/mL E. coli LPS for 4 h. (A 
and B) Cell death was measured using lactate dehydrogenase release assay and 
normalized to mock-infected cells. (C and D) IL-1b levels in the supernatant were 
measured by ELISA. Shown are results representative of two experiments. 
*P<0.05, **P<0.01, ***P<0.001, and ****P<0.0001 by unpaired t-test.      
 
 
3.4.5. Development of GBP1 or GBP2 knockout THP-1 clones using 
CRISPR/Cas9 technology.  
The IFN-inducible family of GTPases known as GBPs promote 
inflammasome responses to a variety of gram-negative bacteria as well as to 
bacterial components including LPS and OMVs (Finethy et al., 2017; Fisch et al., 
2019; Lagrange et al., 2018; Meunier et al., 2014; Meunier et al., 2015; Pilla et al., 
2014; Santos et al., 2020; Santos et al., 2018). Recent findings for human GBPs 
 120 
revealed that human GBP1 promotes caspase-4-dependent inflammasome 
responses to S. Typhimurium and E. coli LPS, while human GBP2 promotes 
noncanonical inflammasome responses to the under-acylated LPS derived from F. 
novicida (Fisch et al., 2019; Lagrange et al., 2018; Santos et al., 2020). In addition, 
our lab discovered that human GBP1 is essential for maximal inflammasome 
responses to L. pneumophila (Chapter 2); however, we used RNAi-mediated 
knockdown techniques rather than a complete cell knockout of GBP1. Although 
we show that siRNA specific for GBP1 led to efficient knockdown, a GBP1 
knockout cell line would eliminate the remaining residual GBP1 and, therefore, 
would abolish any inflammasome response due to the remaining GBP1 left. Here, 
we generated human GBP1 as well as GBP2 knockout THP-1 cells using the 
lentivirus-mediated CRISPR-Cas9 genome editing technology. The lentiCRISPR 
plasmids used contained either GBP1 gRNA that targets exon 8 or GBP2 gRNA 
that targets exon 6, both of which these sequences are highlighted in Fig. 3.6 A 
and B. Targeting these exonic regions will lead to nucleotide mutations within the 
protein coding region and, therefore, will result in a premature stop codon and 
nonfunctional protein. Applying the same process we used to develop the CASP4-
/- and CASP5-/- THP-1 single cell clones, after infecting THP-1 cells with the 
lentivirus containing the gRNA target sequence for GBP1 or GBP2 as well as the 
Cas9-exonuclease protein, we treated the cells with puromycin to maintain the 
cells that contained the lentivirus. We next expanded 12 single cell clones and 
checked for decrease in RNA expression or absence of protein for either GBP1 or 
GBP2 in order to select the three best clones for validating that they originated 
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from a single cell. We validated two GBP1-/- THP-1 clones that each possess two 
allelic mutations. The sequencing electropherogram shows the DNA target 
sequence and adjacent nucleotide sequence of both GBP1 alleles for each clone 
(Fig. 3.6 C and D). In addition, we show the sequence alignment between the WT 
THP-1 and GBP1-/- THP-1 clones, and the nucleotide changes within the GBP1 
target sequence are specified by red boxes or outlines. The GBP1 alleles in clone 
1 have either five nucleotides deleted or have one nucleotide deleted and a 
nucleotide switch (Fig. 3.6 C). Both of these mutations revealed that they lead to 
premature stop codons. Additionally, the GBP1 alleles for clone 6 show either two 
nucleotides deleted or a nucleotide insertion, which result in premature stop 
codons (Fig. 3.6 D). Due to technical complications, we were unable to validate 
the GBP2-/- THP-1 clones, although we did choose two clones that showed the 
best RNA decrease as well as absence of GBP2 protein to use in experiments. 
Future experiments are needed in order to validate and ensure that these GBP2-/- 

































Figure 3.6. Validation of GBP1 and GBP2 knockout THP-1 clones generated 
using CRISPR/Cas9 technology. Schematic representations of the GBP1 gene 
(A) or the GBP2 gene (B) with exons (filled boxes) and introns (lines). The 
respective guide RNA target sequences for GBP1 and GBP2 are highlighted in 
red. Shown are the mutations of the two alleles for GBP1-/- clone 1 (C) or GBP1-/- 
clone 6 (D) THP-1 genomic DNA by electropherogram and sequence alignment 
with WT THP-1 genomic DNA. The CASP5 target sequence is underlined and 























Figure 3.6. Validation of 
GBP1 and GBP2 knockout 
THP-1 clones generated 
using CRISPR/Cas9 
technology. Schematic 
representations of the GBP1 
gene (A) or the GBP2 gene 
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and introns (lines). The 
respective guide RNA target 
sequences for GBP1 and
GBP2 are highlighted in red. 
Shown are the mutations of 
the two alleles for GBP1 
clone 1 (C) or GBP1 clone 6 
(D) THP-1 genomic DNA by 
electropherogram and 
sequence alignment with WT 
THP-1 genomic DNA. The 
CASP5 target sequence is 
underlined and nucleotide 
deletions are indicated by the 
red filled-in boxes. Nucleotide 
insertion or switch is marked 
by a red outline. The 
mutation starting point of 
missing nucleotide or 
inserted nucleotide is 
indicated in the 
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GBP2 are highlighted in red. 
Shown are the mutations of 
the two alleles for GBP1 
clone 1 (C) or GBP1 clone 6 
(D) THP-1 genomic DNA by 
electropherogram and 
sequence alignment with WT 
THP-1 genomic DNA. The 
CASP5 target sequence is 
underlined and nucleotide 
deletions are indicated by the 
red filled-in boxes. Nucleotide 
insertion or switch is marked 
by a red outline. The 
mutation starting point of 
missing nucleotide or 
inserted nucleotide is 
indicated in the 




or switch is marked by a red outline. The mutation starting point of missing or 
inserted nucleotide is indicated in the electropherogram by a black line.   
 
After choosing two GBP2-/- THP-1 clones for experimental use, in addition 
to the validated GBP1-/- THP-1 clones, we compared the protein expression levels 
of GBP1 and GBP2 in these clones as well as in WT THP-1 cells. The purpose of 
this is to confirm that the GBP1 gRNA did not affect GBP2 expression and vice 
versa. We initially primed the WT THP-1 cells and GBP knockout clones with IFN-
g to upregulate GBP expression, since GBPs are interferon-inducible and will not 
be expressed unless stimulated with IFN. We found that GBP1-/- THP-1 clones 1 
and 6 have no GBP1 protein expression, while WT THP-1 and GBP2-/- THP-1 
clones 1 and 7 have normal GBP1 levels (Fig. 3.7 A). Moreover, GBP2-/- THP-1 
clones 1 and 7 show absent GBP2 protein expression, whereas WT THP-1 and 
GBP1-/- THP-1 clone 1 have normal GBP2 expression (Fig. 3.7 B). Interestingly, 
GBP1-/- THP-1 clone 6 shows lower GBP2 protein levels, although this observed 
decrease may be due to lower amount of lysate added since b-actin levels are 
lower in this sample compared to the other samples. A repeat of this western blot 
is needed to confirm whether GBP1-/- THP-1 clone 6 has its GBP2 protein levels 
affected by the GBP1 gRNA. Since we see that GBP1 is knocked out of the GBP1-
/- THP-1 clones and that GBP2 is knocked out of the GBP2-/- THP-1 clones, we felt 
that we could continue and conduct experiments with these clones in order to 
determine their role in response to intracellular LPS derived from L. pneumophila 





Figure 3.7. Expression of GBP1 and GBP2 in GBP1 or GBP2 knockout THP-
1 clones. (A and B) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, 
and GBP2-/- THP-1 clones were primed with IFN-g (100 U/mL) for 18 h. Immunoblot 
analysis was conducted on lysates for GBP1 and GBP2. Blots were stripped and 
reprobed for b-actin.  
 
3.4.6. GBP1 and GBP2 are important for cell death in response to L. 
pneumophila, while GBP1 plays a role in cell death in response to LPS 
derived from L. pneumophila and E. coli. 
We recently found that human GBP1 promotes inflammasome responses 
to L. pneumophila and that these inflammasome responses led to caspase-1, -4, 
and -5 activation (Chapter 2). In addition to knocking down human GBP1 using 
siRNA, we also individually knockdown GBP2, 3, 4, and 5, but we did not see a 
decrease in inflammasome activation upon knockdown of these GBPs. We sought 
to use the newly developed GBP1-/- and GBP2-/- THP-1 clones in order to confirm 
the role of human GBP1 in inflammasome responses to L. pneumophila and 
whether the complete absence of GBP2 influences inflammasome responses as 
well. Since THP-1 cells have different kinetics of inflammatory responses to 
pathogens compared to primary human macrophages, we conducted a time 
course experiment using IFN-g-primed WT THP-1 cells, GBP1-/- THP-1 clones, and 
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GBP2-/- THP-1 clones that were infected with L. pneumophila. We determined at 
each time point (1, 2, or 4 hpi) that knockout of GBP1 and GBP2 in THP-1 cells 
results in a significant decrease of cell death but not IL-1b secretion (Fig. 3.8 A 
and B). These results are in partial agreement with our previous findings that 
knockdown of GBP1 leads to a decrease in cell death. However, IL-1b is not 
decreased upon knockout of GBP1, contrary to what we found with siRNA 
knockdown of GBP1. Additionally, our results reveal a new finding that human 
GBP2 may also be important for promoting cell death during L. pneumophila 
infection. 
Previous studies showed that GBPs are important for promoting 
noncanonical inflammasome responses to LPS. Specifically, it was found that 
human GBP1 promotes caspase-4 activation in response to E. coli LPS, while 
human GBP2 promotes caspase-4 activation in response to F. novicida LPS and 
not E. coli LPS (Lagrange et al., 2018; Santos et al., 2020). In addition, mouse 
GBPs located on chromosome 3 promote caspase-11 activation in response to 
LPS derived from L. pneumophila (Pilla et al., 2014). Therefore, we wanted to 
investigate whether human GBP1 or GBP2 promoted noncanonical inflammasome 
responses to L. pneumophila LPS as well as to confirm that human GBP1 and not 
GBP2 promotes inflammasome activation in response to E. coli LPS. Using the 
GBP1-/- and GBP2-/- THP-1 clones, we found that knockout of only GBP1 resulted 
in decreased cell death in response to L. pneumophila LPS and E. coli LPS, while 
IL-1b release was not affected (Fig. 3.8 C and D). These results are in agreement 
with the previous findings that human GBP1, and not GBP2, is important for 
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stimulating inflammasome response to E. coli LPS. It is also interesting that the 
absence of GBP2 does not lead to decrease in cell death in response to L. 
pneumophila LPS as it does in response to L. pneumophila bacteria. This may 
suggest that GBP2 is activated in response to a different bacterial component of 
L. pneumophila other than LPS. Overall, these data indicate that human GBP1 and 
GBP2 promote cell death during infection with L. pneumophila, while GBP1 












Figure 3.8. GBP1 and GBP2 play a role in cell death but not IL-1b release in 
response to L. pneumophila, while GBP1 plays a role in cell death in 
response to LPS derived from L. pneumophila or E. coli in THP-1 cells. (A 
and B) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, and GBP2-/- 
THP-1 clones were primed with IFN-g (100 U/mL) overnight and either mock 
infected with PBS or infected with T4SS+ Lp for the timepoints indicated. (C and 
D) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, and GBP2-/- THP-1 
clones were primed with IFN-g (100 U/mL) overnight and either mock transfected 
with FuGENE HD alone or transfected with FuGENE HD and 10 µg/mL L. 
pneumophila LPS or 2 µg/mL E. coli LPS for 2.5 h. (A and C) Cell death was 
Figure 3.8.























































































































Mock L. pneumophila 
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Figure 3.8. GBP1 and GBP2 play a role in cell death but not IL-1β release in response to L. pneumophila, 
while GBP1 plays a role in cell death in response to LPS derived from L. pneumophila or E. coli in THP-1 
cells. (A and B) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, and GBP2-/- THP-1 clones were 
primed with IFN-γ (100 U/mL) overnight and either mock infected with PBS or infected with T4SS+ Lp for the 
timepoints indicate . (C and D) PMA-differentiated WT THP-1 cells, GBP1-/- THP-1 clones, and GBP2-/- THP-1 
clones were prim d with IFN-γ (100 U/mL) overnight and either mock transfected with FuGENE HD alone or 
transfected with FuGENE HD and 10 µg/mL L. pneumophila LPS or 2 µg/mL E. coli LPS for 2.5 h. (A and C) Cell 
death was measured using lactate dehydrogenase release assay and normalized to mock-infected cells. (B and 















measured using lactate dehydrogenase release assay and normalized to mock-
infected cells. (B and D) IL-1b levels in the supernatant were measured by ELISA.  
 
3.5. Discussion 
Our data suggests that the human noncanonical inflammasome is activated 
in response to differentially acylated and phosphorylated LOS derived from Y. 
pestis, and that IFN-g promotes these inflammatory responses. One possibility of 
why the human noncanonical inflammasome is activated by these various LOS 
structures, in contrast to the murine noncanonical inflammasome that is not 
activated by under-acylated LPS, is that humans possess two putative orthologs 
of murine caspase-11, which are caspase-4 and caspase-5. Thus, these two 
inflammatory caspases may be working together in order to recognize different 
types of LPS structures. The CASP4-/- and CASP5-/- THP-1 clones we developed 
using CRISPR/Cas9 genome editing technology are useful tools that can help to 
distinguish the functions of caspase-4 and caspase-5 to differentially 
phosphorylated and acylated LPS variants. Future studies testing the 
inflammasome responses to the seven LOS variants from Y. pestis in these THP-
1 clones are needed to fully examine the distinct roles of caspase-4 and caspase-
5. Additionally, previous work found that caspase-5 may be activated by a different 
pathway compared to caspase-4. Specifically, caspase-5 is cleaved and activated 
in response to treatment with extracellular E. coli LPS in monocytes and 
macrophages (Casson et al., 2015; Vigano et al., 2015). No additional work has 
been done to investigate this alternative LPS activation process. Thus, additional 
experiments testing extracellular LPS treatment in these CASP4-/- and CASP5-/- 
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THP-1 clones either left as monocytes or in differentiated macrophages to 
determine whether there is a difference in caspase-5 activation. It would be of 
interest to also determine whether TLR4 is important for the activation of caspase-
5, as TLR4 is the extracellular LPS sensor and may somehow internalize LPS after 
binding and transport LPS to caspase-5 directly. Therefore, caspase-4 and 
caspase-5 may be activated by different LPS structures but may also be involved 
in different mechanisms of activation depending on the route of LPS entry into the 
cytosol.  
Our data indicate that caspase-4 promotes noncanonical inflammasome 
responses to E. coli LPS in both Pam3CSK4-primed macrophages as well as in 
Pam3CSK4 and IFN-g-primed macrophages, while we do not see a role for 
caspase-5 in response to transfected L. pneumophila LPS or E. coli LPS. However, 
we did see that CASP4-/- THP-1 clone 6 transfected with L. pneumophila LPS 
resulted in significantly decreased IL-1b release, indicating that caspase-4 is 
important for promoting inflammatory cytokine release. It is intriguing, however, 
that we see decreased IL-1b release but no decrease in cell death, since cell death 
is initiated before cytokine release during noncanonical inflammasome activation. 
Therefore, an alternative and more sensitive cell death assay, such as propidium 
iodide (PI) uptake, is needed in order to determine whether the cell death 
phenotype of the CASP4-/- THP-1 clones in response to L. pneumophila LPS is 
accurate. PI is a DNA-binding dye that is significantly smaller in size compared to 
the LDH enzyme. Thus, PI is able to enter cells more easily through smaller pores, 
while LDH may not be released from these pores.    
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We also developed GBP1-/- and GBP2-/- THP-1 clones to determine the roles 
of human GBP1 and GBP2 in response to intracellular L. pneumophila LPS and to 
confirm the role of human GBP1 in response to L. pneumophila bacteria. Our data 
suggest that GBP1 and GBP2 were necessary for cell death in response to L. 
pneumophila, highlighting a potential new role for GBP2 that we did not observe in 
previous experiments using siRNA-mediated knockdown. It is possible that siRNA 
treatment results in residual amounts of GBP2 protein and that this remaining 
presence of GBP2 may account for the observed cell death. Therefore, this may 
be why we detect a decrease in cell death only in the complete absence of GBP2. 
The mechanism of how GBP2 is promoting cell death during L. pneumophila 
infection is unclear, but future experiments that test whether GBP2 is important for 
vacuolar or outer membrane rupture would be of interest and would reveal another 
human GBP that facilitates the exposure of L. pneumophila into the cytosol, as we 
previously saw with human GBP1 (Chapter 2).  
Additionally, we observed that GBP1 may be important for promoting cell 
death in response to L. pneumophila LPS, whereas GBP2 does not. However, we 
only observed this phenotype with GBP1-/- THP-1 clone 1. Thus, repeated 
experiments are required to confirm whether human GBP1 is an essential mediator 
of cell death in response to L. pneumophila LPS and whether the second GBP1-/- 
THP-1 clone reveals the same phenotype. Additionally, we noticed that there was 
no change in IL-1b release between WT THP-1 cells and the GBP1-/- and GBP2-/- 
THP-1 clones. One reason as to why there is no difference in IL-1b secretion 
between WT and GBP knockout cells is that these THP-1 cells are differentiated 
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into macrophages using PMA, which robustly promotes IL-1b production. 
Consequently, there may be such a high background of IL-1b being produced that 
knockout of one gene that is partially responsible for IL-1b release is not sufficient 
enough to see a difference. Therefore, we may need to change the differentiation 
conditions to generate THP-1-derived macrophages that have normal IL-1b 
production as well as may need to conduct a time course since we may be looking 
too early for IL-1b release. Different differentiation conditions, such as with Vitamin 
D3, may generate THP-1-derived macrophages that produce normal amounts of 
IL-1b in order to examine the role of human GBPs in inflammatory cytokine release 
in response to LPS. 
Our study focuses on the individual roles of caspase-4 and caspase-5. 
Whether knockout of both caspase-4 and caspase-5 would produce a synergistic 
effect and greater decrease in inflammasome responses to LPS is unclear. The 
development of a double CASP4/5-/- THP-1 cell line is needed to address this 
question. Since caspase-4 and caspase-5 may be activated through different 
mechanisms, it would be helpful to compare the inflammasome response to the 
treatment of extracellular LPS or transfection of LPS into the cytosol using these 
CASP4/5-/- cells in addition to the CASP4-/- and CASP5-/- THP-1 clones.  
Furthermore, the GBP knockout experiments in this study suggest that 
human GBP1 plays a role in response to L. pneumophila LPS and E. coli LPS. It 
would be of interest to determine how GBP1 is promoting this cell death response 
in THP-1-derived macrophages. A couple of experiments that could be done are 
to conduct confocal microscopy after transfection of biotinylated LPS and staining 
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of GBP1 or perform an LPS pull-down assay and determine whether these LPS 
variants are binding to GBP1, which may be transferring the LPS directly to these 
inflammatory caspases. Thus, GBP1 may be acting as an LPS binding protein, 
similar to the TLR4 pathway.   
This study provides a better understanding of the roles of caspase-4 and 
caspase-5 to LPS variants and how IFN-inducible GBPs contribute to these 
inflammasome responses. Our findings provide insight into potential therapeutic 
targets for gram-negative sepsis.  
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3.7. Materials and Methods 
3.7.1. Primary Human Samples 
All studies on primary human monocyte-derived macrophages (hMDMs) 
were performed in compliance with the requirements of the US Department of 
Health and Human Services and the principles expressed in the Declaration of 
Helsinki. Samples obtained from the University of Pennsylvania Human 
Immunology Core are considered to be a secondary use of deidentified human 
specimens and are exempt via Title 55 Part 46, Subpart A of 46.101 (b) of the 
Code of Federal Regulations. 
 
3.7.2. Cell Culture 
Primary human monocytes from deidentified healthy human donors were 
obtained from the University of Pennsylvania Human Immunology Core. 
Monocytes were cultured in RPMI supplemented with 10% (vol/vol) heat-
inactivated FBS, 2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin, 
and 50 ng/mL recombinant human M-CSF (Gemini Bio Products). Cells were 
cultured for 4 days in 10 mL of media in 10 cm-dishes at 4-5 × 105 cells/mL, 
followed by addition of 10 mL of fresh growth media for an additional 2 days for 
complete differentiation into macrophages. The day before macrophage 
stimulation, cells were rinsed with cold PBS, gently detached with trypsin-EDTA 
(0.05%) and replated in media without antibiotics and with 25 ng/mL M-CSF in a 
48-well plate at a concentration of 1 × 105 cells per well. 
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THP-1 cells (TIB-202; American Type Culture Collection) were maintained 
in RPMI supplemented with 10% (vol/vol) heat-inactivated FBS, 0.05 nM b-
mercaptoethanol, 100 IU/mL penicillin, and 100 µg/mL streptomycin at 37°C in a 
humidified incubator. One or two days before stimulation with IFN-g or Pam3CSK4, 
respectively, cells were replated in media without antibiotics in a 48-well plate at a 
concentration of 2 × 105 cells per well and incubated with phorbol 12-myristate 13-
acetate (PMA) for 24 hours to allow differentiation into macrophages. Media was 
replaced with RPMI without serum for L. pneumophila infections or replaced with 
Opti-MEM I Reduced Serum Media for LPS transfection experiments.  
 
3.7.3. Macrophage Stimulation 
For the experiment using primary human macrophages, cells were primed 
with Pam3CSK4 (1 µg/mL) for four hours before LPS transfection.  
For the LPS transfection experiment using only PMA-differentiated WT 
THP-1 or the LPS transfection experiment using PMA-differentiation WT THP-1 
cells, CASP4-/- THP-1 clones, and CASP5-/- THP-1 clones, cells were either left 
unprimed or were primed overnight with recombinant human IFN-g (R&D Systems) 
at a concentration of 100 U/mL, followed by priming with Pam3CSK4 (1 µg/mL) for 
four hours before LPS transfection. 
For the L. pneumophila infection and LPS transfection experiment using 
PMA-differentiated WT THP-1 cells, or GBP1-/- THP-1 clones, and GBP2-/- THP-1 
clones, cells were primed overnight with recombinant human IFN-g at a 
concentration of 100 U/mL before infection or transfection.  
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For experiments involving harvesting lysates for RNA and protein analyses 
from PMA-differentiated WT THP-1, CASP4-/- and CASP5-/- THP-1 clones, and 
GBP1-/- and GBP2-/- THP-1 clones, cells were either left unprimed or primed with 
recombinant human IFN-g at a concentration of 100 U/mL for 16 or 18 hours. 
 
3.7.4. Bacterial Strain and Macrophage Infection 
The Legionella pneumophila infection experiment comparing WT THP-1 
cells to GBP1-/- and GBP2-/- THP-1 clones used the strain derived from the 
serogroup 1 clinical isolate Philadelphia-1. The strain utilized was a flagellin 
mutant, DflaA, derived from the Lp02 strain (rpsL, hsdR, thyA), which is a thymidine 
auxotroph (Ren et al., 2006). L. pneumophila DflaA was grown as a stationary 
patch for 48 hours on charcoal yeast extract agar plates at 37°C (J. C. Feeley et 
al., 1979). Bacteria were resuspended in PBS and added to the cells at a 
multiplicity of infection (MOI) of 10 in a 48-well plate. Infected cells were then 
centrifuged at 290 × g for 10 min and incubated at 37°C for 1, 2, or 4 hours. Mock-
infected cells were treated with PBS.  
 
3.7.5. Lipopolysaccharide (LPS) or Lipooligosaccharide (LOS) Variants and 
Macrophage Transfection 
 All LPS and LOS used in this study were isolated from whole bacteria in the 
laboratory of Robert Ernst. L. pneumophila LPS was isolated from L. pneumophila 
LP02 DflaA strain. E. coli LPS was isolated from E. coli K-12 W3110 strain. Y. 
pestis LOS was isolated from Y. pestis grown at 26°C, including the WT strain as 
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well as the mutants generated through the addition of specific enzymes to the WT 
strain. After stimulation of primary human macrophages or THP-1-derived 
macrophages with IFN-g and/or Pam3CSK4 as described above, the media was 
replaced with 300 µL of Opti-MEM I Reduced Serum Media per well. Cells were 
either mock-transfected with FuGENE HD (Promega) alone or transfected with a 
mixture of 0.75 µL FuGENE HD [0.25%(vol/vol)] plus LPS or LOS (2 µg/mL of Y. 
pestis LOS or E. coli LPS and 10 µg/mL L. pneumophila LPS). Plates were then 
centrifuged at 805 × g for 5 min and incubated at 37°C for 4 or 20 hours.  
 
3.7.6. LDH Cytotoxicity Assay 
Macrophages were infected or transfected in a 48-well plate as described 
above and harvested supernatants were assayed for cell death by measuring loss 
of cellular membrane integrity through lactate dehydrogenase (LDH) release from 
cells. LDH release was quantified using an LDH Cytotoxicity Detection Kit 
(Clontech) according to the manufacturer’s instructions and normalized to mock-
infected cells.  
 
3.7.7. ELISA 
Macrophages were infected or transfected in a 48-well plate as described 
above and harvested supernatants were assayed for cytokine levels using ELISA 
kits for human IL-1b (BD Biosciences).  
 
3.7.8. Quantitative RT-PCR Analysis 
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RNA was isolated using the RNeasy Plus Mini Kit (Qiagen) following the 
manufacturer’s protocol. Cells were lysed in 350 µL RLT buffer with b-
mercaptoethanol and centrifuged through a QIAshredder spin column (Qiagen). 
cDNA was synthesized from isolated RNA using SuperScript II Reverse 
Transcriptase (Invitrogen) following the manufacturer’s protocol. Quantitative PCR 
was conducted with the CFX96 real-time system from Bio-Rad using the SsoFast 
EvaGreen Supermix with Low ROX (Bio-Rad). Transcript levels for each gene 
were normalized to the housekeeping gene HPRT for each sample, and samples 
were normalized to unprimed sample or to control siRNA-treated sample using the 
2-DDCt (cycle threshold) method to calculate fold change. Relative expression was 
calculated by normalizing gene-specific transcript levels to HPRT transcript levels 
for each sample using the 2-DCt method. Primer sequences from primer bank used 
for HPRT1, CASP4, CASP5, GBP1, and GBP2 are the following (all 5’ à 3’): 
HPRT1 forward: CCTGGCGTCGTGATTAGTGAT 
HPRT1 reverse: AGACGTTCAGTCCTGTCCATAA 
CASP4 forward: TCTGCGGAACTGTGCATGATG 
CASP4 reverse: TGTGTGATGAAGATAGAGCCCAT 
CASP5 forward: TCACCTGCCTGCAAGGAATG 
CASP5 reverse: TCTTTTCGTCAACCACAGTGTAG 
GBP1 forward: AGGAGTTCCTTCAAAGATGTGGA 
GBP1 reverse: GCAACTGGACCCTGTCGTT 
GBP2 forward: CTATCTGCAATTACGCAGCCT 
GBP2 reverse: TGTTCTGGCTTCTTGGGATGA 
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3.7.9. Immunoblot Analysis 
In experiments where THP-1-derived macrophages were used, cells were 
lysed in 1X SDS/PAGE sample buffer. Protein samples were boiled for 5 min, 
separated by SDS/PAGE on a 12% (vol/vol) acrylamide gel, and transferred to 
PVDF Immobilon-P membranes (Millipore). Primary antibodies specific for 
caspase-4 (4450S; Cell Signaling), caspase-5 (D3G4W; 46680S; Cell Signaling), 
GBP1 (ab131255, Abcam), GBP2 (sc-271568, Santa Cruz), and b-actin (4967L; 
Cell Signaling) were used. HRP-conjugated secondary antibodies anti-rabbit IgG 
(7074S; Cell Signaling) and anti-mouse IgG (7076S; Cell Signaling) were used. 
For detection, ECL Western Blotting Substrate or SuperSignal West Femto (both 
from Pierce Thermo Scientific) were used as the HRP substrate.  
 
3.7.10. Development of CRISPR/Cas9 Knockout THP-1 cells 
To generate CASP4, CASP5, GBP1, or GBP2 knockout in THP-1 cells, 
pLentiCRISPR v2 plasmids encoding the specific gRNA and Cas9 were purchased 
from GenScript. The following target sequences were used:  
CASP4 gRNA 1: TCCTGCAGCTCATCCGAATA 
CASP5 gRNA 2: CGTCAACCACAGTGTAGCCC 
GBP1 gRNA 3: ACAAAGAGACGATAGCCCCC 
GBP2 gRNA 2: AACTTTCGGATGCACAACCG 
Initial production of lentiviral particles were made using the pCMV-VSV-G 
and psPAX2 plasmids that were generously provided by Paul Bates at the 
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University of Pennsylvania. HEK293T cells were plated at 2.0 × 106 cells in a 10 
cm-dish in 10 mL of DMEM supplemented with 10% (vol/vol) heat-inactivated FBS, 
2 mM L-glutamine, 100 IU/mL penicillin, 100 µg/mL streptomycin. 24 hours after 
plating HEK293T cells, the plasmids were transfected using the Lipofectamine 
2000 protocol. A DNA master mix of the plasmids contained 1 µg of pCMV-VSV-
G, 2.5 µg of psPAX2, and 5 µg of pLentiCRISPR v2 with the specific gRNA. 50 µL 
of Lipofectamine 2000 transfection reagent was used per 10 cm-dish. Transfected 
HEK293T cells were incubated at 37°C for 18 hours, followed by careful removal 
of the media and replacement with 6 mL of fresh HEK293T cell growth media per 
dish. 24 hours later, the supernatant containing the lentiviral particles was 
harvested and filtered using a 0.22 µM filter. 5 × 105 THP-1 cells were infected with 
1 mL of lentiviral particles treated with 8 µg/mL of polybrene and plated in a TC-
treated 12-well plate. Infected THP-1 cells were then centrifuged at 1250 × g for 
90 min at 25°C. Cells were then carefully pipetted out of the wells and added to a 
conical tube respective for each gRNA condition. Cells were centrifuged at 805 × 
g for 3 min at 25°C. Media was aspirated and cells were resuspended in fresh 
THP-1 growth media and 2 mL of resuspended cells were added per well of a 12-
well plate. Cells were incubated at 37°C for 48 hours. After 48 hours, puromycin 
was added at a final concentration of 1 µg/mL. Cells were maintained in puromycin 
for 2-3 weeks and then harvested for western blot analysis and clonal selection. 
For clonal selection, cells were plated at a concentration of 0.5 cell per 200 µL of 
THP-1 growth media in flat-bottom 96-well plates and incubated at 37°C for 4-6 
weeks until single clones were noticeable at the bottom of the well. 12 single cell 
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clones for each gene were expanded from the 96-well plate to a 48-well plate, 24-
well plate, 12-well plate, 6-well plate, and finally 10 cm-dish. The cells from each 
single cell clone were plated in a 48-well plate at a concentration of 2 × 105 cells 
per well in 500 µL of media treated with PMA for differentiation into macrophages, 
the next day either stimulated with IFN-g overnight or left unstimulated, and 
harvested for DNA, RNA, and western blot analyses.  
 
3.7.11. Validation of CRISPR/Cas9 Knockout THP-1 Single Cell Clones for 
CASP5 and GBP1 
After choosing three single cell clones for CASP5 or GBP1 based on RNA 
knocked down and protein knocked out, DNA from the selected single cell clones 
was purified using the DNeasy Blood and Tissue Kit (Qiagen). The genomic region 
comprising the gRNA target sequence for each gene was amplified by PCR using 
the following primers (all 5’ à 3’):  
CASP5 forward: GGTTAGGGAAGGTGGCAGC  
CASP5 reverse: GGGGCTACATCCCAATCACC  
GBP1 forward: GGTGAGGAGGCTGTCAGTTTC  
GBP1 reverse: ACTCTCTTTGATGAGCACCTAGGAC  
  The PCR product was purified using the QIAquick PCR purification Kit 
(Qiagen). The purified PCR product was then ligated into the pGEM-T vector 
(Promega) and transformed into DH5a high efficiency competent cells using the 
protocol from the pGEM-T Vector Systems Protocol. Following blue-white 
screening, colony PCR was conducted on 10-15 white colonies using the primer 
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sequences shown above and PCR product was run on an agarose gel. Positive 
colonies showing the correct bp amount were sequenced using the M13/pUC 
primer: 5’ CCCAGTCACGACGTTGTAAAACG 3’. 
 
3.7.12. Statistical Analysis 
GraphPad Prism software was used for graphing of data and all statistical 
analyses. Statistical significance for experiments with THP-1 cells was determined 
using the unpaired two-way Student’s t test. Statistical significance for hMDMs was 
determined using the paired two-way t test in experiments comparing multiple 
donors. In hMDM experiments that compare cells from multiple donors, data are 
graphed so that each data point represents the mean of duplicate wells for each 
donor, and all statistical analysis was conducted comparing the means of each 














A. Data Summary  
The innate immune response to bacterial pathogens is crucial for pathogen 
clearance and host survival. Specifically, the inflammasome, which is a cytosolic 
multimeric protein complex activated in response to bacterial components or 
danger signals, is important for initiating an inflammatory form of cell death known 
as pyroptosis and IL-1 family cytokine release to signal to additional immune cells 
for their recruitment and/or activation. IL-1 family cytokines can act in an autocrine 
or paracrine manner to upregulate a family of cytokines termed interferons (IFNs).    
For instance, IL-18 is a cytokine produced and released by infected cells that can 
then stimulate other immune cells, such as NK or T cells, to produce the cytokine 
IFN-g. IFN-g has been shown to promote inflammasome responses to a variety of 
gram-negative bacterial pathogens as well as to bacterial components. 
Specifically, a family of IFN-induced GTPases known as guanylate binding 
proteins (GBPs) are the key factors responsible for promoting inflammasome 
responses through a number of functions, including the rupture of pathogen-
containing vacuoles or bacteriolysis of bacterial outer membranes. Although most 
studies focused on the role of GBPs during inflammasome activation have been 
conducted using murine models, recent findings using human cells have identified 
key human GBPs for promoting inflammasome responses to certain bacteria. 
However, the role of human GBPs in inflammasome responses during infection 
with the vacuolar bacterium Legionella pneumophila has not been investigated.  
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Additionally, the noncanonical inflammasome, which is activated by 
intracellular LPS from gram-negative bacteria, is comprised of caspase-11 in mice 
and the two orthologs, caspase-4 and caspase-5, in humans. LPS can vary in its 
acylation and phosphorylation state depending on the bacterial species and 
environmental conditions. Recent findings revealed key differences between 
murine caspase-11 and human caspase-4 activation. Specifically, tetra-acylated 
LPS was found to evade caspase-11 detection, while it activates caspase-4 in 
human macrophages. Moreover, the role of caspase-5 in response to intracellular 
LPS is unclear and whether IFN or human GBPs promote inflammasome 
responses to LPS from L. pneumophila has not been studied.  
Mice and humans possess differences in their innate immune genes and 
these differences may play a role in how they respond to invading pathogens. 
Therefore, it is essential to gain a better understanding of human inflammasome 
responses to the vacuolar intracellular bacterial pathogen, L. pneumophila, and its 
corresponding LPS and whether IFN or human GBPs play a role in these 
responses. 
In Chapter 2, we determined that IFN-g promotes caspase-1, caspase-4, 
and caspase-5 inflammasome responses to L. pneumophila in human 
macrophages. By utilizing siRNA-mediated knockdown of the individual human 
GBPs, we found that human GBP1 is essential for this maximal inflammasome 
response. Furthermore, we revealed that IFN-g treatment leads to the rupture of L. 
pneumophila-containing vacuoles (LCVs) and that GBP1 contributes to this 
rupture. In contrast to the murine model which shows that GBPs do not rupture the 
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LCV but instead rupture the outer membrane of L. pneumophila, our findings 
indicate that human GBP1 does rupture the LCV. It remains to be determined 
whether additional human GBPs, along with human GBP1, help promote the 
rupture of the LCV or whether human GBPs also induce bacteriolysis of the outer 
membrane of L. pneumophila.  
In Chapter 3, we found that the human noncanonical inflammasome is 
activated by a variety of differential acylated and phosphorylated LPS variants 
isolated from Y. pestis in primary human macrophages, and that IFN-g promotes 
this response to both tetra-acylated and hexa-acylated Y. pestis LPS. We also 
utilized CRISPR/Cas9 gene editing technology to knockout caspase-4, caspase-
5, GBP1, and GBP2 in the THP-1 monocytic cell line. We used these generated 
knockout cell lines to elucidate the role of these genes in response to LPS derived 
from L. pneumophila and E. coli. We found that caspase-4 is essential for 
promoting noncanonical inflammasome responses to E. coli LPS, while caspase-
5 may not play a role in detecting intracellular E. coli or L. pneumophila LPS. 
Furthermore, we found that human GBP1 may play a role in promoting cell death 
to L. pneumophila LPS and E. coli LPS, while human GBP2 may not. While these 
experiments need to be repeated to confirm these findings, they suggest that 
caspase-4 and caspase-5 have distinct roles in response to different LPS variants, 
and that human GBP2 does not promote inflammasome responses to L. 
pneumophila LPS but may promote cell death during L. pneumophila infection.  
 Overall, our studies bring insight into human inflammasome responses to 
the vacuolar pathogen, L. pneumophila, as well as to LPS variants from different 
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bacteria. Moreover, our studies reveal key findings on how IFN-g and, more 
specifically, IFN-inducible GBPs contribute to the activation of the human 
inflammasome. However, there are additional questions pertaining human GBPs 
and the human noncanonical inflammasome that are still left unanswered. In this 
chapter, I will discuss these questions and propose future experiments in order to 
gain a better understanding of human inflammasome responses to gram-negative 
bacterial pathogens (Fig. 4.1 and 4.2). 
 
B. Future Directions  
Figure 4.1. Model and future directions for human inflammasome responses 
to L. pneumophila. Our data reveal that human GBP1 is important for maximal 
inflammasome responses during L. pneumophila infection and indicate that human 
GBP1 mediates the rupture of the LCV. Whether and how additional human GBPs 
or host factors are involved in inflammasome responses to L. pneumophila are 
unknown. Future directions for these studies are discussed in this chapter. 
 
Does human GBP1 have a synergistic role with additional human GBPs to 
promote inflammasome responses to L. pneumophila? 
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We find that upon individual knockdown of human GBP1-5 using siRNA, 
only knockdown of GBP1 resulted in significantly decreased cell death and IL-1 
family cytokine release, indicating that human GBP1 is important for maximal 
inflammasome response to L. pneumophila. One possible reason as to why only 
GBP1 was shown to be essential for inflammasome response compared to the 
remaining GBPs tested is that human GBP1 may be the initiator GBP that 
responds during L. pneumophila infection and additional GBPs follow suit. This 
assumption is based on human GBP findings during Shigella flexneri infection. 
Specifically, it was revealed that human GBP1 is recruited to the outer membrane 
of S. flexneri, followed by human GBP2, 3, 4, and 6 to inhibit the actin motility of 
S. flexneri (Piro et al., 2017; Wandel et al., 2017). In addition to S. flexneri, human 
GBP1 initiates the assembly of a GBP complex, including GBP1-4, on the surface 
of S. Typhimurium outer membrane in order to recruit caspase-4 for inflammasome 
activation (Santos et al., 2020; Wandel et al., 2020). Therefore, human GBP1 may 
also initiate binding to the LCV as well as the outer membrane of L. pneumophila 
in order to recruit additional GBPs for their disruption of the LCV and outer 
membrane to release L. pneumophila components into the cytosol for downstream 
inflammasome sensing. In fact, we found that GBP2, in addition to GBP1, is also 
recruited to L. pneumophila. However, we did not test whether GBP1 knockdown 
resulted in decreased GBP2 binding.  
Since GBPs can homo- or hetero-dimerize (Britzen-Laurent et al., 2010), 
we want to investigate whether knockdown of other human GBPs, in addition to 
human GBP1, leads to a further decrease in inflammasome response during L. 
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pneumophila infection compared to knockdown of human GBP1 alone. This 
experiment can be accomplished by conducting double knockdowns of human 
GBP1 with either human GBP2, 3, 4, or 5, followed by IFN-g priming and L. 
pneumophila infection. In addition, we can conduct siRNA-mediated knockdown of 
human GBP2, 3, 4, or 5 in the GBP1-/- THP-1 clones. These experiments will 
determine whether human GBPs play a synergistic role with human GBP1 to 
stimulate inflammasome responses during L. pneumophila infection.  
 
Does human GBP1 directly interact with and rupture the LCV?  
Our study in Chapter 2 indicates that human GBP1 ruptures the LCV of L. 
pneumophila, however the precise mechanism of vacuolar rupture as well as the 
vacuolar components that GBP1 may be binding to are unknown. Experiments to 
address these questions are technically challenging because L. pneumophila 
derives its vacuole from the ER and, thus, isolation of the LCV following infection 
with L. pneumophila in human macrophages may include ER components as well 
as the LCV. However, purification of LCVs from amoebae and phagocytes has 
been conducted (Hoffmann, Finsel, & Hilbi, 2012). Therefore, we can purify the 
LCV from L. pneumophila infected human macrophages using this specific 
optimized protocol followed by proteomic approaches to identify any interacting 
proteins. An additional step that would be needed to specifically determine what 
vacuolar components are interacting with human GBP1, would be to conduct a 
pull-down of GBP1 following the LCV purification and then use mass spectrometry 
to identify the interacting protein partners of GBP1. Furthermore, super-resolution 
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microscopy may also be used to stain for any identified interacting LCV proteins 
with GBP1 to visualize these interactions. Although technically challenging, if these 
proposed methods are successful, then this study would reveal novel human 
GBP1 interactions with bacterial vacuolar components. 
In Chapter 2, the phagosome integrity assay we conducted in control 
siRNA-treated and GBP1 siRNA-treated primary human macrophages suggests 
that GBP1 is essential for LCV rupture, since we saw decreased anti-L. 
pneumophila antibody staining in macrophages with GBP1 knocked down. 
However, these results may also indicate that GBP1 simply promotes anti-L. 
pneumophila antibody binding to the bacterial surface. Thus, additional 
experiments are needed to address whether GBP1 actually promotes rupture of 
the LCV. An alternative experiment to assess the vacuolar integrity of the LCV 
would be to stain for galectin proteins. Galectins are a family of b-galactoside-
binding proteins that target the inner leaflet of ruptured vacuoles and are therefore 
characterized as being markers for vacuolar rupture (E. M. Feeley et al., 2017). To 
determine if human GBP1 induces rupture of the LCV, we can stain for galectin-3 
or galectin-8 in IFN-g-primed primary human macrophages that are treated with 
control siRNA or GBP1 siRNA and infected with dsRED-expressing L. 
pneumophila. If we observe a decreased presence of galectin staining with L. 
pneumophila upon GBP1 knockdown, then these results indicate that there are 
fewer disrupted vacuoles in the absence of GBP1 and would reveal that human 
GBP1 contributes to the rupture of the LCV. Additionally, another approach of 
quantifying the amount of cytosolic L. pneumophila or L. pneumophila with 
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ruptured vacuoles would be to conduct a flow cytometry-based assay in digitonin 
and saponin permeabilized primary human macrophages in the presence and 
absence of GBP1. These results would reveal whether or not human GBP1 
contributes to the presence of cytosolic L. pneumophila, as we see using 
microscopy. Flow-cytometry can also be used to stain galectin as previously 
mentioned and can therefore serve as a confirmatory assay for our microscopy-
based experiments. These proposed experiments may provide insight on whether 
human GBP1 contributes to the vacuolar rupture of L. pneumophila or just allows 
the anti-L. pneumophila antibody to target the bacteria more efficiently. 
 
Does human GBP1, as well as other human GBPs, disrupt the outer 
membrane of L. pneumophila?  
 Mouse GBPs on chromosome 3 do not rupture the LCV, but they induce 
bacteriolysis on the outer membrane of L. pneumophila (B. C. Liu et al., 2018). In 
contrast, our study in Chapter 2 indicates that human GBP1 ruptures the LCV, 
although it is possible that GBP1 can disrupt the outer membrane as well. Recent 
studies focused on human GBPs revealed that human GBP1-4 bind to the outer 
membrane of cytosol exposed S. Typhimurium and potentially result in the loss of 
membrane integrity, thus making LPS more accessible for caspase-4 detection 
(Santos et al., 2020; Wandel et al., 2020). Therefore, in order to determine whether 
human GBP1 facilitates the disruption of the L. pneumophila outer membrane, we 
need to utilize the cytosol-exposed L. pneumophila DsdhA mutant, which is not 
able to maintain the vacuole integrity of the LCV. We can conduct a bacterial 
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morphology assay coupled with super-resolution microscopy as a way to 
qualitatively determine whether the L. pneumophila DsdhA mutant either sustains 
its rod-shape, indicating that its outer membrane is intact, or assumes a swollen 
and truncated morphology, signifying that its outer membrane was disrupted. This 
assay would be conducted in IFN-g-primed WT and GBP1-/- THP-1-derived 
macrophages infected with a dsRED-expressing L. pneumophila DsdhA mutant. 
Thus, if human GBP1 facilitates the disruption of the L. pneumophila outer 
membrane, WT macrophages would show a perturbed L. pneumophila shape, 
while GBP1-/- THP-1-derived macrophages would reveal an undamaged L. 
pneumophila. Furthermore, we can also test whether additional human GBPs 
disrupt the L. pneumophila outer membrane by applying RNAi-mediated 
knockdown of an individual GBP compared to control-knockdown in either primary 
human macrophages or in THP-1-derived macrophages, followed by IFN-g 
treatment and infection with the dsRED-expressing L. pneumophila DsdhA mutant.  
Another method to determine whether the L. pneumophila outer membrane 
is disrupted is by measuring the amount of L. pneumophila DNA released into the 
cytosol comparing WT macrophages or macrophages with individual human GBPs 
knocked down. This experiment requires a L. pneumophila DsdhA mutant that 
harbors a non-transferable pJB908 plasmid that is only released into the cytosol if 
the outer membrane is disturbed (B. C. Liu et al., 2018). Altogether, this proposed 
experiment along with the bacterial morphology assay will reveal whether human 
GBPs promote bacteriolysis of L. pneumophila, ultimately leading to its increased 
access in the host cytosol for inflammasome sensing.  
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Are additional host factors involved in promoting inflammasome responses 
during L. pneumophila infection? 
In addition to GBPs, another IFN-inducible family of GTPases was 
discovered to promote inflammasome responses to bacterial pathogens in mice—
the immunity related GTPases (IRGs). Specifically, IRGB10 is recruited to F. 
novicida in a GBP-dependent manner and is essential for mediating bacterial killing 
for downstream AIM2 inflammasome activation in mice (Man et al., 2016). In 
contrast to mice, which have 23 IRG proteins, humans only possess two IRG 
proteins, IRGM and IRGC, both of which are not interferon inducible due to the 
loss of the interferon response element ahead of their transcription start site 
(Bekpen et al., 2005). Additionally, there is no human ortholog of mouse IRGB10 
and the only function that human IRGM has been shown to have during bacterial 
infections is to limit M. tuberculosis infection through an autophagy-mediated 
pathway (Singh et al., 2006). It is unknown whether human IRG proteins are 
involved in inflammasome responses during bacterial infections. We have 
previously conducted knockdown experiments of IRGM and IRGC in primary 
human macrophages, followed by infection with L. pneumophila, and found that 
the relative expression levels of these genes are very low and their knockdown 
does not lead to decreased inflammasome response. Therefore, IRGM and IRGC 
may not play a role in inflammasome responses during L. pneumophila infection 
in human macrophages.   
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There are most likely additional undiscovered host factors that are important 
in promoting inflammasome responses to L. pneumophila in human macrophages. 
A genome-wide RNAi screen followed by L. pneumophila infection and analysis of 
cell death and IL-18 or IL-1b release is one way to discover novel host genes that 
are important for contributing to the inflammasome response. An alternative 
method would be to conduct a pull-down followed by mass spectrometry. In 
Chapter 2, we show that L. pneumophila activates both canonical and 
noncanonical inflammasomes and that human GBP1 plays a large role in these 
inflammasome responses. To identify additional host factors that may play a role 
with human GBP1, we can conduct a pull-down assay of GST-tagged GBP1 using 
glutathione agarose beads. This experiment would involve initial transfection of 
GST-tagged recombinant GBP1 into human macrophages, then infection with L. 
pneumophila. The cell lysate from these infected macrophages would be incubated 
with glutathione agarose beads and, after washing steps, would elute the GST-
tagged GBP1. Any bound proteins to human GBP1 can be analyzed by mass 
spectrometry to identify these unknown interactors. Therefore, this experiment 
may bring insight into host proteins that interact with human GBP1 to help facilitate 







Figure 4.2. Future directions for human inflammasome responses to LPS 
variants. Our data suggest that the human noncanonical inflammasome is 
activated by different LPS variants and that IFN-g-promotes these responses. 
However, the specific roles that caspase-4 and caspase-5 have in response to 
different LPS variants are unclear and whether human GBP1 is directly involved in 
recognizing L. pneumophila LPS is unknown. Future directions for these studies 
are discussed in this chapter.  
 
Do caspase-4 and caspase-5 have a synergistic function or play distinct 
roles in response to intracellular LPS from different gram-negative bacteria? 
It is intriguing that humans possess two inflammatory intracellular caspases 
that bind to LPS, whereas mice only have one caspase that recognizes LPS. 
Human caspase-4 and caspase-5 are thought to have resulted from a gene 
duplication event from the ancestral gene, caspase-11. It is also known that 
humans are more sensitive to LPS compared to mice. Since human caspase-4 
was found be activated in response to tetra-acylated LPS, which is known to evade 
murine caspase-11 detection in addition to other under-acylated LPS,  it is possible 
that humans need two LPS-sensing caspases in order to identify diverse LPS from 
different gram-negative bacteria to initiate inflammatory responses to eliminate the 
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these invading pathogens. Thus, it would be of interest to determine whether 
caspase-4 and caspase-5 work together to respond to different gram-negative 
bacterial infections, either through synergistic functions or distinct roles. Using 
CASP4-/- and CASP5-/- THP-1 cells, we observed in Chapter 3 that caspase-4 is 
important for mounting an inflammasome response to E. coli LPS as well as 
possibly to L. pneumophila LPS, while caspase-5 did not seem to play a strong 
role in response to either LPS. This indicates that caspase-4 and caspase-5 may 
respond to LPS variants from different bacteria. Moreover, we can use these 
CASP4-/- and CASP5-/- THP-1 cells to test the roles of caspase-4 and caspase-5 
to other LPS variants, including the seven differential acylated and phosphorylated 
LOS variants derived from Y. pestis that we determined all activate the human 
noncanonical inflammasome. This investigation will be a starting point to determine 
whether caspase-4 and caspase-5 identify and respond to distinct LPS variants.  
However, it may be also possible that caspase-4 and caspase-5 are 
activated by the same LPS variants from specific gram-negative bacteria. 
Therefore, comparing the single knockout clones of CASP4-/- and CASP5-/- THP-1 
cells to double CASP4/5-/- THP-1 cells will be necessary to determine whether 
caspase-4 and caspase-5 stimulate a synergistic response to LPS. If the CASP4/5-
/- THP-1 cells show a decreased inflammasome response compared to the CASP4-
/- and CASP5-/- THP-1 cells, then capase-4 and caspase-5 carry out a synergistic 
role. Following LPS binding on the CARD domains of caspase-4 and caspase-5, 
these caspases oligomerize before activation (Shi et al., 2014). In addition, the 
caspase-4 and caspase-5 CARD domains share 56% protein identity, suggesting 
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that they are capable of interacting with each other through their CARD domains. 
Therefore, it may be possible that caspase-4 and caspase-5 hetero-oligomerize to 
generate a stronger inflammasome response. To test whether caspase-4 and 
caspase-5 form a hetero-dimer, we can conduct a bimolecular fluorescence 
complementation (BiFC) assay to visualize the interactions of caspase-4 and 
caspase-5. First, we will fuse the N- and C-terminal non-fluorescent fragments of 
Venus fluorescent protein, a variant of yellow fluorescent protein (YFP), to the 
amino-terminus of caspase-4 and caspase-5, respectively. Then, we will clone 
these fused proteins into a mammalian expression vector, followed by transfection 
of these caspase-4 and caspase-5 vectors into HEK293T cells, which do not 
possess inflammasome components, and subsequent transfection of LPS. If 
caspase-4 and caspase-5 hetero-dimerize, then the N- and C-terminal non-
fluorescent fragments would come together to produce a fluorescent signal, which 
we would visualize by microscopy. This study would provide molecular insight into 
caspase-4 and caspase-5 interactions that may contribute to noncanonical 
inflammasome activation. 
 
Do caspase-4 and caspase-5 engage in different pathways of activation 
depending on the mode of entry of LPS?  
Caspase-4 and caspase-5 were previously shown to have different 
mechanisms of activation in response to E. coli LPS. Specifically, caspase-4 was 
found to be cleaved and activated in response to transfected LPS, whereas 
caspase-5 is cleaved in response to extracellular LPS treatment in primary human 
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macrophages (Casson et al., 2015). These results suggest that caspase-4 and 
caspase-5 may engage in distinct pathways of activation based on the mode of 
entry of LPS. Additional experiments in monocytes revealed that caspase-5 is 
activated upon extracellular treatment with E. coli LPS or P. aeruginosa OMVs, 
both of which enter the monocytes via endocytosis (Bitto et al., 2018; Vigano et 
al., 2015). These combined findings indicate that caspase-5 activation may involve 
an alternative extracellular pathway through endocytosis. TLR4 is present on the 
plasma membrane and is known as the extracellular LPS sensor that is 
endocytosed upon LPS detection. Whether TLR4 and its cofactors are involved in 
caspase-5 activation through this extracellular LPS sensing mechanism has not 
been studied. Since we have only looked at the role of caspase-4 and caspase-5 
in THP-1-derived macrophages that are transfected with LPS derived from L. 
pneumophila or E. coli, we additionally want to investigate the role of caspase-4 
and caspase-5 in human macrophages that are extracellularly treated with these 
LPS variants. Thus, we would conduct an experiment in which either WT, CASP4-
/-, and CASP5-/- THP-1-derived macrophages are either extracellularly treated or 
transfected with LPS from L. pneumophila or E. coli in order to distinguish the 
conditions in which caspase-4 and caspase-5 are activated. Additionally, to 
determine whether TLR4 is involved in the activation of caspase-4 or caspase-5 
during treatment or transfection with these LPS variants, we can treat the three 
different THP-1 cells with the TLR4 pharmacological inhibitor, TAK-242, before 
introduction of LPS. These findings would bring insight into the mechanism of 
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human noncanonical inflammasome activation by extracellular LPS or intracellular 
LPS and how TLR4 may be involved. 
 
Does human GBP1 directly bind to L. pneumophila LPS? 
Human GBPs localize to the outer membrane of different gram-negative 
bacteria including S. flexneri, S. Typhimurium, and F. novicida (Kutsch et al., 2020; 
Lagrange et al., 2018; Piro et al., 2017; Santos et al., 2020; Wandel et al., 2020; 
Wandel et al., 2017). Human GBP1 was found to target the S. flexneri rough 
mutant, which lacks the O-antigen on its LPS, less efficiently compared to S. 
flexneri that possesses its O-antigen (Piro et al., 2017). More specifically, the O-
antigen is important for allowing the transition of surface-docked GBP1 polymers 
into GBP1 protein sheets that coat the entire surface of S. flexneri outer membrane 
(Kutsch et al., 2020). These results combined with recent findings that human 
GBP1 directly binds to LPS from E. coli and S. Typhimurium indicate that human 
GBP1 initially binds to LPS on the outer membrane of these bacteria followed by 
recruitment of addition GBPs to control host response against these pathogens 
(Santos et al., 2020). However, whether human GBP1 or other GBPs can bind to 
L. pneumophila LPS has not been investigated. Our results in Chapter 3 showed 
that human GBP1 may be promoting cell death in response to L. pneumophila 
LPS, therefore, GBP1 may be directly binding to LPS in this setting. A pull-down 
assay would be one way to determine whether this human GBP1-L. pneumophila 
LPS interaction is occurring. To test this, we would transfect biotinylated L. 
pneumophila LPS in human macrophages, followed by a pull-down using 
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streptavidin magnetic beads, washes, and immunoblot for human GBP1. These 
results may bring a better understanding of human GBP1 interactions and may 
reveal that human GBP1 also binds to the outer membrane in addition to the LCV. 
 
Concluding Remarks  
Our results bring insight into human inflammasome responses to L. 
pneumophila and LPS variants from different bacteria. We found that human GBP1 
is important for promoting inflammasome responses and vacuolar disruption 
during L. pneumophila infection, which is in contrast to mouse GBPs that rupture 
the outer membrane of L. pneumophila. Additional experiments must be conducted 
to understand the mechanism of GBP1 rupture of the LCV and whether human 
GBPs contribute to bacteriolysis as well. We also show that the human 
noncanonical inflammasome is activated by LPS variants that differ in their 
acylation and phosphorylation state and that caspase-4 plays a significant role in 
response transfected LPS. Future studies must be conducted to establish the role 
of caspase-5 and human GBPs in response to LPS.  
Overall, these studies provide insight into the role that IFN-g plays during 
infection with gram-negative bacteria in human macrophages. There are currently 
no approved treatments for sepsis in humans and studies in mice do not always 
correlate to what happens in humans. Therefore, it is important to understand 
human innate immune responses involved in combatting bacterial infections, 
which, if left unregulated, can ultimately lead to septic shock and death. These 
studies investigate host-pathogen interactions in human macrophages, which are 
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one of the first responders to invading pathogens, and reveal potential therapeutic 
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